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Abstract 
The analysis of several derivatives of the human cell lines HeLa and VA2-B, 
selected for resistance to methotrexate (MTX), shows a striking variability in the 
dihydrofolate reductase (DHFR) enzyme levels, chromosome constitution and growth 
characteristics in the absence of MTX. In contrast to the mouse system, the number of 
double minutes of the human cells does not correlate with either the increased DHFR 
levels or the instability of the amplified phenotype. 
The isolation of human DHFR eDNA by differential hybridization or by phenotypic 
expression in E. coli, facilitates the characterization of the human DHFR coding region 
and its multiple mRNAs. Comparison of the DNA sequences of several DHFR cDNAs 
shows a high degree of homology between the coding regions of the human and mouse 
genes (89%) with no obvious identity in the 3'-untranslated region. The analysis also 
demonstrates that cDNAs of the 3 identified mRNAs are colinear in the 3'-end sequence, 
and that polyadenylation occurs at different sites. 
Hybridization of EcoRI digested nuclear DNA from the MTX-resistant 6A3 cells 
with DHFR cDNAs shows EcoRI fragments that are either unamplified or amplified 
relative to the same fragments of human sperm, HeLa cell, and VA2-B cell DNA. Two of 
the unamplified fragments were isolated from a cosmid library made from human sperm 
DNA. The DNA sequence analysis shows that these two fragments contain a DHFR 
intronless pseudogene including the EcoRI site found in the DHFR cDNAs. If an RNA 
intermediate directs the formation of this pseudogene, an RNA larger than the 1.0 kb 
DHFR mRNA must be involved. In contrast to the unamplified DNA fragments, the 
amplified fragments contain the exons of the human DHFR gene. The gene is about 
29 kb in length, with five introns interrupting the DHFR coding region in the same 
positions found in the mouse gene. The DHFR mRNAs were mapped as a major 5'-end at 
position -71 of the human DHFR gene. In addition, six minor 5'-ends of DHFR-specific 
polysomal RNA were mapped from positions -449 to -480 and represent about 1% of the 
major transcripts. The upstream transcripts are relatively enriched in the nuclear RNA 
fraction, indicating a different regulation of expression for these minor transcripts. 
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Dihydrofolic acid reductase (DHFR, EC 1.5.1.3) 1s the enzyme responsible for 
reducing folic acid to tetrahydrofolic acid in an NADPH dependent reaction. 
Tetrahydrofolic acid then undergoes various modifications to act as a single-carbon donor 
in the cell and is particularly important in the de novo synthesis of purines, thymidylate 
and some amino acids. The enzyme can be inhibited by 4-amino analogs of folic acid, 
such as amethopterine (methotrexate, MTX) or aminopterine, due to their high affinity 
binding to the enzyme. This property makes the analogs suitable as chemotherapeutic 
drugs in the treatment of malignant tumors (Jolivet et al., 1983). However, continued 
treatment with MTX can result in the tumors becoming resistant to the drug (Bertino 
et al., 1963). These observations of DHFR led to many studies of drug resistance in 
mammalian cells. Below is a brief summary of the available data about drug resistance, 
gene amplification and DHFR gene expression, followed by a summary of the results of 
this thesis for the human DHFR gene. 
Drug Resistance 
Cells cultured in vitro can become resistant to folate analogs. In particular, 
several mammalian cell lines have been selected for resistance to MTX (see Schimke, 
1982). Three mechanisms have been identified for this resistance: (i) reduced 
permeability of the drug (Fisher, 1962; Sirotnak et al., 1968; Flintoff et al., 1976); (ii) an 
alteration in the DHFR enzyme resulting in a decreased affinity for MTX (Abrect et al., 
1972; Flintoff et al., 1976; Flintoff and Essani, 1980; Haber et al., 1981); and (iii) 
increased DHFR enzyme levels (Fisher, 1961; Hakala et al., 1961; Biedler et al., 1972; 
Alt et al., 1976; Flintoff et al., 1976; Melera et al., 1980). Little is known about the first 
mechanism for MTX resistance, other than that it may represent a locus concerned with 
the active transport of MTX and that it is inducible by mutagens (Flintoff et al., 1976). 
In regard to the second mechanism, a recent report characterizes an altered DHFR 
enzyme with a MTX-binding affinity of l/270th of the wild type enzyme (Haber et al., 
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1981 ). A DNA sequence analysis of a DHFR eDNA for the altered enzyme shows that it 
differs from the wild type enzyme at a single nucleotide of the coding region; a Leu 
codon (amino acid number 22) in the wild type enzyme is changed to an Arg codon in the 
mutant enzyme (Simonsen and Levinson, 1983). In this case, a hydrophobic residue is 
replaced by a basic residue in a position implicated as part of the MTX binding site 
(Matthews et al., 1978; Volz et al., 1982). The third mechanism, increased DHFR enzyme 
levels, has been shown to result from an amplification of the DHFR gene (Alt et al., 
1978; Nunberg et al., 1978; Dolnick et al., 1979; Melera et al., 1980). 
Gene Amplification 
Gene amplification in vivo has been shown to be developmentally regulated for 
Xenopus rONA (Brown and Dawid, 1968) and Drosophila chorion genes (Spradling, 1981 ). 
A recent report conclusively demonstrates that DHFR gene amplification is responsible 
for a MTX-resistant tumor in a patient undergoing chemotherapy (Curt et al., 1983). For 
mammalian cells grown in vitro, gene amplification appears to be a general mechanism 
of resistance to toxic substances. It has been documented for various genes including 
metallothionein (Beach and Palmiter, 1981), the multifunctional CAD protein (an 
abbreviation for an enzyme containing the enzymatic activities of carbamylphosphate 
synthetase, aspartate transcarbamylase and dihydrooratase; Wahl et al., 1979), 
asparagine synthetase (Andrulis and Siminovitch, 1982), thymidylate synthetase (Rossana 
et al., 1982), 3-hydroxy-3-methylglutaryl coenzyme A reductase (Luskey et al., 1983) and 
UMP synthase (Kanalas and Suttle, 1984). 
Mutations resulting in lower amounts of gene products or in products of reduced 
specific activities can be corrected by amplifying the mutant genes; this is a form of 
phenotypic reversion. Phenotypic reversion of the Drosophila ''bobbed" mutant occurs by 
gene amplification of rRNA genes (see Tartof, 1975). Gene amplification-directed 
phenotypic reversion of altered gene products in mammalian cell cultures has been shown 
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for vanous genes. These genes include DHFR (Haber et al., 1981), HGPR T 
(hypoxanthine-guanine phosphoribosyltransferase; Brennand et al., 1982; Fuscoe et al., 
1983) and a defective herpes simplex virus thymidine kinase (TK) gene transfected into a 
TK-deficient mouse cell line (Roberts and Axel, 1982). 
A particularly interesting example of gene amplification comes from analysis of 
the phenomenon of multiple drug resistance in mammalian cells (Ling, 1982), where 
resistance to a particular drug confers resistance to other drugs of different chemical 
composition. This resistance is due to a change in the cell membrane which decreases 
the permeability to the drug. This membrane change is associated with an increase in 
the amount of a plasma membrane glycoprotein, which has recently been shown to be 
associated with a gene amplification event (Roninson et al., 1984). Therefore, drug 
resistance due to membrane permeability changes (the first mechanism discussed above), 
could involve gene amplification. 
A variety of methods have been used to measure the rates of mutation generating 
drug-resistant phenotypes. Luria-Delbruck fluctuation analysis (Luria and Delbruck, 
1943) of resistance to MTX in mouse cell cultures (Terzi and Hawkins, 1974) gave a 
mutation rate of 4xl0-5 mutation events/cell division. This rate is similar to those 
estimated for N-(phosphonoacetyl}-L-aspartate resistance (PALA resistance) in CAD 
gene amplification in hamster cultured cells (2-5x10- 5; Kempe et al., 1976) and 
phenotypic reversion of a TK-deficient, transformed mouse cell line (2xl0-5; Roberts and 
Axel, 1982). In the case of the latter two rates, the majority of events were gene 
amplification, indicating that these estimates approximate the rates of gene 
amplification events/cell division. However, a determination of the DHFR gene 
amplification rate utilizing a fluorescence-activated cell sorter for selection (Johnston 
et al., 1983), gave a rate of 1xl0-3 amplification events/cell division. This higher rate 
can be explained by the cell sorter selection technique used, which presumably places 
less hardship on the cells than selection with MTX. If gene amplification is a random 
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event such that any gene would have a similar amplification rate, probably more than one 
gene could be amplified in a given event, depending on the size of the amplified unit. 
The amplification unit of PALA-resistant hamster cells is estimated to be 500-1000 kb 
and other genes besides the CAD gene have also been localized to this amplification unit 
(Brinson et al., 1982; Padgett et al., 1982; Wahl et al., 1984). Coamplification of other 
genes has not been described in the DHFR system. The DHFR amplification unit has 
been reported to be very long in mouse cells, in the order of 500-1000 kb (Nunberg et al., 
1978; Kaufman et al., 1979) or even as high as 3000 kb (Bostock and Clark, 1980). The 
size of this unit is much greater than the 30 kb DHFR gene (Crouse et al., 1982), leaving 
open the question of whether other genes could be coamplified with DHFR. 
Amplified genes have either been found to be organized as extrachromosomal 
elements termed "double minutes" or the genes have been chromosomally localized as 
''homogeneously staining regions" (HSRs) in mammalian cells (reviewed in Cowell, 1982). 
Double minutes are small, acentromeric elements rarely found in parental cell lines. On 
the other hand, HSRs represent expanded regions of chromosomes which were found to 
stain homogeneously in G-banding preparations of chromosomes from amplified cells. 
The term HSR is also applied for expanded nonstaining regions or expanded banding 
regions of chromosomes. 
Amplified DHFR genes were first localized to double minutes (Kaufman et al., 
1979) and HSRs (Nunberg et al., 1978; Dolnick et al., 1979) by in situ hybridization with a 
mouse DHFR eDNA. A general model concerning the stability of the MIX-resistant 
phenotype in the absence of selection is that the resistance is stable if the amplified 
genes are localized to HSRs and unstable if the genes are localized on double minutes 
(Schimke et al., 1980). Since double minutes lack centromeres, they segregate randomly 
in cell division. This random segregation, combined with the selective advantage of cells 
with lower numbers of double minutes having shorter cell-cycle times, results in the loss 
of double minutes from the cell population. Instability of the resistant phenotype has 
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been shown to correlate with a decrease in size of an HSR (Biedler et al., 1980), possibly 
the result of unequal crossing over events between sister chromatids. These results, 
together with the results presented in Chapter 2, indicate that stable and unstable are 
relative terms rather than absolute terms. 
Chinese hamster ovary cells resistant to M TX tend to develop HSRs relatively 
quickly when grown in the presence of the drug (50-1 00 generations; Kaufman and 
Schimke, 1981). This is in contrast to MTX-resistant cells of mouse origin which rarely 
develop HSRs, even when grown for 2-3 years in MTX (Kaufman et al., 1981). Double 
minutes on the other hand, are very prevalent in most of the individual cells from an 
MTX-resistant mouse cell population but found in less than 5% of the cells from initially 
unstable MTX-resistant hamster cells (those cells grown for less than 50 generations in 
MTX). The explanation for this phenomenon is not clear, but it may lie in the fact that 
mouse cells are typically polyploid in their chromosome constitution, whereas Chinese 
hamster cells are generally pseudodiploid. 
There are presently two models for the amplification process involved in gene 
amplification (discussed in Cowell, 1982, and Schimke, 1982). These models are unequal 
crossing over between sister chromatids, as suggested in the gene amplification model 
for carcinogenesis (Pall, 1981) and "replicon misfiring" resulting in disproportionate DNA 
replication of a subset of DNA sequences (Varshavsky, 1981a). The latter model is 
similar to the models proposed for Drosophila chorion gene amplification (Spradling, 
1981) and for the production of free circular simian virus 40 (SV40) DNA when 
nonpermissive, SV40-transformed mouse cells are fused with a permissive monkey cell 
line (Botchan et al., 1978). Recent evidence in support of the replication model comes 
from studies using DNA synthesis inhibitors or tumor promoters, in combination with 
MTX selection to increase the frequency of amplification (Varshavsky, 198lb; Tlsty 
et al., 1982; Brown et al., 1983). Furthermore, Mariani and Schimke ( 1984) used 
hydroxyurea, which indirectly inhibits DNA replication by inhibiting the enzyme 
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ribonucleotide reductase, to amplify the DHFR gene in a single cell cycle. They showed 
that this amplification event takes place in early S phase of the cell cycle and not at the 
other phases of the cell cycle. Hence, DNA synthesis inhibitors appear to cause the 
replication machinery to stall on a given replicon, allowing reinitiation of replication 
once the inhibition is removed. The cell cycle experiments further suggest that the 
replication machinery can reinitiate on templates that have been stalled in the act of 
replication but not on templates that have completed replication. 
DHFR Gene Expression 
In addition to using MTX-resistant cells for studying the mechanisms of gene 
amplification, MTX-resistant cells have been useful for studying the regulation of 
expression of the DHFR gene, normally expressed at low levels in wild type cells. Of 
particular interest is the production of multiple DHFR mRNAs (Setzer et al., 1980), the 
growth dependent expression of DHFR (Alt et al., 1976; Chang and Littlefield, 1976; 
Johnson et al., 1978;) and the cell cycle regulation of DHFR (Mariani et al., 1981). 
Cytoplasmic poly(A)-containing RNA from both mouse and hamster cells were 
shown to express multiple DHFR mRNAs by using RNA transfer hybridization 
experiments with 32P-labeled DHFR-specific eDNA probes (Setzer et al., 1980). 
Analysis of the DNA sequences of mouse cDNAs and of the 3'-untranslated sequence of 
the mouse DHFR gene demonstrated that the four different mouse DHFR-specific 
mRNAs (7 50, 1000, 1200 and 1600 nt) are co linear with the gene in the 3'-untranslated 
region and that the four transcripts differ at the site used for polyadenylation (Setzer 
et al., 1982). These results are consistent with a model which hypothesizes that the 
multiple RNAs also derived from the same precursor transcript by differential 
polyadenylated in the 3'-untranslated region. Only the 1600 nt DHFR mRNA has a 
consensus polyadenylation sequence (AATAAA; Proudfoot and Brownlee, 1976) 10-15 nt 
upstream of the polyadenylation site, while the others have a shortened version (AT AA) 
8 
15-50 nucleotides upstream of their respective polyadenylation sites. This shortened 
sequence is found ten times in the 3'-untranslated region, and not all of the sites were 
associated with polyadenylated transcripts. The hypothesis that polyadenylation sites are 
signaled by these shortened sequences is, therefore, somewhat dubious. 
Multiple RNAs differing in their 3'-untranslated regions are found in other protein-
coding genes of higher eukaryotes, including the mouse a-amylase gene (Tosi et al., 
1981); the mouse B 2-microglobulin gene (Parnes and Robinson, 1983); the chicken pro 
a2(I) collagen gene (Aho et al., 1983); the chicken ovomucoid gene (Gerlinger et al., 
1982); and the chicken vimentin gene (Zehner and Paterson, 1983). The vimentin 
transcripts have two size classes of mRNA, approximately 2.0 and 2.3 kb, that are 
present in muscle cells, fibroblasts, spinal cord and lens. However, the 2.0 kb species is 
predominantly expressed in erythroid cells taken from 10- to 15-day-old chicken 
embryos, in contrast to erythroid cells taken from 4-day-old embryos where both RNAs 
are expressed in equal but lower amounts (Capetanaki et al., 1983). This is the first 
example of developmental regulation of 3'-untranslated sequences and raises intriguing 
questions about the regulation of the other genes expressing RNAs with multiple 3'-ends, 
and of the possible functional roles that these sequences might play. The functions of 
these 3'-ends could include directing mRNA to various subcellular compartments or could 
function in regulating mRNA stability. In the case of DHFR, the 3'-untranslated 
sequences appear to be important in the regulation of the growth dependent expression of 
DHFR in mammalian cells at the level of nuclear DHFR RNA turnover (discussed below). 
Exponentially growing mouse cells contain 10-20 fold more steady state levels of 
cytoplasmic DHFR mRNA than stationary cells, a situation which corresponds to an 
increased abundance of the DHFR enzyme (Kellems et al., 1976). Analysis of 
cytoplasmic RNA accumulation rates by using 3H-uridine labeling of stationary or 
exponentially growing mouse cells indicates that the exponentially growing cells 
accumulate DHFR RNA 3-4 times more rapidly, with no apparent change in the 
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cytoplasmic mRNA stability (Kellems et al., 1979; Hendrickson et al., 1980). This 
difference -in DHFR RNA accumulation is reflected in the nuclear RNA accumulation 
rate. 
An attempt to measure nuclear DHFR RNA synthesis rates in exponentially 
growing mouse cells and stationary cells using 20 min. pulses of 3H-uridine showed higher 
rates of accumulation of nuclear DHFR RNA in exponentially growing cells (Wu and 
Johnson, 1982). Therefore, transcriptional controls were postulated to be responsible for 
the observed growth dependent expression of DHFR gene. In conflict with these results, 
using experiments with shorter 3H-uridine pulses 0-5 min), Leys and Kellems (1981) 
found no differences in the nuclear DHFR RNA accumulation rates from samples of the 
two cell populations. The latter result suggests that the growth dependent regulation of 
DHFR is a post-transcriptional event rather than transcriptional. The differences in 
these results could be explained by nuclear RNA turnover becoming an added 
consideration m the transcription rate experiments using the longer pulses. 
Unfortunately, neither investigation measured the UTP pool sizes in the two cell 
populations, which could vary tremendously in exponentially growing cells and stationary 
cells. 
Support for the post-transcriptional basis of the control of growth dependent 
expression of DHFR comes from gene transfection experiments using a modular DHFR 
gene and a Chinese hamster DHFR-deficient cell line (Kaufman and Sharp, 1983). The 
modular gene consisted of the major late adenovirus 2 promoter containing its 5'-
untranslated region and a 5' splice site, an immunoglobulin 3' splice site, a mouse DHFR 
eDNA containing 3 of the 4 polyadenylation sites in its 3'-untranslated sequence and an 
SV40 polyadenylation site. Analysis of the poly(A)-containing RNA from the Chinese 
hamster cells tranformed to a DHFR + phenotype showed that the transcripts using 
polyadenylation sites in the 3'-untranslated region of the DHFR eDNA were growth 
regulated in their expression. In other words, the steady-state levels of these RNA 
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species were lower in stationary phase cells compared with exponentially growing cells. 
In contrast~ the steady state levels of the most abundant transcript, which uses the more 
efficient SV40 polyadenylation site, did not differ between stationary and exponentially 
growing cells. Transcription experiments using isolated nuclei from stationary cells and 
exponentially growing cells showed no differences in the amount of DHFR-specific RNA, 
indicating that the control of the growth dependent expression of the transfected DHFR 
gene is not at the transcriptional level. These results also indicated that the 3'-
untranslated region plays a role in the regulation of the growth dependent expression of 
DHFR, most likely in post-transcriptional events involving nuclear RNA turnover. 
Cell cycle experiments, using a physical procedure to remove mitotic cells from 
culture dishes for synchronization, demonstrated that the amount of the DHFR enzyme 
peaked in the early S phase of mouse cells (2-3 fold; Mariani et al., 1981). When 
stationary cells were stimulated to enter the cell cycle, an increase in the accumulation 
of DHFR RNA occurred (Johnson et al., 1978) at the same time as DNA synthesis 
increased. This result demonstrates that growth-dependent expression of DHFR is 
related to cell cycle regulation. This cell cycle regulation of DHFR gene expression 
correlates with the need of deoxyribonucleotides for DNA replication and is a general 
feature of other enzymes involved in DNA synthesis (reviewed in Klevecz and Gerald, 
1977). 
Since drug resistance is a general feature of mammalian cells, and the gene 
amplification mechanism of resistance indicates a great plasticity of the genome in these 
cells, MTX-resistant human cell lines were developed. It seemed reasonable to assume 
that knowledge of the organization and expression of the human DHFR gene would be 
required in understanding the mechanism of gene amplification. Therefore, the main 
focus of this thesis is on determining the DHFR gene structure and analyzing its 
expression in MTX-resistant and MTX-sensitive cells. A brief summary of the results 
from the analysis of the human DHFR gene system is described below. 
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Chapter 2: Characterization of the MTX-Resistant Cell Lines 
Analysis of various human MTX-resistant cells derived from HeLa or VA2-B cell 
lines showed that all of the cell lines became resistant to increasing amounts of MTX 
(final concentration of l.8xl o-4M) as a result of an increase in the amount of the DHFR 
enzyme. This increase was most likely due to a DHFR gene amplification event since all 
of the cells exhibited the type of chromosomal abnormalities associated with gene 
amplification, HSRs (Barry Maurer, unpublished results) and double minutes. 
An interesting feature observed in these human MTX-resistant cell lines was the 
variability in DHFR enzyme content, chromosome constitution and growth 
characteristics, despite their resistance to the same level of MTX. This could be 
attributable to a population phenomenon whereby the DHFR enzyme content of 
individual cells in a given population varies widely, similar to that found in populations of 
MTX-resistant rodent cell lines (Brown et al., 1981; Kaufman et al., 1981; Kaufman and 
Schimke, 1981). The enzyme levels for the human MTX-resistant cell lines varied from 
35-27 5 times the level found in the parental cells. Analysis of the chromosome 
constitution of these cell types showed that every MTX-resistant cell line contained 
double minutes. When grown in the absence of M TX, all of the cell lines lost the 
amplified DHFR enzyme activity. However, the number of double minutes did not 
correlate with either the amount of DHFR enzyme or the instability of the resistant 
phenotype in the absence of selection. These results are in contrast to the situation in 
mouse cell lines, where the number of double minutes correlate with both the enzyme 
content and the degree of instability of the M TX-resistant phenotype (Kaufman et al., 
1979) 
Chapter 3: Cloning of Human DHFR-Specific cDNAs 
When polysomal poly(A)-containing RNA was electrophoresed on denaturing agarose 
gels and stained with ethidium bromide, a predominant RNA species (3.8 kb) was 
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observed in the RNA samples from MTX-resistant cells (6A3 or 10B3) but not from the 
RNA sampfes from the parental cell lines (VA2-B and HeLa, respectively). This RNA was 
shown to code for the DHFR enzyme by in vitro translation experiments. These results 
demonstrated that the increased DHFR enzyme content in MTX-resistant cell lines is due 
to an increase in the amount of DHFR-specific mRNA. 
Polysomal poly(A)-containing RNA from 6A3 cells was used to make a eDNA 
library, and two methods were used to select for DHFR-specific recombinant clones. 
The first method was differential hybridization (St. John and Davis, 1979), using 32P-
labeled eDNA from 6A3 cells and VA2-B cells to screen replicate filters of recombinant 
clones. Positive clones containg DHFR inserts were identified by a darker hybridization 
signal using the 6A3 eDNA probe compared to the VA2-B probe. The second screening 
procedure involved phenotypic expression of the human DHFR eDNA in order to protect 
E. coli recombinant cells from growth inhibition when exposed to the bacterial DHFR-
specific inhibitor, trimethoprim (Chang et al., 1978). Comparison of the DNA sequence 
of the 5'-end of a phenotypically-expressed eDNA clone (pHD84), with the sequence of a 
mouse DHFR eDNA clone, confirmed the insert coded for DHFR. 
Various DHFR cDNAs were used to probe RNA transfer hybridization experiments, 
using 6A3 polysomal poly(A)-containing RNA. These results showed that at least three 
RNAs (3.8, 1.0 and 0.8 kb) exist for human DHFR, and that these RNAs differed in the 
length of their 3'-untranslated regions. 
Chapter 4: DNA Sequence of the DHFR Coding Region 
The DNA sequence of the complete DHFR coding region was determined from the 
DHFR eDNA clone, pHD84, a eDNA found to be phenotypically expressed in E. coli 
(Chapter 3). The human DHFR coding sequence (564 nt) showed homology to the mouse 
DHFR coding sequence with an 89% sequence identity; of the 64 nucleotide differences, 
45 represented silent base pair changes. When the derived amino acid sequence of the 
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human DHFR protein was compared to the homologous proteins from chicken, bovine and 
mouse, seq-uence identities of 74%, 81% and 89% were found. 
Chapter 5: Identification of a Human DHFR Pseudogene 
The DNA sequence of four human DHFR cDNAs supports the hypothesis that the 
multiple DHFR mRNAs are generated from the same transcription unit by differential 
polyadenylation of the precursor RNA (Setzer et al., 1982). The data indicate that 
pHD84 is a eDNA of the 0.8 kb mRNA; pHD80 and pHD83 are both cDNAs of the 1.0 kb 
mRNA and pHD41 is a eDNA derived from a longer transcript, possibly the 3.8 kb 
mRNA. The sequences of the 3'-untranslated regions are colinear in each of the eDNA 
clones and differ in the sites of polyadenylation. 
When EcoRI-digested nuclear DNA from human sperm, HeLa cells, VA2-B cells and 
MIX-resistant 6A3 cells were used for DNA transfer hybridization experiments with the 
32P-labeled pHD84 eDNA probe, five DHFR-specific fragments were observed to be 
amplified in the 6A3 DNA samples relative to the other samples (sizes of 13, 6.0, 4.0, 1.8 
and 1.5 kb). This result, combined with data using different DHFR eDNA fragments, 
indicated that these five fragments are part of the amplified DHFR gene (see 
Chapter 6). At least five additional fragments hybridized to the pHD84 probe in all of 
the DNA samples, with sizes of 18, 17, 3.8, 3.5 and 2.3 kb. These fragments, in contrast 
to the DHFR gene segments, were not amplified in 6A3 cell DNA relative to HeLa cell 
and VA2-B cell DNA. 
In order to isolate a complete DHFR gene, a human cosmid library was screened 
with the 32P-labeled pHD84 insert. Ten DHFR-positive clones were identified, but these 
did not contain any of the EcoRI fragments found to be amplified in 6A3 cells (described 
above). However, one of the clones, CosHD37, contained two of the unamplified EcoRI 
fragments (3.5 and 2.3 kb). Restriction enzyme mapping and DNA sequence analysis of 
this clone demonstrated that these fragments contained a eDNA-like insert of the DHFR 
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gene, including the EcoRI site found in the 5'-end of pHD84. A nucleotide sequence 
identity of "92% was observed between the eDNA clones and the homologous region of the 
cosmid clone, with frameshift mutations interrupting the coding sequence. Since this 
DHFR homologous region cannot code for the DHFR enzyme, the cosmid clone contains a 
DHFR intronless pseudogene (1jJHD 1). Chen et al. (1982) have identified two additional 
DHFR pseudogenes that were distinct from l(JHDl. Analysis of other gene systems has 
led to the hypothesis that an RNA intermediate is involved in the formation of intronless 
pseudogenes (Nishioka et al., 1980; Vanin et al., 1980; Karin and Richards, 1982). The 
DNA sequence homology between the DHFR cDNAs and l(JHDl extends beyond the 
polyadenylation site of the 1.0 kb DHFR mRNA. Therefore, if an RNA intermediate is 
involved in generating l(JHDl, then an RNA larger than the 1.0 kb DHFR mRNA must be 
involved. 
Subsequent analysis has localized the human DHFR gene to human chromosome 5, 
utilizing DNA transfer hybridization experiments with DNA from mouse-human and 
Chinese hamster-human cell hybrids and the 32P-labeled pHD84 probe (Maurer et al., 
1984). This analysis also showed that the unamplified DHFR-specific EcoRI fragments 
described above, did not segregate with the functional DHFR gene. Thus, all of these 
unamplified fragments probably represent DHFR pseudogenes or incomplete DHFR 
genes. 
Chapter 6: Isolation of the Human DHFR Gene 
The complete DHFR gene from 6A3 cells was isolated as overlapping inserts from 
four lambda genomic libraries made with two different vectors. Analysis by DNA 
transfer hybridization experiments of nuclear DNAs from 6A3 and HeLa cells showed no 
differences in the structure of the gene in DHFR amplified and unamplified cells. The 
gene is approximately 29 kb long, with the 564 bp coding region separated by five 
introns. The positions of the splice junctions in the DHFR coding sequence are identical 
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to the positions m the homologous mouse gene (Crouse et al., 1982). However, the 
corresponding introns of the human, mouse and Chinese hamster DHFR genes show a 
large variation in their size, except for the first intron. This variation in intron size is 
greatest for intron five, which varies in length of up to fourfold. In contrast to the 
intron size variation, the overall lengths of the DHFR genes are equivalent among the 
three mammalian species. 
A sequence comparison between human and mouse DHFR genes reveals some 
interesting features. There is a relatively high G+C content in the 5'-ends of the human 
gene (an average of 70%) while there is a relatively low G+C content in the remainder of 
the gene (an average of 40%). There is no detectable sequence homology in the intron 
sequences of the human and mouse DHFR genes other than the 15-35 nucleotides directly 
adjacent to the intron/exon splice junctions. However, the overall G+C composition is 
conserved. The 5'-noncoding regions of the mouse and human genes also share a 
significant nucleotide sequence identity (65%) to at least 327 bp upstream of the 
translation initiation codon. This sequence homology suggests that this region plays an 
important regulatory role in the expression of DHFR. In contrast to the 5'-end of the 
DHFR genes from mouse and human cells, the 3'-untranslated regions show no obvious 
sequence homology. Since the 3'-untranslated sequence of the mouse gene has been 
implicated in the control of the growth dependent expression of DHFR (discussed above), 
it would be of interest to determine if a similar mechanism exists for the control of the 
expression of the corresponding human gene. 
Chapter 7: Mapping of the Major and Minor 5'-ends of DHFR-Specific RNA 
Primer extension and Sl nuclease protection experiments have mapped multiple 5'-
ends to DHFR-specific transcripts in the human MIX-resistant cell line, 6A3. One of 
these ends, position -71 nucleotides from the DHFR translation initiation codon, 
corresponds to a major DHFR-specific transcript which totals approximately 99% of the 
16 
DHFR polysomal poly(A)-containing RNA. This end is most likely associated with the 
previously identified DHFR mRNA of sizes 3.8, 1.0 and 0.8 kb. The -71 position has also 
been mapped by Chen et al. ( 1984) and was shown to be a functional transcription 
initiation site in vitro. Six other minor 5'-ends have been mapped to positions -449 to 
-480 of the DHFR gene and total approximately l% of the DHFR-related polysomal 
poly(A)-containing RNA. 
Analysis of polysomal poly(A)-containing RNA from Hela cells and VA2-B cells 
shows that these upstream initiating transcripts are present in MTX-sensitive cells and 
are not specific for DHFR amplified cells. Also, the relative levels of the DHFR-
specific transcripts varied in relation to the extent of DHFR gene amplification. In 
contrast to the DHFR polysomal RNA, the upstream initiating transcripts in the nuclear 
RNA fraction represent approximately 10% of the major transcripts initiating at position 
-71. The differences in the relative levels of DHFR nuclear RNA and polysomal RNA 




Abrect, A., Biedler, J.L., and Hutchinson, D.J. (1972). Cancer Res. 32, 1539-1546. 
Aho, S., Tate, V. and Boedtker, H. (1983). Nuc1. Acids Res. 11, 5443-5450. 
A1t, A.W., Kellems, R.E. and Schimke, R.T. (1976). J. Biol. Chern. 251, 3063-3074. 
A1t, A. W ., Kellems, R.E., Bertino, J.R. and Schimke, R. T. ( 1978). 
J. Biol. Chern. 235, 1357-1370. 
Andrulis, I.L., and Siminovitch, L. ( 1982). In R. T. Schimke (ed.) Gene Amplification, Cold 
Spring Harbor Laboratory. Cold Spring Harbor, New York. Pp. 75-80. 
Beach, L.R. and Palmiter, R.D. (1981). Proc. Natl. Acad. Sci., U.S.A. 78, 2110-2114. 
Bertino, J.R., Donohue, D.M., Simmons, B., Gabrio, B. W ., Silber, R. and Huennekens, 
F.M. (1963). J. Clin. Invest. 42, 446-475. 
Biedler, J.L., Albrecht, A.M., Hutchison, D.J., and Spengler, B.A. (1972). Cancer Res. 32, 
153-161. 
Biedler, J .L., Melera, P. W. and Spengler, B.A. (1980). Cancer Genet. Cytogenet. 2, 47-60. 
Bostock, C.J. and Clark, E.M. (1980). Cell 19, 709-715. 
Botchan, M., Topp, W. and Sambrook, J. (1978). Cold Spring Harbor Symp. Quant. Biol. 
43, 709-719. 
Brennand, J., Chinault, A. C., Konecki, D.S., Melton, D. W. and Caskey, C. T. (1982). Proc. 
Natl. Acad. Sci., U.S.A. 79, 1950-1954. 
Brinson, 0., Adeshir, F. and Stark, G.R. (1982). Mol. Cell. Biol. 2, 578-587. 
18 
Brown, D.O. and Dawid, I.B. (1968). Science, 160, 272-280. 
Brown, P .C., Bever ley, S.M. and Schimke, R. T. ( 1981 ). Mol. Cell. Biol. 1, 1077-1083. 
Brown, P .C., Tlsty, T .D. and Schimke, R. T. (1983). Mol. Cell. Biol. 3, 1097-1107. 
Capetanaki, Y .G., Ngai, J., Flytzanis, C.N. and Lazar ides, E. ( 1983). Cell, 35, 411-420. 
Chang, S.E. and Littlefield, J.W. (1976) Cell, 7, 391-396. 
Chang, A.C.Y., Nunberg, J.H., Kaufman, R.J., Erlich, H.A., Schimke, R.T. and Cohen, 
S.N. (1978). Nature, 275 617-624. 
Chen, M.-J., Shim ida, T., Moulton, A.D., Harrison, M. and Nienhuis, A. W. ( 1982). Proc. 
Natl. Acad. Sci., U.S.A. 79, 7435-7439. 
Chen, M.-J., Shamida, T., Moulton, A.D., Cline, A., Humphries, R.K., Mazel, J. and 
Nienhuis, A.W. (1984). J. Biol. Chern. 259, 3933-3943. 
Cowell, J.K. (1982). Ann. Rev. Genet. 16, 21-39. 
Crouse, G.F., Simonsen, C.C., McEwan, R.N. and Schimke, R.T. (1982). J. Biol. Chern. 
257, 7887-7897. 
Curt, G.A., Carney, D.N., Cowan, K.H., ]olivet, J., Bailey, B.D., Drake, J.C., Kao-Shan, 
C.S., Minna, J.D. and Chamber, B.A. ( 1983). New Engl. J. Med. 308, 199-202. 
Dolnick, B.J., Berenson, R.J., Bertino, J.R., Kaufman, R.J., Nunberg, J.H. and Schimke, 
R.T. (1979). J. Cell Biol. 83, 394-402. 
Fisher, G.A. (1961). Biochem. Pharmacal. 7, 75-80. 
Fisher, G.A., (1962) Biochem. Pharmacal. 11, 1233-1237. 
19 
Flintoff, W.F. and Essani, K. (1980). Biochemistry. 19, 4321-4327. 
Flintoff, W.F., Davidson, S.V. and Siminovitch, L. (1976). Somatic Cell Genet. 2, 245-261. 
Fuscoe, J.C., Fenwick, R.G. Jr., Ledbetter, D.H. and Caskey, C.T. (1983). Mol. Cell. Biol. 
3, 1086-1096. 
Ger linger, P ., Krust, A., LeMeur, M., Perrin, F., Cochet, M., Gannon, F., Dupret, D. and 
Chambon, P. (1982). J. Mol. Biol. 162, 345-364. 
Haber, D.A., Beverley, S.M., Kiely, M.L., and Schimke, R.T. (1981). J. Biol. Chern. 256, 
9501-9510. 
Hakala, M.T., Zakrewski, S.F. and Nichol, C.A. (1961). J. Biol. Chern. 236, 952-958. 
Hendrickson, S.L., Wu, J.-S.R. and Johnson, L.F. (1980). Proc. Natl. Acad. Sci., U.S.A. 77, 
5140-5144. 
Johnson, L.F., Fuhrman, C.L. and Wiedemann, L.M. (1978). J. Cell. Physiol. 97, 397-406. 
Johnston, R.N., Beverley, S.M. and Schimke, R.T. (1983). Proc. Natl. Acad. Sci., U.S.A. 
80,3711-3715. 
]olivet, J., Cowan, K.H., Curt, G.A., Clendeninn, N.J. and Chabner, B.A. (1983). New 
Engl. J. Med., 309, 1094-1104. 
Kanalas, J.J. and Suttle, D.P. (1984). J. Biol. Chern. 259, 1848-1853. 
Karin, M. and Richards, R.I. (1982). Nature, 299, 797-802. 
Kaufman, R.J., Brown, P.C. and Schimke, R.T. (1979). Proc. Natl. Acad. Sci., U.S.A. 76, 
5669-5673. 
Kaufman, R.J., Brown, P.C. and Schimke, R.T. (1981). Mol. Cell. Bioi. 1, 1084-1093. 
20 
Kaufman, R.J. and Schimke, R.T. (1981). Mol. Cell. Biol. 1, 1069-1076. 
Kaufman, R.J. and Sharp, P.A. (1983). Mol. Cell. Biol. 3, 1598-1608. 
Kellems, R.E., Alt. F.W. and Schimke, R.T. (1976). J. Biol. Chern. 251,6987-6983. 
Kellems, R.E., Morhenn, V.B., Pfendt, E.A., Alt, F.W. and Schimke, R.T. (1979). J. Bioi. 
Chern. 254, 309-318. 
Kempe, T.D., Swyryd, E.A., Bruist, M. and Stark, G.R. (1976). Cell, 9, 541-550. 
Klevecz, R.R. and Gerald, L.R. (1977). In G.H. Rothblat and V .J. Cristofalo (eds.) 
Growth, Nutrition and Metabolism of Cells in Culture. Academic, New York. 
Pp. 149-196. 
Leys, E.J. and Kellems, R.E. (1981). Mol. Cell. Biol. 1, 961-971. 
Ling, V. ( 1982). In N. Bruchovsky and J. H. Goldie (eds.) Drug and Hormone Resistance in 
Neoplasia, 1, CRC Press, Boca Raton, Fla. Pp. 1-19. 
Luria, S.E. and Delbri.ick, M. (1943). Genetics, 28,491-511. 
Luskey, K.L., Faust, J.R., Chin, D.J., Brown, M.S. and Goldstein, J.L. (1983). J. Biol. 
Chern. 258, 8462-8469. 
Mariani B.D., Slate, D.L. and Schimke, R.T. (1981). Proc. Natl. Acad. Sci., U.S.A. 79, 
4985-4989. 
Mariani, B.D., and Schimke, R.T. (1984). J. Biol. Chern. 259, 1901-1910. 
Matthews, D.A., Alden, R.A., Bolin, J.T., Filman, D.J., Freer, S.T., Hamlin, R., Hol, 
W.G.J., Kisliuk, R.L., Pastore, E.J., Plante, L.T., Xuong, N. and Kraut, J. (1978). J. Bioi. 
Chern. 253, 6946-6954. 
21 
Maurer, B.J., Barker, P.E., Masters, J.N., Ruddle, F.H. and Attardi, G. (1984). Proc. Natl. 
Acad. Sci., U.S.A. 81, 1484-1488. 
Melera, P.W., Lewis, J.A., Biedler, J.L. and Hession, C. (1980). J. Biol. Chern. 255, 
7024-4028. 
Nishioka, Y., Leder, A. and Leder, P. (1980). Proc. Natl. Acad. Sci., U.S.A. 77, 
2806-2809. 
Nunberg, J.H., Kaufman, R.J., Schimke, R.T., Urlaub, G. and Chasin, L.A. (1978). Proc. 
Natl. Acad. Sci., U.S.A. 75, 5553-5556. 
Padgett, R.A., Wahl, G.M. and Stark, G.R. (1982). Mol. Cell. Biol. 2, 293-301. 
Pall, M.L. (1981). Proc. Natl. Acad. Sci., U.S.A. 78, 2465-2468. 
Parnes, J.R. and Robinson, R.R. (1983). Nature, 302, 449-452. 
Proudfoot, N.J. and Brownlee, G.G. (1976). Nature, 263, 211-214. 
Roberts, J.M. and Axel, R. (1982). Cell, 29, 109-119. 
Roninson, I.B., Abelson, H.T., Housman, D.E., Howell, N. and Varshavsky, A. (1984). 
Nature, 309, 626-628. 
Rossana, C., Rao, L.G. and Johnson, L.F. ( 1982). Mol. Cell. Biol. 2, 1118-1125. 
Schimke, R.T., Brown, P.C., Kaufman, R.J., McGrogan. M. and Slate, D.L. (1980). Cold 
Spring Harbor Symp. Quant. Biol. 45, 785-797. 
Schimke, R.T. (1982). (ed.) Gene Amplification, Cold Spring Harbor Laboratory. Cold 
Spring Harbor, New York. 
Setzer, D.R., McGrogan, M., Nunberg, J.H. and Schimke, R. T. (1980). Cell, 22, 361-370. 
22 
Setzer, D.R., McGrogan, M. and Schimke, R.T. (1982). J. Biol. Chern. 257,5143-5147. 
Simonsen, C.C. and Levinson, A.D. ( 1983). Proc. Natl. Acad. Sci., U.S.A. 80, 2495-2499. 
Sirotnak, F.M., Kurita, S. and Hutchinson, D.J. (1968). Cancer Res. 28, 75-80. 
Spradling, A.C. (1981). Cell, 26, 193-201. 
St. John, T. and Davis, R. W. (1979). Cell, 16, 443-452. 
Tartof, K.D. (1975). Ann. Rev. Genet. 9, 355-385. 
Terzi, M. and Hawkins, T.S.C. ( 1974). Biochem. Exp. Biol. 11, 245-254. 
Tlsty, T., Brown, P.C., Johnston, R. and Schimke, R.T. (1982). In R.T. Schimke, (ed.) 
Gene Amplification, Cold Spring Harbor Laboratory. Cold Spring Harbor, New York. Pp. 
231-238. 
Tosi, M., Young, R.A., Hagenbuchle, 0. and Schibler, U. (1981 ). Nucl. Acids Res. 9, 
2313-2323. 
Vanin, E.F., Goldberg, G.I., Tucker, P.W. and Smithies, 0. (1980). Nature, 286, 222-226. 
Varshavsky, A. (1981a). Proc. Natl. Acad. Sci., U.S.A. 78, 3673-3677. 
Varshavsky, A. (1981b). Cell, 25, 561-572. 
Volz, K.W., Matthews, D.A., Alden, R.A. Freer, S.T., Hansch, C., Kaufman, B.T. and 
Kraut, J. (1982). J. Biol. Chern. 257, 2528-2536. 
Wahl, G.M., Padgett, R.A. and Stark, B.R. (1979). J. Biol. Chern. 254, 8679-8689. 
Wahl, G.M., Vitto, L. and Rubnitz, J. (1984). Mol. Cell. Biol. 3, 2066-2075. 
23 
Wu, J.-S.R. and Johnson, L.F. (1982). J. Cell. Physiol. 110, 183-189. 
Zehner, Z.E. and Paterson, B.M. (1983). Proc. Nat1. Acad. Sci., U.S.A. 80,911-915. 
24 
CHAPTER 2 
Variable Content of Double Minute Chromosomes Is Not 
Correlated with Degree of Phenotype Instability in 
Methotrexate-Resistant Human Cell Lines 
MOLECU LAR AND CELL ULAR BIOLOGY , May !982. p. 498-507 
0270-730618! /050498-1 0$02 .00/0 
25 
Vol. ! . No. 
Variable Content of Double Minute Chromosomes Is Not 
Correlated with Degree of Phenotype Instability m 
Methotrexate-Resistant Human Cell Lines 
JEFFREY MASTERS . BENNETA KEELEY . HELEN GAY, AND GIUSEPPE ATTARD!* 
Din'sion of Biology. California lnsrirure of Technology. Pasadena . California 91125 
Received 3 September 1981 /Accepted 3 December 1981 
Several variants resistant to 1.8 x 10- 4 M DL-methotrexate (MTX) have been 
isolated from the human cell lines HeLa BU25 and V A2-B by exposing them to 
progressive ly increasing concentrations of the drug. A striking variability of 
phenotype and chromosome constitution was observed among the different 
variants. All resistant cell lines exhibited a greatly increased dihydrofolic acid 
reductase (DHFR) activity and DHFR content; however, the DHFR activity 
levels varied considerably among the variants , ranging between about 35 and 275 
times the parental level. In the absence of selective pressure, the increased DHFR 
activity was unstable, and in all cell lines but one was completely lost over a 
period ranging in different variants between 25 and 200 days . The MTX-resistant 
cell lines showed anomalies in their chromosome constitution, which involved the 
occurrence of a duplicated set of chromosomes in most cells of some of the 
variants and the presence of double minute chromosomes in all cell lines . An 
analysis of the correlation of loss of double minute chromosomes and loss of 
DHFR activity in the absence of MTX has given results consistent with the idea 
that the double-minute chromosomes contain amplified DHFR genes. However, 
the most significant finding is that, in contrast to what has been reported in the 
mouse system . the recognizable double-minute chromosomes varied greatly in 
number in different variants without any relationship to either the level of DHFR 
activity or the degree of instability of MTX resistance in the absence of selective 
pressure . These and other observations point to the occurrence in the human 
MTX-resistant variants of another set of DHFR genes, representing a varied 
proportion of the total , which is associated with the regular chromosomes, and 
which may be unstable in the absence of selective pressure. 
One of the most striking examples of the 
plasticity of the genome in animal cells is provid-
ed by the selective amplification of the genes 
coding for proteins with binding specificity for 
certain metabolic inhibitors or other harmful 
chemicals, as demonstrated in cultured mamma-
lian cells resistant to such agents (1 , 5, 29). The 
best-studied case of this nature is the dihydrofo-
lic acid reductase (DHFR) gene amplification in 
mammalian cells resistant to amethopterin 
(methotrexate, MTX) (1 ). In several human and 
experimental tumors and in cultured mouse and 
hamster cell lines , the development of the resist-
ance to MTX has been found to be due to an 
increased cell content , up to several hundred-
fold , of the enzyme (6, 8, 10-12, 15, 22, 26, 27 , 
30). In cultured mammalian cen lines, the in-
creased enzyme level has been shown to result 
from an increased rate of synthesis (2, 16), due 
to a selective amplification of the DHFR genes 
(1, 10, 23, 26) and to a parallel increase in the 
amount of DHFR mRNA (1 , 9, 18, 23). 
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The biochemical investigations mentioned 
above have all been carried out in MTX-resis-
tant cell lines of mouse or hamster origin . Re-
cently , several MTX-resistant cell variants have 
been isolated in this laboratory from two differ-
ent human cell lines, He La BU25 and V A2-B: 
furthermore, the DHFRs have been isolated 
from He La B U25 cells and from two of the 
MTX-resistant derivatives and found to be indis-
tinguishable in their physical and enzymatic 
properties (25). In this paper , we report that the 
human MTX-resistant cell lines isolated here 
exhibit a striking variability in phenotypic prop-
erties and chromosome constitution , even 
among sublines. Most significantly, they contain 
a highly variable number of double minute chro-
mosomes which is not correlated with either the 
level or the stability of their resistance to MTX. 
MATERIALS AND METHODS 
Materials. Dihydrofolic acid and NADPH were ob-
tained from Sigma Chemical Co . The MTX used as a 
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select ive agent for the drug-re sistant variants was the 
DL-form from Sigma (consisting of - 50o/c L-form ). 
Cell lines and methods of growth. The human cell line 
He La BU25 . a mutant subline of He La S3 deficient in 
th ymidine kinase acti vit y (! 9) . kindl y provided by S . 
Kit. was grown in petri dishes in Eagle medium 
supplemented with I 0'1? calf serum in the absence or 
pre sence of 25 f.Lg of bromodeox yuridine (BUdRl per 
mi. The human cell line VA~-8. an azaguanine-re sist -
ant subclone of the simian virus 40-transformed line 
WI-18-VA, (28). was grown in petri dishes in Eagle 
medium supplemented with 10'1? calf serum and 3 f.Lg 
of 8-azaguanine per mi. The MTX-resistant variants of 
these two cell line s were grown in the media described 
above supplemented with IOo/c extensivel y dialyzed 
ca lf serum and variou s concentra tions of DL-MTX as 
specified below. 
Chromosome analysis. Cells were arrested in meta-
phase by treatment with 0.05 f.Lg of colchicine per ml 
for 3 to 5 h. Karyot ype analy sis was performed as 
described previou sly (24). 
Cell extraction preparation and enzyme assay. When 
a cell extract had to be prepared for enzyme assay. the 
cells were grown in the absence of MTX for 7 days 
before harvesting . The preparation of cell extracts and 
the enzyme assays were carried out essentially as 
described by Frearson et al. (13) . except that in the 
enzyme assay the concentration of dihydrofolic ac id 
was doubled . One unit of enzyme activit y was defined 
as the amount of enzyme required to reduce I nmol of 
dihydrofolic acid in 15 min at 21 oc. 
Electrophoretic analysis. Electrophoresis of the cell 
extracts was carried out by using the Laemmli sodium 
dodecyl sulfate-polyac rylamide gel system (20) as pre-
viousl y desc ribed (25). 
RESULTS 
Isolation of MTX-resistant variants. HeLa 
BU25 cells previously grown in the absence or 
presence of BUdR (25 IJ.g/ml) were exposed to 
2 x 10- 8 or 5 x 10-8 M DL·MTX in BUdR-free 
(-BUdR) or BUdR-containing (+BUdR) medi-
um. respectively; similarly, V A2-B cells were 
treated with either 5 x 10-8 or 1 x 10- 7 M DL-
MTX . Almost all of the cells treated with the 
above concentrations of MTX died in the first 2 
weeks. Four colonies of BU25 (- BUdR) cells 
and four colonies of BU25 ( + BUdR) cells resis-
tant to 2 x 10-8 M DL-MTX, four colonies of 
BU25 ( + BUdR) cells resistant to 5 x 10-8 M 
DL-MTX, four colonies of V ArB cells resistant 
to 5 x 10- 8 M DL-MTX, and four colonies of the 
same cell line resistant to 1 x 10-7 M DL-MTX 
were picked up by trypsinization 3 weeks after 
plating, and each was grown to a large culture. 
These clones , designated with a number indicat-
ing the plate and a letter indicating the clone 
picked up in each plate (for example , lOA , lOB , 
lOC, and lOD), were then exposed to increasing 
DL-MTX concentrations. Steps corresponding 
to two- to fourfold increases in MTX concentra-
tion were used, the final concentration being 1.8 
x 10-4 M DL-MTX. Considerable cell death 
occurred after each increase : the surviving cells 
were grown for several weeks until no obvious 
cell death occurred before the next increase in 
MTX concentration in the medium was made . In 
the course of this process . each variant popula-
tion was often subdivided into subpopulations. 
which were exposed to different schedules of 
increasing MTX concentrations, being thereaf. 
ter maintained separate (designated by a pro-
gressive number following the clone letter desig-
nation , for example, lOBI , 10B2. 10B3). The 
whole process took between 7 and 11 months for 
different variants . Eleven variant cell lines. six 
derived from BU25 (- BUdR) cells . one derived 
from BU25 ( + BUdR) cells . and four derived 
from V A2-B cells , which had acquired resistance 
to 1.8 x 10- 4 M DL-MTX. were selected for 
further investigation (Table 1 ). Because of the 
continuous changes occurring in the MTX-resis-
tant variants during growth in the presence of 
the drug , each variant is designated by its sym-
bol and a subscript indicating the number of 
months of exposure to 1.8 x 10-4 M DL-MTX. 
Growth characteristics of the MTX-resistant 
variants. All variants were found to grow more 
slowly in the presence of the drug than the 
parental cell lines grew in the absence of the 
drug. In particular, in the first few months after 
their adaptation to 1.8 x 10-4 M DL-MTX , their 
population doubling times varied between 35 h 
and more than 70 h. A marked acceleration in 
growth rate occurred in the variants after pro-
longed exposure to the drug , their population 
doubling time approaching that of the parental 
cell lines . The slower growth rate of the MTX-
resistant variants was not due exclusively to the 
presence of the drug, as indicated by the obser-
vation that in several MTX-resistant variants , in 
the first 3 weeks after removal of the drug, the 
rate of cumulative growth was appreciably slow-
er than that of the V A2-B parental cell line, 
gradually increasing thereafter. 
Levels of DHFR in MTX-resistant and MTX-
sensitive cell lines. All of the MTX-resistant cell 
lines analyzed here exhibited an increased 
DHFR activity relative to the parental MTX-
sensitive cell lines (Table 1 ). The increase in 
DHFR levels in MTX-resistant variants , as mea-
sured within the first 10 months after their 
adaptation to 1.8 x 10-4 M DL-MTX , varied 
between about 35 and 275 times the levels found 
in the corresponding parental cell lines . It is 
interesting that a great variation in DHFR activi-
ty was observed also among sublines derived 
from the same original MTX-resistant clone 
(compare, for example, 7D2 and 7D3). 
That the increase in DHFR activity in the 
MTX-resistant variants analyzed here reflected 
an increase in enzyme protein was shown by an 
electrophoretic analysis of the cell extracts . 
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TABLE I. OHFR activit y and chromosome constitution of MTX -sensitive and MTX-resistant cell line s 
No. of days for decay 
DHFR 
of DH FR activit y in Chromosome constitution" 
Relative MTX -frec medi um 
Ce ll line" acti vit y DHFR (Uimg of 
acti vity No . of No . of doub le prmein I To sor-~c To 20'1( Complement ' chromosomes/ minutes per 
cell" cell ' 
Parental 
HeLa 8U~5 50 .5 :!: 14. 7 IS <lOOJ 59 :!: I 0.5 W-61 
(-8UdRl 
Variant s 
!OBI, 11 .500 228 13 33 ISOOOl 57 :!: 2 19 (0-132) 
IOB2, 9.100 180 21 38 
IS (95) 58 = 3 28 W-130) 2S (5) 93 . Ill 
!083, 13.800 273 16 31 
IS (97) 57 :!: 4 
7 (Q-42) 
2S OJ 113 
1S03l 55 :!: I 
lOCI, 5.400 107 14 21 2S (24) 106 :!: 5 75 (4-257) 
3S (3) 166 
10C2, 5.200 103 47 86 
IS (19) 55 = 5 73 (5-265) 
2S (81J 112 :!: 3 
IS (8) 56 :!: 2 
IOC3. 5.400 107 11 27 2S (89) 110 :!: 5 219 (46-475) 
4S (3) 210 
Parental 
IS (88J 58 :!: I 
HeLA 8U25 45.8 = 7.2 2S (12) 109:!: 6 < 0.3 <+ 8UdRJ 
Variant 
140t 9 .600 210 12 49 IS (100) 56 :!: 2 26 (0-100) 
Parental IS (97) 68 :!: 2 
Wl-18 VA, -8 79 .3 :!: 5.9 2S (3) 136 
<0 .3 
Variants 
IS (97) 58 :!: 2 
6A28 11 .300 142 8 20 2S (3) 115 
18 2 (34-84]) 
6A3, 7.300 92 34 08Y 240 (39f 
IS (94) 56 :!: I 154 (42-391) 
2S (6) 106. 112 
702 10 11.400 144 18 90 2S (100) 118 :!: 5 98 (2- 261) 
703, 2.600 33 29 49 2S (100) 122 = 5 120 (9-348) 
" The subscripts in the symbols of the variants refer to the time when the analysis of DHFR activ it y was 
carried out. 
h A total of 32 to 40 metaphase spreads were analyzed from each ce ll line within the first 6 months of 
maintenance in the presence of 1.8 x 10- 4 M DL-MTX. 
' Nu mbers within parenthe ses indicate the percentage of cells in each category. 
d Average :!: standard deviation. Whenever only one or two metaphases were found in a given group . the 
individual val ues are reported . 
" Since it was often difficult to identify the pairs of double minutes . especially when present in cl usters . and 
since many of these elements appeared to be unpaired . the values reported here represent the mean and range of 
numbers of individual minutes per cell. From 45 to 74% of these minutes in different cell lines were in clearly 
recognizable pairs. 
f The numbers withi n parentheses represent the number of days calculated after subtrac ting the contribution of 
the relatively s table DHFR fraction to the individual values of overall OHFR activity (see Fig. 6BJ . 
When equal amounts of protein were run 
through sodium dodecyl sulfate-polacrylamide 
gels. a band corresponding to a polypeptide with 
an Mr of -22.000 comigrating with the purified 
DHFR (25) was observed in the extracts from 
the MTX-resistant variants. but not in those 
from the MTX-sensitive parental cell lines (Fig . 
1). The extracts from 10C2 and 10C3 cells exhib-
ited a band corresponding to DHFR which was 
clearly less pronounced than expected from 
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their degree of resistance to MTX and from their 
DHFR activity (Table 1). 
BehaYior of increased DHFR activity in the 
MTX-resistant variants in the absence of MTX. 
All of the MTX-resistant cell lines. at the time 
when they were analyzed (within the first 10 
months after their adaptation to 1.8 x 10- 4 M 
DL-MTX). were unstable in the absence of MTX 
(Fig. 2 and Table 1 ); in fact. they gradually lost 
all or . in one case. most of their excess DHFR 
activity over periods ranging in different vari-
ants between 25 and 200 days . The cell line 6A3 
was unique in that it showed a biphasic loss of 
the excess DHFR activity: this declined to about 
307( in 50 days . and thereafter decreased only 
very slowly to reach -107( in 400 days. 
The loss of DHFR activity in the MTX-resis-
tant variants in the absence of selection was 
accompanied by the loss of drug resistance. 
Thus. 10B3 cells which had been adapted to 
grow in the presence of 1.2 x 10-4 M DL-MTX 
(DHFR specific activity of 10.4 x 103 U/mg of 
protein) and were then maintained in the ab-
sence of the drug for 7 weeks (during which time 
the DHFR activity had dropped to -17% of the 
original value) gave only 0.37C survivors when 
challenged again with 1.2 x 10- 4 M DL-MTX. 
These survivors showed the same level of en-
zyme activity and. upon removal of the drug. the 
same degree of instability of MTX resistance as 
the original variants (Fig . 2). 
Chromosome constitution. An analysis of the 
chromosome constitution of the MTX-resistant 
variants again revealed a marked variability. As 
illustrated in Table 1 and Fig . 3 and 4. which 
present the results of an analysis carried out 
within the first 6 months of maintenance of the 
variants in the presence of 1.8 x 10-4 M DL-
MTX. some cell lines exhibited predominantly a 
number of chromosomes close to that of their 
parental line . and others exhibited predominant-
ly a duplicated number of chromosomes. This 
variability in chromosome number was also ob-
served among sublines derived from the same 
original clone . as can be seen for the 1 OC sub-
lines . One interesting observation is that. in all 
cases where no duplication of the chromosome 
complement occurred . the modal number of 
chromosomes in the MTX-resistant variants was 
lower than in the corresponding parental line 
(Table 1 and Fig . 3 and 4) . 
The most striking feature of the chromosome 
constitution of the MTX-resistant variants was 
the presence of double minute chromosomes. 
small. acentromeric chromosomal elements. 
which were absent or very rare in the parental 
obcdefgh k m n 
BSA 









FIG . 1. Electrophoretic patterns in sodium dodecyl sulfate-polyacrylamide gel of the cell extracts from the 
parental lines and from the eleven MTX-resistant variants described in this work . Lanes : a. BU25 (- BUdRJ; b. 
BU25 ( + BUdR): c, !OBI ; d. 1082 : e. 1083; f. lOCI ; g. IOC2; h. IOC3 ; i. 140: j. 6A2: k. 6A3 : I. 702; m. 703; n. 
VA 2-B . 
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FIG. 2. Quantitative behavior of the DHFR activity of the MTX-resistant variants after removal of the 
selective pressure. The curve designated 1083-R+ refers to partial revertants of 1083 cells resistant to 1.2 x 
10-• M DL-MTX which had been maintained for 7 weeks in drug-free medium and which had then survived 
reexposure to the same concentration of the drug. See text for details . The curve designated I 083, refers to cells 
resistant to 1.8 x 10- 4 M DL-MTX ; an identical curve was obtained for cells resistant to 1.2 x 10- 4 M DL-MTX. 
cell lines (Table 1 and Fig. 3. 4, and 5). As 
indicated by their name. the minute chromo-
somes appeared typically in pairs , though the 
distance between the members of each pair was 
highly variable ; furthermore , the minute chro-
mosomes frequently appeared as unpaired ele-
ments . In this paper, we refer to the minute 
chromosomes. whether single or in pairs, as 
double minute chromosomes or double minutes , 
although for quantitative purposes the minute 
chromosomes have been counted individually . 
They varied considerably in size and stainability 
with orcein. The predominant size and stainabil-
ity of the double minutes of the individual cell 
lines tended to be reproducibly different (com-
pare, for example , the double minutes of the 6A3 
[Fig. 5D], 10C3 [Fig. 5E], and 7D3 [Fig. 5F) 
cells) . 
The number of double minute chromosomes 
varied greatly among different MTX-resistant 
variants, even among sublines. Some variants 
(lOBI, 10B2, 10B3, and 14D) exhibited a rela-
tively small average number per cell of recogniz-
able double minutes (8 to 26) (Fig. 3 and 5C) ; in 
these variants, an analysis of the distribution of 
the number of these elements per cell in each 
cell population revealed very wide fluctuations . 
from 0 to more than 100 per cell (Table 1). Other 
variants (10C3, 6A2, 6A3 , and 7D3) had a large 
average number of double minutes per cell (120 
to 220) (Fig. 5D, 5E, and 5F); others (10C1, 10C2 
and 7D2) had an intermediate number. In both 
cases there was again a wide range of values in 
each cell population (Table 1 and Fig. 3 and 4) . 
An examination of Table 1 shows the absence of 
any correlation in the various MTX-resistant 
variants between the average number of double 
minutes per cell and either the level of DHFR 
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FIG. 3. Frequency distribution of number of chro-
mosomes and number of double minutes per cell in the 
parental line BU25 (- BUdR) and its MTX-resistant 
derivatives 1083. lOCI. and IOC3. The arrow pointing 
to the ordinate axis in the uppermost right panel 
indicates the number of cells with no double minutes. 
activity or the degree of instability of the in-
creased DHFR level upon removal of MTX. 
Thus. the variants lOBI. 10B2. and 10B3 had a 
much smaller number of identifiable double min-
ute chromosomes than did the 10C2 and 702 
variants, yet they lost their excess DHFR activi-
ty much faster. The line 10C3 had three times as 
many double minutes as the line lOCI, yet they 
lost their excess DHFR activity at the same rate. 
Correlation of loss of double minute chromo-
somes and loss of DHFR activity upon removal of 
MTX. In mouse cell lines with unstable MTX 
resistance. a phenotype which in these cell lines 
appears to be correlated with the presence of 
double minute chromosomes, removal of the 
selective pressure leads to the loss of the double 
minutes (17). The same observation has been 
made here in the human MTX-resistant variant 
6A3. When a suspension culture of these cells 
was grown for 6 days in the absence of MTX. the 
average number of double minute chromosomes 
dropped from 150 to 59. These cells were then 
tested for the behavior of the DHFR activity and 
the number of double minute chromosomes 
upon further growth in the absence of MTX. 
Both DHFR activity and the number of double 
minutes declined progressively over the next 100 
days (fig. 6A) . However , the kinetics of loss of 
enzyme activity. which paralleled that observed 
in cells grown on plates (Fig. 6A). differed 
significantly from the kinetics of loss of double 
minute chromosomes, which was likewise simi-
lar to that observed in cells grown on plates 
(data not shown). As mentioned above. the 
observed loss of DHFR activity from 6A3 cells 
was biphasic. with a phase of rapid loss superim-
posed upon a slow loss (fig. 2). When the 
contribution of the slow decrease was subtract-
ed from the individual values of DHFR activity, 
the resulting curve. which represented only the 
rapid loss of DHFR activity, showed an excel-
lent agreement with the kinetics of loss of double 
minute chromosomes (Fig. 6B). One could cal-
culate in this experiment that for every minute 
chromosome lost there was a decrease of about 
80 U of DHFR activity . 
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FIG. 4. Frequency distribution of number of chro-
mosomes and number of double minutes per cell in the 
parental line V A~-B and its MTX-resistant derivatives 
6A2. 6A3. 702. and 703 . 
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FIG . 5. Representative orcein-stained metaphase spreads from the BU25 (-BUdR) (A) and VA~-B (8) 
parental cell lines and from the MTX-resistant variants 1081 11 (C) . 6A34 (D). lOC3. (E ). and 703. (F) . 
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FIG. 6. Quantitative behavior of the DHFR activity and number of double minute chromosomes per cell in 
the variant 6A3 after removal of the selective pressure. (A) Original data pertaining to cells grown in two spinner 
cultures and on plates . (B) DHFR data for one spinner culture . corrected by subtracting the contribution of the 
relatively stable DHFR fraction. See text for details . 
DISCUSSION 
In the present work . all the human cell vari-
ants isolated for their resistance to 1.8 x 10-4 M 
DL-MTX exhibited a greatly increased DHFR 
activity. Work reported elsewhere (C. Morandi . 
1. Masters , M. Mattes , and G. Attardi , J. Mol. 
Bioi. . in press) has revealed a large increase in 
the amount of DHFR-specific mRNA in the 
several variants which have been analyzed , de-
rived from both the V A~-B and the HeLa BU25 
parental lines . Furthermore , a genomic analysis 
of the 6A3 , 7D3 , and 10B3 cell lines , using 
probes derived from cloned DHFR eDNA, has 
shown a large increase in DHFR-specific DNA 
sequences as compared to the parental lines 
(unpublished observations). Therefore , it seems 
reasonable to conclude that a DHFR gene ampli-
fication has occurred in the human variants 
investigated here. 
Although the resistance to high levels of MTX 
and the underlying basic mechanism appeared to 
be a common denominator of all of the variants 
investigated here , a striking diversity in growth 
behavior , relative level of DHFR activity or 
DHFR protein . chromosomal constitution, and 
degree of instability of the phenotype in the 
absence of selective pressure was observed 
among the various resistant cell lines analyzed in 
the first 10 months after their isolation and even 
among the sublines deriving from the same origi-
nal MTX-resistant clones. Another aspect of the 
variability observed in the properties of the 
human MTX-resistant cell lines was the dynamic 
character of the changes detected , which was 
most obvious in their growth behavior and in 
their chromosome constitution . 
In the cell lines 10C2 and 10C3, the detectable 
amount of DHFR protein was reproducibly 
much lower than that found in other variants 
exhibiting a similar increase in DHFR activity; 
this observation may indicate the occurrence in 
these variants of a structural gene mutation 
resulting in a protein product with a reduced 
affinity for MTX and an increased specific activ-
ity . 
No completely stable MTX-resistant human 
variant has been found so far, in contrast to what 
has been reported for mouse and hamster cell 
lines. Although we have only limited data on this 
point , it does not seem that the above-mentioned 
difference merely reflects the fact the variants 
analyzed here represent relatively recent iso-
lates . In fact , two of the variants (6A2 and 7D2) , 
which were examined after 8 to 10 months of 
growth in the presence of 1.8 x 10-4 M DL-
MTX, exhibited an instability of phenotype 
comparable to that of the other variants. In some 
of the mouse MTX-resistant cell lines previously 
investigated by others, stability of the pheno-
type has been shown indeed to arise during 
prolonged growth in selective medium (17); 
however, other mouse and Chinese hamster cell 
lines have exhibited a stable resistance to the 
drug very early after their isolation (10, 26) . 
The most striking alterations observed in the 
variant cell lines analyzed here are the anoma-
lies found in their chromosome constitution . 
These anomalies involved a change in chromo-
some number and the presence of double minute 
chromosomes. A third type of alteration . i.e .. 
the appearance in one or more identifiable chro-
mosomes of some variants of a homogeneously 
staining region (HSR) containing DHFR genes , 
analogous to that described in Chinese hamster 
and mouse MTX-resistant cell lines with stably 
amplified DHFR genes (7, 10, 26) , will be de-
scribed elsewhere (H. Gay, B. Maurer, and G. 
Attardi , manuscript in preparation) . 
The occurrence of a duplicated set of chromo-
somes in most cells of the population . as has 
been observed here in some of the MTX-resis-
506 MASTERS ET AL. 
tant variants, has not been reported previously 
in MTX-resistant cell lines. It seems likely that 
this chromosome duplication event, which oc-
curred during the development of the resistance 
to MTX . conferred an advantage upon the cells 
undergoing it by rapidly doubling the DHFR 
gene complement and therefore, presumably, 
the cell content in DHFR. Consistent with this 
interpretation is the observation that , in variants 
with a duplicated set of chromosomes, the chro-
mosome(s) containing an HSR is present in 
duplicate (Gay et al.. in preparation) . 
All MTX-resistant variants investigated here 
exhibited the presence of double minute chro-
mosomes. Such small. acentromeric elements 
have been described previously in many experi-
mental and human tumors (for references. see 
references 3 and 21 ), where they are relatively 
stable in the absence of any known selective 
pressure . Recently , it has been reported that the 
double minutes from a mouse adrenocortical 
tumor contain amplified DNA sequences (14) . 
Furthermore, the presence of double minutes 
has been described in several MTX-resistant 
mouse cell lines , and evidence has been present-
ed strongly suggesting that these elements con-
tain amplified DHFR genes (26). In the present 
work. the observation of a parallel loss of double 
minute chromosomes and DHFR activity in the 
variant 6A3 is likewise consistent with the idea 
that, in this variant, such elements contain 
DHFR genes . Preliminary in situ hybridization 
experiments with a high-specific-activity probe 
derived from cloned DHFR eDNA have provid-
ed direct evidence of the presence of DHFR-
coding sequences in double minute chromo-
somes from several MTX-resistant human 
variants (B. Maurer, unpublished observations). 
We do not know whether and to what extent the 
differences in size and stainability with orcein of 
the double minute chromosomes observed in 
cells of different human variants and among cells 
of the same variant and within the same meta-
phase can be accounted for by a variability in 
chromosome condensation. However. the re-
producibility of the differences detected in the 
appearance of double minutes in the various 
resistant cell lines suggests the possibility that 
the amount of DNA can vary among different 
minutes. Such differences in DNA content may 
conceivably reflect a variation in the size or 
number (or both) of the amplified units con-
tained in each minute . On the other hand, the 
observation that the double minute chromo-
somes vary greatly in number in different vari-
ants having a comparable degree of DHFR gene 
amplification (as estimated from the increase in 
DHFR activity [present work) and the increase 
in DHFR mRNA and DHFR specific sequences 
in the genome [unpublished observations)) with 
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no obvious inverse relationship between their 
number and their size or stainability suggests 
that there must be another set of DHFR genes. 
representing a varied portion of the total. which 
is associated with the regular chromosomes . 
Recent observations indicate that. in some . but 
not all, variants, these chromosomal genes are 
located in HSRs associated with identifiable 
chromosomes (Gay et al., in preparation) . 
In previous studies on mouse MTX-resistant 
cell lines, the instability of the resistance in the 
absence of selective pressure has been found to 
be associated with the presence of double min-
ute chromosomes: furthermore. in subpopula-
tions of these unstable cell lines. a rough propor-
tionality has been observed between the number 
of double minutes and the number of amplified 
DHFR genes (26) . More recently. in uptake 
mutants of neuroblastoma cells. unstable drug 
resistance has also been correlated with the 
presence of double minute chromosomes (41. It 
has been hypothesized that. in the above-men-
tioned cell lines. unequal distribution of the 
double minutes at cell division and selective 
growth advantage for cells with lower numbers 
of these elements would account for the instabil-
ity of the phenotype (17) . The observations 
made in the present work may point to a more 
complicated situation in the human MTX-resis-
tant variants. In fact, the average number of 
identifiable double minutes per cell in these 
variants has been found to be totally unrelated to 
the rate of loss of the excess DHFR activity in 
the absence of MTX . Our data suggest that 
instability of MTX resistance may also be asso-
ciated with a chromosomal localization of the 
amplified units , and depend on a particular sus-
ceptibility of these chromosomal genes to be 
lost. Preliminary observations indicate that the 
presence of these unstable chromosomal genes 
in the human MTX-resistant variants is not 
obligatorily correlated with the occurrence of 
morphologically recognizable HSRs. An insta-
bility of MTX resistance associated with a re-
duction in size of the HSR present in an identifi-
able chromosome has been reported in a 
hamster cell line (J. L. Biedler and B. A. Speng-
ler, J. Cell Bioi. 70:117a, 1976). 
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The programming capacity for the synthesis of human dihydrofolic acid reductase 
in a rabbit reticulocyte lysate has been found to be greatly enhanced in the 
polysomal poly(A)-containing R::\A from a methotrexate-resistant human cell 
\·ariant (6A3), as compared to the R~A from its parental line (VA 2-B). A major 
fraction of this promoting activity is associated with a 3·8 x 103 base RNA species 
detectable as a band in the ethidium bromide-stained electrophoretic pattem of the 
RXA from 6A3 cells . but not in the RXA from \' A2-B cells. Furthermore. sucrose 
gradient fractionation experiments have indicated that another substantial portion 
of the messengf'r activity is associated with R~A components around 103 bases in 
size. Double-stranded complementary DNA synthesized from total poly(A)-
containing RXA of 6A3 cells has been size fractionated . and both large (1400 to 
3800 base-pairs) and small size complementary DNA (600 to 1400 base-pairs) 
species have been used separately to transform EscherichW. coli x2282 with pBR322 
as a \'ector . Of 76 transformants obtained with the large size complementary DNA, 
identified by a differential colony hybridization assay, none has expressed the 
dihydrofolic acid reductase coding sequence in E. coli , as judged by resistance to 
trimethoprim. By contrast, eight trimethoprim-resistant transformants have been 
obtained using the small size complementary DNA, and their plasmids have been 
shown to contain the dihydrofolic acid reductase coding sequence by restriction 
mapping and DNA sequencing ; moreover, immunoautoradiographic experiments 
have revealed the presence in the extracts of two of these transformants of a 
protein with the electrophoretic mobility and immunoreactivity of human 
dihydrofolic acid reductase. Restriction mapping and DNA transfer hybridization 
experiments have further indicated that the inserts of the chimaeric plasmids 
conferring trimethoprim resistanct> upon the host and of those lacking this capacity 
cover together a complementary DNA region of about 3·35 x 103 base-pairs, in 
which the 564 base-pair dihydrofolic acid reductase coding stretch is located near 
the 5' end of the sense strand. RNA transfer hybridization experiments using 
different cloned complementary DNA fragments as probes have shown the 
presence of three species of dihydrofolic acid reductase-specific messenger RNAs, 
with sizes of 3·8 x 103 , 1·0 x 103 and 0·8 x 103 bases, differing in the length of the 3' 
t Present address: Istituto di Genetica. Universitil di Pavia. 27100 Pavia. Italy. . . . 
0022-2836/82/110583-25 $03.00/0 
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untranslated region. in the poly(A )-containing RX A from two methotrexate-
resistant ,-ariants. tiA3 and IOB3. and , in greatly reduc-ed amounts . in the RXA 
from thei r respectin· parents. VA 2B and HeLa BU25. 
1. Introduction 
In re<·ent years . several mammalian cultured cell systems have been described that 
ha ,-e de,·eloped resistance to high concentrations of the foli c acid analog 
methotrexate as a result of exposure to gradually increasing concentrations of the 
drug (Hakala PI rd .. 1961 : Littlefield . 1969 : Biedler el a! .. 1972 : Flintoff el a! .. 19i6: 
.-\It PI rd .. Hl7() : Xunberg el a! .. 19i8: Bostock eta! .. 19i9). The most common 
mechanism of this resistance has been shown to be a selective amplification of the 
strurtural geJH• for dihydrofolir acid reductase. the target enzyme of the drug (Ait 
et rd .. Hl78: Xunberg el a! .. 1978: Dolnick eta!.. 19i9 ; Melera eta! .. 1980). with 
resulting overproduction of the DHFRaset messenger RXA (Chang & Littlefield . 
1976 : .-\It el a! .. 19i8: Melera el a! .. 1980) and of the enzyme (Hakala eta! .. 1961 : 
Littlefield . 1969 : Biedler el a! .. 19i2 : Flintoff el a! .. 1976: A It el a! .. 1976 : X unberg 
el a! .. 1978) . The eontent of the latter in the above-mentioned methotrexate-
resistant cell lines is in creased up to several hundred-fold . reaching levels exceeding 
the amount inartivated by the drug . 
The recent availability of cloned DHFRase specifi c cDXA from methotrexate-
resistant mouse cells (Chang el a! .. 1978) has allowed a detailed analysis of the 
mouse DHFRase mRXA (f:ietzer eta! .. 1980). One intriguing result of this analysis 
has been the demonstration of the occurrence of four functional DHFRase mRXAs. 
ranging in size from i50 to 1600 nt . in cultured mouse cells with or without 
amplified DHFRase genes and in mouse liver. These mRXAs appear to differ 
prim a ril~- in the size of the 3' untranslated region . Multiple DHFRase mRXAs have 
also been detected in Chinese hamster ovary cells resistant to methotrexate (Setzer 
el rd .. 1980). The origin and significance of this multiplicity of forms of DHFRase 
mRXA are unkn own. 
We have isolated and partially characterized several methotrexate-resistant cell 
variants derived from two different human Jines. He La BU25 and V A2-B (:\1asters 
eta!. , 1982) . In these methotrexate-resistant variants , the DHFRase has been 
shown to be increased to levels comparable to those observed in methotrexate-
resistant mouse and Chinese hamster cell lines . In the work reported here. a 3·8 kb 
RXA component. i.e . a species about seven times as long as the DHFRase coding 
stretch . has been detected in the ethidium bromide-stained electrophoretic pattern 
of the polysomal poly(A)-containing RXA from these cells, but not in the pattern of 
RXA from the parental cells. This RXA has been functionally characterized as 
DHFRase mRXA : furthermore , the occurrence of smaller size DHFRase-specific 
mRXAs. besides the 3·8 kb component , has been demonstrated in a methotrexate-
resistant variant by translation assays in vitro. cDN"A copies of these mR~As have 
been cloned in Escherichia coli , and the sequence coding for the human DHFRase 
t Abbreviations used : DHFRase. dih~·drofolic acid reductase ; cD!'\A . complementar~- D~A ; kb. 103 
bases or base-pairs; bp . base -pairs ; nt . nucleotides ; IgG . immunoglobulin G ; ds- . double-stranded: 88-. 
single-stranded. 
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shown t o be expressed in the bacterial host. By us ing these c loned cD~A probes. it 
has been fo und that there are at least three different forms of human DHFRase-
specific mRXAs. which haYe in common the polypeptide coding sequence near the ir 
5' end. and differ in the length of the 3' untranslated region . 
2. Materials and Methods 
(a) Materials 
DL-:'IIt-thotrexate (consisting of -.50°-0 L-form) and trimethoprim were from Sigma, 
oligo( <iT) 12 _ 18 from .\lil e~ Lab . Inc .. oligo(dT)-cellulose (T3) from Collaborative Research . 
methylmen·uric h~·droxide from Alpha products, restriction enzymes from Xew England 
Biolabs or from Bethesda Research Laboratories , Aspergillus orizae 8 1 nuclease from Sigma. 
E . roli DXA pol~·merase I from Boehringer-Mannheim, calf thymus terminal transferase 
from PL Biochemicals. reticulocyte lvsat~ from Bethesda Research Laboratories . Pansorbin 
from C'albiochem. , and Seaplaq~e Agarose from Marine Colloids. 
(b) Cell lines and methods of growth 
The human cell line\' A2 -B , an azaguanine-resistant subclone of the simian virus 40 (SV 40) 
transformed line \\'I-18-\ 'A 2 (Ponh\n et al. , 1963) was grown in suspension in Eagle 's 
phosphate medium supplemented with 3 f--Lg 8-azaguanine/ml and 5°;0 (v/v) calf serum. The 
human cell line HeLa Bl'25. a mutant subline of HeLa S3 deficient in thymidine kinase 
activity (Kit eta/ .. 1966) . kindly provided by DrS. Kit. was grown in suspension in Eagle 's 
phosphate med ium supplement~d with 10° 0 (v/ v) calf serum . The methotrexate-resistant 
variants of the \'A 2 -B cell line (6A3) and of the BC25 cell line (IOB3. lOCI. IOC2 and I0C3) 
were grown in suspension in the media described above . supplemented with 10% (v/ v) 
ex tensiHly dialyzE>d calf serum and 1·8 x 10- 4 ~1-DL-methotrexate . 
(c) Extraction and analysis of cytoplasmic RSA 
Cytoplasmic polysomal RXA was prepared essentially as described by Padgett et al. 
(1979) . The polysome pellet , separated from the I2 ,000g supernatant of the cell lysate by 
centrifugation through aIM-sucrose cushion, was resuspended in 0·01 M-Tris (pH 7·0), O·I M-
KaC'l. 0·001 M-EDTA . 0·5% (w/v) sodium dodecyl sulfate (0·6 to I ml per gram of cells). After 
incubation for I h at room temperature with IOO f--Lg of self-digested Pronase/ ml , the RXA 
was extracted 3 times with phenol/chloroform/isoamyl alcohol (25: 24: I , by vol.). Following 
precipitation with ethanol. the Pronase/phenol extraction procedure was repeated. Poly(A)-
containing RXA was isolated by passage through an oligo(dT)-cellulose column according to 
Amalric et al. (I978). 
Fractionation of the poly(A)-containing RXA by electrophoresis through a I ·2% (w/v) 
agarose/CH 3HgOH slab gel was carried out as described by Bailey & Davidson (I976) , 
except that the concentration of CH 3 HgOH in the gel was 20 mM and the electrophoresis 
buffer was 50 mM-sodium borate (pH 8·2). 0·1 mM-EDTA . The gels were stained with 
ethidium bromide (I 1-Lg/ml in 0·5 M-ammonium acetate) . For the isolation from the gel of an 
RXA cut containing the 3·8 kb DHFRase mRNA, the method of\Vieslander (I979) , utilizing 
low melting temperature Seaplaque agarose for the preparation of the gel and extraction of 
the RXA with phenol from the melted agarose. was followed. 
For preparative fractionation in a sucrose gradient under denaturing conditions, 200 f--Lg of 
poly( A)-containing RXA were denatured with 20 mM-CH 3HgOH in a 500-~--Ll volume and run 
through a 5% to 20<).0 (w/v) sucrose gradient in I mM-Tris (pH 6·7), I mM-NaCl , I mM-EDTA 
(Cantatore & Attardi. I980) in a Beckman SW4I rotor for 13 h at 35,000 revs/ min at 2°C. 
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(d) Preparation of antibodies against human DH FRase 
Tht> human DHFRast> was purifit>d from mt>thotrexate-resistant V A2-B 6A3 cells as 
dt>~<:rilwd b~· ~[orandi & Attardi (1981 ). Two rabbits wen· injected subcutaneously in the 
back 4 timPs. at I month inten·als. with I mg of pure enzyme in 50 m)l-potassium phosphate 
(pH /·0). t>rnu lsifit>d with an equal ,-olume of Frt>und ·s complete adjU\·ant. Blood (40 ml) was 
collt>ctt>d from t>a!'h rabbit e\· Pr~- 2 wpeks for 4 months. starting 4 weeks after the 4th 
injt>ction. The IgG fraction was purified as described by Palmiter eta/. (1971): the 
DHFRase-spe('ifk IgC content wa;; estimated to be about 3°0 of the total IgG from tht> 
prt>ripitin rurw (Kabat & ~layer. 1948). 
(e) Translation in ,-itro 
The rabbit rt>til'ulor\·te in ritro translation svstem was used under tht> conditions 
suggt>stl:'d by tht> vend-or. using I 0-1-.d reaction ~ixtures and ( 35S]methionine. For the 
analysis of thl:' sucrose gradit>nt fractions. an equal volume of each fraction was used. For 
indirt>d immunoprt>cipitation (Kessler. 1975). 5 1-'1 of each reaction mixture were diluted with 
9.5 1-'1 of XET buffpr (50 m~t-Tris (pH /·4) . 150 m~1-XaCI. 5 mM-EDTA, 0·25°0 (w/v) sodium 
dodeeyl sulfatE>. 0·/;) 0 0 (v ,l\·) Triton X-100) containing 2 ruM-methionine and 1001-'g 
o\·albumin/ml. Tht>n ;) 1-'1 of prt>-immune serum were addt>d and the samples left overnight at 
4°C. After addition of 30 1-'1 of 10°0 (v/ v) Pansorbin (fixed Staphy/oc.oc.cu-• aureu.s cells). the 
mix turps wl:'re left on ice for 20 min and centrifuged for 30 sin an Eppendorf microfuge. The 
supernatants were transferrt>d to new tubes. each mixed with 5 1-'1 of anti-DHFRase 
antiserum (st>e bt>low). incubated at 4°(' for 3 hand then treated with Pansorbin as before. 
The Pansorbin pellets were washed 3 times with XET buffer. and the proteins eluted with 
0·063 M-Tris (pH 6·8). 0·002 )1-mt>thionine. 2°.0 (wj,·) sodium dodecyl sulfate at room 
temperature for I h. After centrifuging the insoluble residues , the supernatants were 
remo,·ed and ele!'trophoresed using the Laemmli sodium dodecyl sulfate/polyacrylamide gel 
system (Laemmli. 1970). with 15°0 (w/v) polyacrylamide in the separating gel and 5'?0 (w/v) 
polyacrylamidt> in the stacking gt>l (acrylamide to bisacry lamidt>. 30. 0·8 (w/w) in both gels). 
The gels wt>re trt>ated for ftuorography according to Laskry ( 1980). 
(f) Cloning of double-stranded cDSA. 
Douule -strandt>d cDXA was synthesized following published procedures (Efstratiadis & 
\"illa -Komaroff. 1979 : Friedman & Roshach. 1977: Buell eta/. , I978). For single-stranded 
cDXA synthesis. ,-anadyl ribonucleoside complex (BRL) was included in the reaction 
mixture at a concentration of 4 m~l as an RXAase inhibitor (Berger & Birkenmeier, I979: 
Rice & St rauss. 1981 ). The concentration ofpoly(A)-containing R~A was 500 1-'g/ ml, and the 
ratio of 5 units of a ,-ian myeloblastosis virus reverse transcriptase per 1-'g of RXA was found 
to be optimal for the synthesis of large cDXA. 
The double-stranded cDXA was fractionated on a 5°0 to 20°0 linear sucrose gradient in 
10 mM-Tris · HCI (pH 8·0). 300 m)l-sodium acetate . I mM-EDTA. by centrifugation in a 
Spinco S\\'41 rotor at 37 .000 revs/min for 14 hat 19°C. 
The pBR322 DXA was linearized by Pstl. electrophoresed through an agarose gel in 
40 m~1-Tris · HCI (pH 7·8) . 5 mM-sodium acetate. I mM-EDTA. eluted according to Yang 
eta/ . (1979). and then dG-tailed according to Roychoudhury & Wu (1980): an average of 
about 13 dG~lP molecules was added to each 3' end. The double-stranded cDXA was dC-
tailed in the same way. with 9 to 16 dCMP molecules being added to each 3' end. Equimolar 
amounts of tailed cDXA and tailed pBR322 were then annealed according to Steinmetz el a/. 
(1981 ). 
(g) Transformation of E. coli 
E. coli strains x2282. a thy+ variant of xi776 (Chang eta/ .. I978). and HBIOI (Boyer & 
Roulland-Dussoix. 1969) were used with the indicated plasmids. All work was done in 
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accordance with the Xational Institutes of Health Guidelines (1980) for recombinant DXA 
resea rC'h . x2282 E. roli eells were transformed with pBR322 containing human DHFRase 
cD XA insert s according to a procedure described by D. Hanahan (personal communication ). 
The recombinant colonies. which were obtained at a frequency of approximately I 0 per ng of 
DX.-\. were replica plated in duplicate onto nitrocellulose filters , and those containing 
DH FRase sequences were identified by differential hybridization screening (St. John & 
Da,·is. 1979 : \\'ahl el a/ .. 1979) . For this purpose. twin replica filters were incubated with 
5 x 105 cts/min per filt er of 32 P-Iabeled cDX.-\ prepared from total poly(A)-containing RXA 
of ei ther \.A2-B or 6A3 C'ells. for 20 h at 42cC in 50~0 (,- ; ,·) formamide . 50 mM-sodium 
phosphate (pH 6·8). 5 X sse (Sf.IC is 0·15 M-XaCI. 0·015 M-sodium citrate. pH 7). IO~o (w/v) 
dextran sulfatP. I x Den hardt 's solution (0·02° 0 (w j \·) Ficoll. 0·02° 0 (wf\· ) poJy,·inyl-
pyrrolidone. 0·02°0 (w/ ,·) bovinP serum albumin (Denhardt. 1966)). 0·1°0 (w/ v) sodium 
dodPcyl sulfatP and 100 1-'-g of hPat-denaturPd. sonicated salmon sperm DXA /ml. ThP filters 
were rinsed oncp for 20 min at 42 T in hybridization buffer. then 3 times for 30 min at 68°C in 
2 x s:-;c. 0·1 ° 0 (w; ,·) sodium dodecyl sulfate. and once for 30 min at 68 ' (' in 0·5 x'SSC. For 
direet phPnotypir selection of clones that synthesize human DHFRase. the tetracycline-
resistant transformants were repli ca plated on agar plates in :\19 medium supplemented with 
diaminopimelic acid (I 00 1-'-g/ml). tetrac~·clinP (10 1-'-g/ ml) and trimethoprim (4 1-'-g/ ml). HBIOl 
cells were transformed according to th e procedurt> described by Cohen el a/. (1972) . 
(h) Plasmid DSA preparation 
Plasmid-!'ontaining E. coli x2282 wpre grown to saturation in LB broth. supplemented 
with 100 1-'-g diaminopimeliC' acid/ml and 15 1-'-g tetracycline/ ml at 37°C'. under vigorous 
shaking. Cells were han·ested and processed as described by Haseltine el a/. ( 1980). with the 
modifications that the cleared Triton X-100 bacterial lysate was incubated at 65°C for 15 
min and the denaturPd prote ins pelleted. and subsequently the macromolecular components 
of the supernatant werP concentrated by precipitation with 10°0 (w/v) polyeth.\'lene glycol 
6000 for at least 2 h in ice before the CsCI/EthBr density-gradient centrifugation. 
Plasmids harbored by E. coli HBIOI w<>rt> prepared in the sam<> way . except that plasmid 
duplication during growth was indurt>d by chloramphenicol (Clewell. 1972). For rapid 
plasmid DX A isolation . tht> tetrar~·cline-resistant plasm ids were grown in 10 ml of LB broth 
culturP. as dt>scribed by Davis el a/. (1980). 
(i) Re8lriction enzyme analysis 
Plasmid DXA was treated with rt>striction enzymes und<·r conditions recommended by the 
vendors and the products werP electrophoresed on either agarose gels using Tris-
acetate/EDTA buffer (McDonnell et al.. 19i7) or polyacrylamide gels using Tris-
borate/ EDTA buffer (Maniatis el a/ .. 1975b). and stained with ethidium bromide. DXA 
restriction fragments were isolated from slab gels by the electroelution method of Yang el a/. 
(1979) 
( j) Preparati.on of radioar.t1:1'e probes 
32 P-Iabeled. random primed cDXA was prepared from total poly(A)-containing RXA of 
\.A 2-B or 6A3 cells according to :\fullins el a/. (1980). using lOOng of RXA .. )Of-LC'i of [l-
32P]dCTP (800 Ci/mmol) and the other unlabeled dNTPs at 100 f-LM. 15 units of reverse 
transcriptase and 4 1-'-g of calf thymus primer DXA, kindly provided by Dr J. Casey (Dept. of 
Biochemistry , Louisiana State University Medical Center). in a reaction volume of 25 1-'-1. 
Total plasmid DNA and isolated restriction fragments were nick-translated according to 
Maniatis el al. (1975a) in 25-1-'-1 reaction volumes containing 100 ng of DNA. I 1-'-g 
DXAase 1/ ml. 2 units of E. coli DXA pol~·merase I. 25 1-'-Ci of [:l.· 32 P]dCTP (2000 to 3000 
Ci/mmol) and the other unlabeled dNTPs at 20 f-LM. 
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(k) RSA and DSA transfer techniques 
R:\A transfer to nitrocellulose was done according to Thomas (1980). using the 
formaldehydf' gel systf'm of Ran el a/. ( 1979): 5 J.Lf?. of RXA per sample were used. 
Quantitati\·f' transfer of RXA~ a~ largf' as :28 S ribosomal RXA was accomplished without 
trf'ating thf' gel bf'fore transff'r. Hybridization with probes 32 P-labeled by nick translation 
wa~ done in 50°0 (\'/Y) formam ide. 0·0:2 :'>!·SOdium phosphate (pH 6·8). 5 X SSe. 0·1% (w j \·) 
sod i urn dodecyl sulfate. 10° 0 (w /\·) dextran sulfate. I 0 x Denhardt 's solution at 42°e for 10 to 
15 h. Thf' filters Wf're then washed for I h at 4:2°(' with 5 X sse. 0·1 ~-0 sodium dodecyl sulfate. 
IOxDenhardt',: solution. and then at 68 ' C for :2h with :2xSSC. 0·1°;0 sodium dodecyl 
sulfate. and for 2 h with 0·5 X SS('. with 2 buffer changes in each case. 
(I) D SA 8equenring 
Sequencing reactions \\·f'rf' carried out as described by :\Iaxam & Gilbert (1980). The 
pH D84 plasmid was cut with EroRI at the single pBR322 site and at the single site in the 
insert loeatf'd at 137 nt from the closer Psti site. After fill-in labeling the 3' ends with[~-
32PjdXTP~ and the Klenow fragment of E. coli D:\A polymerase I or labeling the 5' ends 
\\·ith [y- 32 P]ATP and phage T4 polynucleotide kinase subsequently to treatment with 
baPterial alkaline phosphatase. the labeled fragments were digested with Pstl. The 137 nt 
fragment of the insert. 32 P-labeled at the EroRI-produced end in one or the other strand . 
was then isolated on a polyacrylamide gel. eluted and subjected to the sequencing reactions. 
(m) lmmunoautoradiography of E. coli extracts 
E. roli x2282 carrying tetracycline-resistant and trimethoprim-resistant plasmids were 
grown on"rnight in 50 ml of :\19 medium supplemented with 0·5°0 (w/ \') Casamino acids 
(DIFCO). 0·2° 0 (wf,·) gluc·ose. 201-'-g thiamine/mi. 101-'-g biotin/ml: tetracycline was used at 
J;) 1-'-g!ml. trimethoprim . when appropriate. at 0·1 mg/ ml or 1 mg/ ml. The cells were 
han·e~ted. washed with saline. resuspended in 1·5 ml of 50 mM-potassium phosphate 
(pH 7·0) and sonieated with a Branson sonifier equipped with a microtip at maximum power 
setting 3 times for 5 s. After spinning down the eell debris. the supernatant was run through 
a sodium dodecyl sulfate/ 12·5~0 (w/Y) polyacrylamide gel (acrylamide to bisacrylamide. 
37·5: I). Intubation of the slab gel with anti-DHFRase IgG and 1251-labeled protein A was 
carried out as described by Granger & Lazarides (1979) , using an IgG solution at 175 J.Lg/ml 
and ~ 10 1-'-Ci of 125 1-labeled protein A. The dried gel was exposed for 1 month at -60°C 
using a preflashed film and a DuPont Cronex intensifying screen. 
3. Results 
(a) Detection and assay of DHFRase mRSA in ,·itro 
Preliminary to the cloning of the DHFRase mRXA. an investigation of the 
DHFRase mRXA in methotrexate-sensitiYe and resistant cell lines was carried out. 
In preYious experiments im·olYing sodium dodecyl sulfate/polyacrylamide gel 
electrophoresis of cell extracts of methotrexate-sensitive and resistant human cell 
lines. a pronounced band corresponding to DHFRase was observed in the 
C'oomassie blue-stained patterns of methotrexate-resistant. but not in those of the 
methotrexate-sensitin cell extracts (Morandi & Attardi. 1981; Masters et al .. 
1982). In order to investigate whether a corresponding accumulation of 
DHFRase-specific mRXA in the form of discrete band(s) could be detected in the 
RXA from the resistant variants. cytoplasmic polysomal RNA was isolated from 
the parental cell lines VArB and HeLa Bu25 and from their respective 
methotrexate-resistant variants 6A3 and IOB3. When the poly(A)-containing RNA 
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fractions of these preparations were electrophoresed through agarose/CH 3 HgOH 
slab gels and stained with ethidium bromide, a band corresponding to a molecular 
size of 3·8 kb was seen in the patterns from the two methotrexate-resistant cell 
lines. but not in those from the parental lines (Fig. I). This 3·8 kb RNA was also 
obsen·ed in the other Yariant cell lines (Masters et al., I982) analyzed so far (lOCI , 
IOC2 , IOC3. data not shown). 
The total poly(A)-containing R~A from V A2 -B and 6A3 cells was used to 
program a rabbit reticulocyte lysate translation system in vitro, and the products 
were electrophoresed through a sodium dodecyl sulfate/polyacrylamide gel. A band 





FIG. I. Dewction of the 3·8 kb poly( A)-containing RNA in methotrexaw-resistant human cell lines. 
Samples (5 ~<g) of poly( A)-containing RNA from methotrexaw-sensitive VA 2 -B(a) and He La Bu25(d) 
cells and from their respective methotrexaw-resistant variants 6A3(b) and IOB3(c) were electrophoresed 
through an agarose/CH 3HgOH slab gel. and stained with ethidium bromide. 
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- .,._ DHFRase 
FJG . :2 . Synthesis of human DHFRase in vitro. Samples of poly(A)·containing RNA were used to 
program translation reactions in vitro in a reticulocyte lysate. the products were electrophoresed 
through a 15% sodium dodecyl sulfate/polyacrylamide gel and the gel was subjected to fluorography. 
From left to right. the first 2 lanes show the translation products s~·nthesized under the direction of 
equal amounts of RXA from V A2-B and 6A3 cells: the next 2 lanes contain the translation products 
s~·nthesized using equal amounts of RNA recovered from the 3·8 kb region of the 2 lanes of a gel 
containing the poly(A)·containing RNA of 6A3 and VA 2 -B cells; the last 2 lanes show the products 
formed in vitro immunoprecipitated indirect]~·. using pre-immune or anti-human DHFRase serum. from 
a translation reaction in vitro programmed with RNA from 6A3 cells. The translation products 
obtained in vitro without added RNA are similar to those shown m the first lane of Fig. 3 (data not 
shown) . 
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product;; syntht'sizt>d under thP direction of the 6A3 RXA. but was not recognizab le 
among thE' \'A 2 -B RXA-programmt>d products (Fig. 2). There is a somewhat more 
slowly migrating band in the latt{'r pattern that probably does not represent 
DHFH.a;;p_ and whieh is. in any ewnt. of a much lower intensity. Indirect 
immunoprt>l·ipitation of the products in t'ilro with antiserum against human 
DH FRasP showpd that the specific band in the pattern of 6A3 RXA-programmed 
produc·ts does correspond to human DHFRase (Fig. 2). To test whether the 3·8 kb 
component in the 6.\3 RXA pattern codes for DHFRase. a segment of the gel 
containing it and a comparable segment of the gel in which the VArB RXA had 
been fractionated wpre cut out and the RX A was extracted from them according to 
\\'ieslandPr (I !li9) . \\'hen the two RX A samples were tested in the translation 
systpm in ritro. a component with the mobility of DHFRase was found to be 
synthPsizPd in the 6A3 RXA-dirPcted reaction : a considerably smaller amount of 
an id t> ntically migrating component was detected among the products of the \"ArB 
RXA dirPctNI rPaction (Fig. 2) . 
In ordt>r to invPstigat.e whether other forms of DHFRase mRXA. besides the 
3·H kh form. oc·cur in the methotrexate-resistant cell lines. the poly(A)-containing 
polysomal RX A from 6A3 cells was fractionated on a 5° 0 to 20°;0 sucrose gradient 
in lo,,· ionic· strength buffer. and alternat{' or successive fractions. as shown in 
Figure 3. were tested by the translation assay in vitro. Two broad peaks of 
DHFRasP synthesis were obsen·ed . one centered around a position corresponding 
to thP 3·8 kb DHFRase mRXA (fractions 9 to 18) , and the other. less pronounced. 
cPntered around a position corresponding to about 1 kb (fractions 20 to 24) . It is 
clear that the translation products in vitro in fractions 13 to 16 are enriched in 
DHFRase as compared to fractions 22 to 23 : from the analysis of less exposed 
ftuorogram s. it could be estimated that this enrichment is three- to sixfold. The 
nature of the RXA with which the latter peak of DHFRase synthesis promoting 
activity is associated is examined further below. 
(b) Cloning of DHFRase cDSA 
In prt>vious work by others (Chang et al .. 1978) on the cloning in E. coli of the 
DXA sequence coding for the mouse DHFRase. the much lower sensitivity of the 
mammalian enzyme to the antimetabolite trimethoprim as compared to the 
bacterial enzyme (Burchall & Hitching. 1965) was exploited to select for 
transformants that phenotypically expressed the D~A sequence. This approach. 
besides facilitating the screening of the transformants carrying plasmids with 
DHFRase cDXA inserts. automatically identified the resistant clones as harboring 
the DHFRase coding sequence. In the present work. the 3·8 kb form of DHFRase 
mRXA described above, for its abundance. appeared to be a suitable template for 
preparing cD~A to be cloned. On the other hand . because of its unusually large size 
and of the probability that the DHFRase coding sequence would be located near its 
5' end. as in the mouse DHFRase mR~A (Chang et al., 1978). it was anticipated 
that there would be difficulties in obtaining a complete copy of the DHFRase 
coding stretch with reverse transcriptase. The smaller size RXA with DHFRase 
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H:\.-\ from 6.-\:~ cell;. fractionatPd on sucrose gradients. was expected to be a better. 
though IPs,.; abundant. source of cD:\A for cloning the DHFRase coding sequence 
and for obtaining Pxpression of this sequence in E. coli. Furthermore . since the 
human DH FHa,.;t> <'oding sequence was expected to ha\·e a size similar to that of the 
mou,.;p enz:·mt· ('oding sequen<'e (Chang eta!.. 1978). it seemed reasonable to expect 
that ewn relati\·ely small doublt>-stranded cD:\A molecules (0·6 to 1·0 kb) 
s.Ynthesized from any eomplete single-stranded cDXA copies of the 3·8 kb RXA 
might (·ontain the DHFRase coding sequenre. On the basis of the arguments 
presentPd abon'. both the larger size ( > 1·4 kb) and the smaller size cDXA 
(<Lt. kb) transcrilwd from the total poly(A)-containing RXA were used 
independent!.\· in the (·Inning experiments desrribed below. The approaches 
follm1·t>d are illustrated in schematic form in Figure 4. 
J>ouhlt•-stranded cD:\A was prepared. as described in Materials and Methods. 
from total poly(.-\)-containing RXA of the methotrexate-resistant cell line 6A3. 
Lane (b) in Figure.') shows the electrophoretic pattern of the ss-cDXA in an 
alkaline agarose gel. while lanes (c) and (d) show the patterns in the same gel of the 
d,.;-c I>:\.-\ before and after digestion with S 1 . It is clear that the bulk of the ss-cDN A 
has size;.; ranging between 400 and 3000 nt. with eYidence of the presence of larger 
molecule;; up to at least 4000 nt: the non-S 1-treated. denatured ds-cDNA reveals an 
approximate doubling of its molerular length. The S 1-treated ds-cDXA. covering in 
the alkaline agarose gel a size range between 300 and about 4000 nt (lane (d)). was 
frartionated on a 5° 0 to 20° 0 neutral sucrose gradient to separate fragments 
;;mailer than 600 bp. which would compete during bacterial transformation. from 
the rest (Fig.;)). The ds-cD:\A larger than 600 bp was separated into three cuts. 
\l·ith size,.; ranging from 600 to 1400 bp. 1400 to 3000 bp and 3000 to 3800 bp, as 
estimated from their migration in the sucrose gradient relative to that of known 
restrirtion fragments. and as verified by electrophoretic analysis in an alkaline 
agarose gel (Fig. 5. lanes (e). (f) and (g)) . 
The two fractions of ds-cDXA containing molecules larger than 1400 bp were 
pooled to yield - 0·25 1-Lg of ds-cDX A. which was then dC-tailed, annealed with Pstl 
digested and dO-tailed pBR322. and utilized to transform E. coli x2282 (Chang 
PI al .. 1978). About 4000 tetracycline-resistant transformants were obtained that 
were also ampicillin sensitive . due to the insertional inactivation of the ,q-Iactamase 
gene. These transformants were replica plated on agar plates in minimal medium 
supplemented with 4 1-Lg of trimethoprim/ml , in order to test for the possible 
FH;. 3. Fra<'tionation of poly(A)-containing R!'\A from tiA3 cells by sedimentation through a sucrose 
gradient and anal:•si~ of the programming capacit~· for protein synthesis in vitro of the individual 
fra!'tions. The upper panel shows the A 260 profile in a sucrose gradient of the poly( A)-containing R~A of 
tiA3 <'elb (e) and the profile of the acid-precipitable radioactivity incorporated into protein in 
translation reaction~ in 1:ilro (0) programmed with equal volumes of the given fractions. 
The lower panel shows the electrophoretic patterns of the products of the translation reactions in vitro 
carried out using portions of the various fractions. The lanes designated V A 2 and 6A3 contain the 
products of reactions programmed with the total poi~·(A)-containing RNA from VA 2 -B and 6A3 cells; 
the lane designated - RXA shows the products obtained with no added RNA in the translation mixture 
in l'ilro. The o\·erexposure of the fluorogram has artificiall~· accentuated the difference in amount of 
radioactivit~· between gel tracks II to 17 and gel tracks 21 to 23. 
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Total pol y•(A) -containing RNA 
(]) AMV reverse transcriptase 
iZ) NaOH digest ion 
<3> DNA polymerase I 
@ S 1 digest ton 
<$ Sizmg by sucrose gradient 
@ dC tailing 
ds-cDNA 
5
"-, =====ecce ecce- ~ 
ANNEALING 
([> Transformation of X 2282 
with pBR322 annealed 
with ~-sized eDNA 
\{; TcR selection 
EcoRl 
~ Colonies screened by 
differentia l hybr~d,zat ion 
<D Transformation of X2282 
with pBR322 annealed 
with small-stzed eDNA 
~ TcR selec!ton 
~ TmpR select ion by replica 
plating 
FIG . 4. Scheme illustrating the experimental approaches followed for cloning the human DHFRase 
cD~A and detecting its expression in E . coli. AMY. a\·ian myeloblastosis virus. Sequence hyphens have 
been om itted for clarity. 
expression in these bacteria of the human DHFRase sequence ; however , none of 
the colonies exhibited trimethoprim resistance. 
In order to detect the presence in the transformants of any recombinant plasmid 
molecules containing a D~A insert complementary to the 3·8 kb DHFRase mRNA. 
2000 transformants were screened using the differential colony hybridization 
technique of St. John & Davis (1979) , as modified by Wahl et al. (1979) . For this 
approach. advantage was taken of the fact that the putative mRNAs for DHFRase 
are present in the total population of poly(A)-containing RNA from methotrexate-
resistant 6A3 cells at a much higher level than in the parental cell line V A2 -B 
(Fig. 1 ). The colonies were replica plated in duplicate onto nitrocellulose filters. and 
one filter of each pair was incubated with 32P-labeled eDNA synthesized from the 
total poly(A)-containing RNA of 6A3 cells. and the other filter with an equal 
amount of radioactivity of eDNA from the parental VA 2-B cells: 76 colonies 
exhibited a much stronger hybridization with the 6A3 eDNA probe. Figure 6 shows 
a typical pair of nitrocellulose filters subjected to the differential colony 
hybridization test: one can recognize several clones showing a clearly different 
hybridization with the two probes. 
The smaller eDNA fragments , with sizes ranging between 600 and 1400 bp. 
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( 0) ( 0 )' 
.. • • a.--~ - -.pH05 tf • s; fr..; - ·- • • ~. 
• •• • J ,, . ...  --· • • • • ... VA2B • 6A3 
I b l (b)' 
" •• -· -- .,. ... - 4# .. • ~ • -• . - .... • -· .... pH041 - • • 
• 6A3 
FIG . 6. Diffen>ntial colon.' · h_,·bridization. A total of 112 tetracycline-resistant and ampicillin-sensitive 
transformants of r: . wli x2282 were replica plated on each pair of nitrocellulose filters ((a). (a)' and 
(b). (b)') and h,,·bridized with 32 P -labeled cDXA from total poi~·(A)-containing RXA of the parental 
\'.-\ 2 -H rt' lb ((a ). (b)) or of the methotn>xate-resistant 6.-\3 <·ell~ ((a)'. (b)'). The arrows point to 
colonies @:i,·ing an enhanced signal with the 6.-\3 probe. 
anrwaled with Pstl -cut and dG-tail£>d pBR322 . and utilized to transform E. coli x2282 
<'elb . From 0·1 1-Lf! of eD:\A. :2600 tetracyclin£>-resistant and ampicillin-sensitive 
c-olonies w£>re obtain£>d. Among them. eight were able to grow. although with 
diffpr£>nt pffiei£>nei£>s. in th£> pr£>s£>nc£> of 4 f.Lg of trimethoprim/ml. These clonE's were 
th£>n test £>d for r£>sistane£> to high£>r doses of trimethoprim (10. 25. 50, 75, 100. 500. 
1000 1-Lg/ ml) in ord£>r to det£>rmine the maximum concentration that allowed 
growth. As shown in Tabl£> I. this varied between about 4 J.Lg/ml and more than 
I mg 1ml. with only one clonE> (subsequently shown to harbor the plasmid pHD84) 
£>x hihiting resistarH·£> to the lattpr concentration. In ord£>r to check whether 
trimethoprim r£>~;istanef' in the eight clones did indeed result from the 
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(no . bp) 
Colon.\· 
h\· brid iza t ion 
test! 
Clones selerled by differential hybridi:ollon (pH I!/ -16) 
pH Dl 1600 + 
pHJJ,; 2:!50 + 
pH 1>:!:1 fl40 + 
pHI>:!.'\ 2o:IO + 
pH IJ:l,'\ 860 + 
pH 1>41 2:!00 + 
pH IJ4:l !lfi() + 
pH 1>.'\fi :WRO + 
pH 1>.58 1000 + 
Remaining plasmids i50-1500 + 
('/ones selected by lrimethoprim resi8lo nre 
pH l>ii -1000 + 
pH lliR -1000 + 
pHili!l JO:lO + 
pH llRO !IRO + 
pH I>RI -1000 + 
pH 1>8:! 980 + 
pH T>ft! 1010 + 
pH 1>84 120 + 




































! Kt>fer.-; t o thP difff'rPntial h~· bridization assa\· for thP dorws nf !!roup A. and to tht> dirt><'l 
h~· bridization as;.ay for thP dorws nf !!rou p B. 
transformation of E. coli x2282 with recombinant plasmids containing DHFRase 
cD:\A sequences. a colony hybridization test was performed using. as a probe , the 
nick-translated 2300 bp insert of one of the plasmids (pHD41) that had pre,·iously 
given a positive result in the differential hybridization experiment , and thus 
presumably contained at least a portion of the 3·8 kb mRX A sequence. All of the 
eight clones gave positive signals in this test. 
Finally. in order to prow that the trimethoprim-resistance phenotype was 
plasmid-bome in the transformants . and at the same time to introduee the 
plasm ids into a host easier to grow, the two plasm ids that had conferred upon 
E. coli x2282 the highest trimethoprim resistance (pHD82 and pHD84) were 
purified and utilized to transform the trimethoprim-sensitive E. coli HBIOI strain. 
With both plasm ids. I 00% of the tetracycline-resistant transformants were found 
also to be trimethoprim-resistant. 
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(<") !'hysical rharnrlni::;ation of the rloned r:DS.-1 segm ent8 
Tahi P I ~ummarizes the data concerning the size of the inserts in the plasmids 
("arTI·i ng I>HFRase d):\:\ sequences that ha1·e been described in the preYious 
~Pf'tion. and the as>'ays utilized for the identifi ca tion of the clones transformed with 
t lw>"P plasm ids . The plasm ids harbored in bacteria identified by differential 
h_Yhridization ha1·p inserts Yar:·ing in size between i50 and 2300 bp : those whose 
bacteria I hosb were identified on the basis of the phenotypic expression of 
I>HFRa,.;(" c-1).:\.\ ,.;equences han" inserts with sizes ranging from i50 to IOOO bp. 
FiH of th e latter plasrnids (pHDi9. pHD80. pHD82. pHD83 and pHD84) . fin' of 
t lw pla,.;m id>" origina l I.\" identified by differential hybridization (pHD I. pH D5 . 
pH()2,). pHI>-t-1 ami pHIXi(i) . and another group ofplasmids from the same set 
(pHI>2:l. pHD:1,). pHD-1:1 and pHD58). whic·h were subsequently shown to gin a 
po>"iti1·p signa l in a colony h.1·bridization test using the nick-translated insert of 
pH I >K-t.. 11 e re U:<Pd to C"onstruct a physical map of the cloned DHFRase cD:\A 
>'Plple li< 'P>' h_1· U>"ing a 1·ariety of restriction enzymes (Fig. i ). On the basis of the 
di,;trihution of the res tri (· tion sites. the inserts of the plasmids mentioned above 
11 erp found to form a set of oYerlapping sequences coYering a region that extends 
o\·pr approximately 33.50 bp. This size is fairly close to that of the 3·8 kb DHFRase 
rnH:\A. ,;uggesting that most of the sequences of this mRXA are represented in the 
C" lorwd segments. The insert of plasmid pHD5 was found to contain a Pvuii site 
that i,; ah,;ent from the o1·erlapping segment of the insert ofpHD4l. This could be 
due to heterogerwity in the R:\A or t o a copying error by the reYerse transcriptase 
or to ,;ome e1· ent that has occurred in the bacterial host . From the alignment of the 
in,;ert:,; of the plasmid:< ana lyzed here and from their orientation relative to 
rwighhoring restri ction sites in the wctor . it could be established that. in the 
pla,;m id,; of t ht-> clones that expressed trimethoprim resistance (pHDi9 . pHD80. 
or------5~o~o----~~ooo~----~~,5o~o----~~~----~2~5o~o~--~3ooo~---- bp 
"''»li:"''»Il_lll_lll 
I ' I 
EcoRl Socl Acrl Hmcll: 8giii Hmdlll Spi>I ' 




























I I I 
'I 
Fru . I . Re~triction map of the cD:'\A s~·nthesized from the human DHFRase mRXA. as constructed 
b\· anal~· s i s of the inserts of the recombinant plasmids cloned in E. coli . In the map. the filled bar 
indi<·a tes the limits of the DHFRase coding sequenoe. as determined from the DNA sequence 
(unpublished resu lts). The pHD5 insert exhibits a Pt'UII restriction site absent from pHD41 (see the 
text). See the text for the o rientation of the inserts in the recombinant plasm ids. 
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pHD8:2. pHD83 and pHD84) and in plasmids pHD5. pHD43 and pHD58. the 
cDXA is orientf'd in the opposite direction as in plasmids pHDI. pHD23. pHD35 
and pHD41 (data not sho\\·n). 
The sequences of the inserts of the plasmids phenotypically expressed in E. coli 
and therefore presumed to contain the complete DHFRase coding region. are 
located rwar one extremity of the restriction map (Fig. 7) . This extremity was 
expected to correspond to the 5' end of the strand with the same polarity as the 
3·8 kh mRXA. b~· analogy with the situation described in the mouse system. where 
the main DHFRase mRXA. -1600nt long. contains the 564 nt long coding 
sequence near its 5' end (Xunberg et al .. 1980). This expectation has been fully 
confirmed by DXA sequence analysis (see below) . The distribution of restriction 
site8 pointed to the occurrence of only one DHFRase coding stretch in the 3350 bp 
long span of cDXA sequences. A DXA transfer hybridization experiment in which 
the plasmids pHD.5 . 41 and 56. digested with Pstl. and the plasmid pHD4l. doubly 
digested with !'sti and Bglii. were hybridized with the nick-translated Pstl insert 
of pHD84. the plasmid with the strongest phenotypic expression. gave results that 
clearly confirmed the conclusion of the restriction enzyme analysis (data not 
shown). 
(d) D.YA sequence analysis 
Both strands of the small137 bp Psti -EroRI fragment ofpHD84 were sequenced 
in order to determine the orientation of the coding sequence . The sequence of the 
sense strand is presented in Figure 8. It shows a reading frame , starting at 23 nt 
downstream of the poly(dG) tail. that can be recognized as DHFRase coding 
sequence by its homology to the mouse DX A sequence (Chang et al ., 1978 : N unberg 
et al .. 1980). which is also shown in Figure 8. These results confirm the previously 
stated assumption that the coding region is at the 5' end of the 3·8 kb mRXA . The 
homology between the mouse and human DHFRase coding sequences in the first 75 
nucleotides (i .e. those known so far for this portion of the mouse reading frame 
(Chang et al .. 1978)) is 82%. while the amino acid sequence homology between the 
mouse (Stone et al. , 1979) and human enzyme in the first 32 amino acid residues is 
94° 0 . A nucleotide sequence homology of about 80~0 is found between the mouse 
and human DNA sequences also in the 12 nucleotides preceding the coding stretch 
while . further upstream , the sequence homology decreases . There is , at 16 nt from 
the initiator AUG. a 6 nt sequence. 5'. , . G-G-A-G-G-T .. . 3' , which shows a 
perfect base complementarity to the Shine-Dalgarno sequence , 3' . . . C-C-l. -C-C-
T . .. 5' (Shine & Dalgarno. 1974) . 
From the sequence data of Figure 8 and the above-mentioned orientation of the 
cDXAs in the vector, it can be inferred that. in the plasmids of the trimethoprim-
resistant clones analyzed here (pHD79 , pHD80. pHD82. pHD83 and pHD84). the 
DHFRase coding sequence is oriented in the same direction as the coding sequence 
of the ,8-lactamase gene ; the homologous strand in plasm ids pHD5. pHD43 and 
pHD58 is also oriented in the direction of reading of the ,8-lactamase gene . while it 
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-40 -30 -20 -10 I 
s' T G c A G G G G G G G G G G G G G G G G IC]GIG A G Gnc c TIC c c G c T G cfTGlr cAT G G T T[GjG[T] 
..... ~GATTTTATC CCCGCTGC~TCATGGTT~G~ 
Met Vol Gly 
Arg 
~ ~ ~ ~ ~ w 
~C~T~AACTGCATCGTCGC[T]GTGTCCCA~AA~ATGGG~AT~GGCAAGAAC 
~C~~AACTGCATCGTCGC~GTGTCCCA~AAWATGGG~ATWGGCAAGAAC 
Ser Leu Asn Cys lie Vol Ala Vol Ser Gin Asn Met Gly lie Gly Lys Asn 
Pro 
70 80 90 
GG[GjGACCT[GjCCCTGGCCACCGCTCAGGAATGAATT 
GG~GACCT~CCC ..... 
Gly Asp Leu Pro Trp Pro Pro Leu Arg Asn Glu 
FH;. 8. D.\".-\ sequen(-e ufthe 13i nt Psti-EcoRI fragment ofpHD84. The upper D.\" A sequence is that 
of a segment ofth£> sense strand of pHD84. the lower sequence is that available for the mouse DHFRase 
cDXA (Chang PI a/ .. J!.li8 : .\"unberg eta/ .. 1980). Th£> numbering starts from the ATG initiator codon . 
Th£> id!'ntity of th£> tirst 4 nudeotides was dPduced from the sequence of the opposite strand. Boxed 
regions rt>present the non -homologous nucleotides . Below the DXA sequences is the amino acid sequence 
deduPed from them : whert> 2 amino acids are indicated at the same position. the upper refers to the 
human DHFRase and the lower to the mouse DHFRase (Chang el al .. 19i8 : Stone el a/ .. 1979). The 
sequpncp h\·phPns ha ,.e been omitted for clarity. 
(e) !>election of human f>HFRa .se in E. coli x2282 transjormant.s 
The prHiously discussed eYidence. concerning the expression of trimethoprim 
resistance in E. coli x2282 transformants carrying plasm ids \\·hose inserts contain the 
DHFJ{a;;e coding sequence . strongly suggested that the basis for the drug 
resistance was the synthesis of the human enzyme in the bacterial host. It was in 
fact expected that the human DHFRase. as other mammalian DHFRases , is less 
sensitiYe to trimethoprim than the bacterial enzyme (Burchall & Hitching. 1965). 
In order to verify the presence of the human enzyme in E. coli x2282. an 
immunoautoradiographic assay was carried out. For this purpose. E. coli x2282 cell 
extracts harboring different plasmids were fractionated on a 12·5~0 polyacrylamide 
slab gel: th e latter was then incubated with IgG prepared from rabbit anti-human 
DHFRase antiserum and then with 1251-labeled protein A. following a published 
proced ure (Granger & Lazarides . 1979). Figure 9 shows the autoradiographic 
patterns of the cell extracts from E . coli x2282 strains harboring pHD84 or pHD82 
plasmids. grown with and without trimethoprim. In the four samples. a band 
migrating with the same mobility as the purified human DHFRase can be 
observed. This band is . on the contrary. absent from a cell extract from E. coli 
x2282 harboring pHD5. a plasmid whose insert lacks the DHFRase coding 
sequence (Fig. i). In the autoradiography in Figure 9, one can see in the extracts 
from the trimethoprim-resistant strains a specific band migrating slightly faster 
than the human DHFRase. The possible significance of this polypeptide is 
discussed below . 
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Fl!; !l. Irnmunoautoradiography aftn sodium dodecyl sulfate/pol~·ac~·lamide slab gel electrophoresis 
of ex tra et" of bacteria harboring plasm ids with DHFRase cD.:'\A inserts. E. coli x2282 harboring pH ()84 
or pH DR:! pla~mids were grown in the presence (+Tmp) or absenc-e (-Tmp) of trimethoprim (I or 
0·1 rn g 'rnl ). Th e extract of E. coli x2282 harboring pH D5 and not expressing trimethoprim resistanee 
was run as a {'ontrol. On ea<'h slot. approximately 85 JJ.g of E. roli extract were loaded. In the left-hand 
lane . 0·:!5JJ.g of pure human DHFRase (Morandi&: Attardi. 1981) was run for comparison of its 
migration with that of th<" protein synthesized in bacteria. The arrows and M, ,-alues on the right 
represO"nt the positions of migration and molecular weights of the protein standards run in a separate 
lane. 
(f) J/uftipfe for/118 of RXA homo1ogou8 to DH FRa se cf)SA. 
Th{' results shmm in Figure 3 had suggested the possibility that the 6A3 cells 
may contain more than onP RXA species coding for DHFRase. In order to 
investigate this possibility further. equal amounts ofpoly(A)-containing RXA from 
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Fie:. 10. Poly(A)-containing RXA from methotrexate-sensitive and resistant cells transferred to 
nitroeellulose paper and h~·bridized with different nick-translated DHFRase eDNA probes. i:iamples 
(51-'gl of poi.\·( A)-containing RXA from ea<'h of the methotrexate-sensitive YA 2 -B and HeLa Bu25 cell 
lines and of their methotrexate-resistant deriYatives 6.-\3 and IOB:l were electrophoresed through a 
formaldehyde/agarose geL transferred to nitrocellulose paper and hybridized with nick -transl.ated 
plasmid DXA. as indica ted. Lane Ml <'Ontains 3'-end labeled. digested pBR322 DXA size standards. and 
lane M2 contains total HeLa cell c~·toplasmie RXA 32 P-Iabeled in vivo. The autoradiograms were 
exposed at -lO T with intensifier screens for II h for the HeLa Bu25 lane . and for 2 h for the other 
lanes. 
respertin' methotrexat~-resistant variants 6A3 and IOB3 were electrophoresed on 
formaldeh,vde/agarose gels. transferred to nitrocellulose paper and hybridized with 
the nick-translated plasmid D~As pHD5. pHD41 and pHD84 (Fig. 10). The results 
obtained with the pHD84 and pHD41 probes show that at least three RNA species 
56 
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hybridizing with DHFRase·specific eDNA. with molecular sizes of about 3·8. 1·0 
and 0·8 kb . are present in the methotrexate·resistant variants and also. in much 
reduced amounts. in their parental cell lines. In contrast to pHD84 and pHD41 . the 
plasmid pHD5 hybridized only with the large DHFRase mRNA (Fig. 10). The 
same resu lt as with pHD5 was obtained when nick·translated pHDI. pHD25 and 
pHD56 DXAs were used to probe the 6A3 RNA (data not shown). These 
obserYati ons indicate that the 1·0 and 0·8 kb RNAs must contain sequences 
corresponding to the 5' end proximal half of the 3·8 kb mRNA and. in particular. 
must o\·erlap the DHFRase coding sequence at least in part. 
4. Discussion 
Among the transformants obtained in the present work using plasmids with 
insert s deriYing from eDNA molecules larger than 1400 bp. 76 out of2000 analyzed 
renaled the presence of DHFRase eDNA sequences by differential colony 
h~·bridiza tion. but none of them ( <5 X 10- 4 ) proved to be trimethoprim resistant. 
In agreement with this result. restriction enzyme mapping and colony 
hybridization data indicated that 71 out of 76 chimaeric plasmids did not contain 
in their insert an~· portion of the DHFRase coding sequence (among them , pHD I. 
pHD5. pHD25 and pHD56) . while four contained an incomplete coding sequence 
(pHD23 . pHD35. pHD43 and pHD58) . The seventy-sixth plasmid . pHD4l. was 
found to contain an insert possibly including a complete DHFRase coding 
sequence: however. the orientation of this coding sequence in the opposite direction 
to that of the ,8-lactamase gene would probably have allowed it to be expressed only 
weakly. even if it were complete (Chang et al .. 1980). The mapping positions of the 
inserts of the nine above-mentioned recombinant plasm ids were consistent with the 
view that they may ha,·e resulted from incomplete extension by the reverse 
transcriptase of the single-stranded eDNA to the 5' end of the 3·8 kb RNA and/or 
from incomplete synthesis of the second strand by E. coli DNA polymerase I. 
In contrast to the negative results . in terms of phenotypic expression , obtained 
with the plasmids containing large size eDNA-derived inserts, eight clones out of 
2600 transformants ( -3 X 10- 3 ) harboring plasmids with inserts derived from 
eDNA molecules in the range 600 to 1400 bp were found to be trimethoprim 
resistant. A restriction enzyme mapping of the inserts of these plasmids revealed 
that the:v all contained the DHFRase coding stretch , as identified in one of the 
plasmids (pHD84) by DNA sequencing. It is not possible to say whether this 
DHFRase coding sequence derived from eDNA synthesized from the 5'-end portion 
of the 3·8 kb mRXA or from the 5'-end portion of smaller DHFRase mRNAs. The 
available evidence indicates that the trimethoprim resistance in these clones was 
due to the expression of the exogenous DHFRase coding sequence , as previously 
shown for E. coli cells transformed with plasmids carrying the mouse DHFRase 
coding seq uence (Chang et al., 1978) . Both the above-mentioned restriction 
mapping and DNA sequencing data. and the observation of the presence of a 
protein immunoreactive with anti-human DHFRase in extracts of these 
transformants. but not in extracts of clones harboring plasmids that lacked the 
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DH FKase coding streteh. containing instead other segments of DHFRase cDXA. 
strongly support the aboYe condusion. Aecording to this interpretation. the great 
\·ariability in degree of trimethoprim resistance obserYed in these clones 
presumably reflects differences in the rate of expression of the DHFRase coding 
sequPrH·e . ...\.s preYiously suggested for the mouse DHFRasP coding sequence eloned 
in E . roli (Chang el rrl .. 1980). it seems very likely that the above differences result 
from ,·ariations in the degre(• of homology between the :-1-D sequence at the 3' end of 
thP lti :-; rRXA and the ribosome attachment site in thP mRXA on the 5' side of the 
coding stretch. and/or Yariations in the distance between this ribosome binding site 
and the initiator codon. HowPH'r. this point has not been inYestigated. In the 
chima(:'ric plasmid pH D8-l. whieh eonferred upon the host the highest resistance to 
trinwthoprim (>I mg/ml). eomparable to that of the ''strong expressors " described 
among tlw badpria transformPd with mouse DHFRase cDXA (Chang el al .. 19i8). 
the DXA sequencp analysis has re,·ealed. at a distance of 16 nucleotides from the 
start eodon .-\TG. tlw presencP of the sequence 5' ... G-G-A-G-G-T ... 3'. showing 
a pPrfeet homology to the :-1-D spqupnce 3' ... C-C-l'-C-C-A ... 5' (Fig. 8). 
ThP significance of the polypeptide present in the extracts from trimethoprim-
resistant transformants. which migrated on pol~·acrylamide gel electrophoresis 
slightly faster than the human DHFRase. and which showed immunoreacti,·ity to 
anti-human DHFRase antibodies . is not clear. It is conceivable that it represents a 
slight !.'" shorter form of the enzyme. synthesized starting at t he GCG at positions 
31 to 33 in the sequence shown in Figure 8. There is indeed. at a distance of 18 
nueleotides upstrpam of this Gl'G. a sequence (5' .. . A-T-Q·Q-T-T-Q-Q-I-I·Q-G-
C . .. 3' ) showing homology of nine nucleotides (underlined) . within a 13-n ucleotide 
segmpnt. with thP sPquence surrounding and including the S-D sequence: a similar 
degree of homology has preYiously been interpreted to be adequate for expression 
of the mouse DHFRase coding sequence in transformed bacteria (Chang el a! .. 
1980). Further work is needed. however. to verify the possibility mentioned abo,·e 
concerning the nature of the faster migrating polypeptide. 
The sequence reported here of the first 32 amino acid residues of the human 
DHFRasp shows a 94° 0 homology with the sequence of the mouse enzyme (Stone 
el al .. 19iH) . This finding is fully consistent with the available evidence. indicating 
the high degree of sequence conservation among DHFRases of vertebrate origin 
(Kumar et a! .. 1980). The complete sequence of the human DHFRase will be 
reported elsewhere . 
The most significant obsen·ations made in the present work concern the 
presence. in human methotrexate-resistant and sensitive cells. of multiple forms of 
DHFRase mRXA differing in the length of the 3' untranslawd region. These 
observations confirm and extend those made by Setzer el al . (1980) in mouse cells. 
The most abundant DHFRase mRXA species in the human cells analyzed here is a 
3·8 kb poly(A)-containing RXA. which has a coding stretch of 564 nucleotides 
(unpublished obserYations) near its 5'-end and an apparently untranslawd 3' tail of 
-3·2 kb. XPver before has an mR~A with such a long 3' untranslated segment 
relative to the coding stretch been observed. This mRNA appears to be functional. 
because it is found in polysomes and because it is capable of programming a 
reticulocyte lysate for the synthesis of DHFRase. 
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Two other forms of poly(A)-containing R~A having sequences of the DHFRase 
coding stretch. with sizes of 1·0 and 0·8 kb. have been detected in the RXA transfer 
hybridization experiments. There is strong. although indirect. evidence that these 
two poly(.-\)-eontaining R~As are also functional forms ofDHFRase mR~A . Their 
size corresponds well to the slowt:>r sedimenting peak of DHFRase synthesis 
in titro: promoting acti\·ity in the sucrose gradient fractionation of the poly(A)-
containing RX.-\ from the methotrexate-resistant 6A3 cells: furthermore, the 
reproducibility of their size and relatin amounts in both methotrexate-sensitive 
cell lines and mPthotrexate-resistant variants with amplifiPd DHFRasP genes 
would speak against thPir arising from degradation of the 3·8 kb mRKA : also . the 
obspn·ation that these R~A species contain both a poly(A) tail and at least a 
portion of the DHFRase coding strPtch argues against degradative phenomena 
being rPsponsible for thPir presence. The most plausible interpretation of the 
prPsent observations is that these species represent forms of functional DHFRase 
mRXA containing the coding stretch near their 5' end as the 3·8 kb mR~A. but 
differing from the latter in the length of the 3' untranslated segment. 
The significance of the existence of multiple forms of DHFRase mR~A observed 
herE' in human cells . and previously reported in mouse and hamster cells (Setzer 
eta! .. 1980) . is obscure. Xo essential function for protein synthesis of the 3' non-
coding stretch of m R~ A has been identified. The experiments by Kronenberg eta!. 
( 197!)) tend to exclude an absolute requirement of this region for translation 
in citro. Furthermore. in mammalian mitochondria . the mRXAs utilized for 
mitochondrial translation laek completely a 3' non-coding stretch (Ojala eta! .. 
1981). Therefore . it is not surprising that multiple forms of DHFRase mR~A 
ha \·ing a different length of the 3' non-coding stretch may be utilized in vivo for 
DHFRasf:' synthesis in mammalian cells . On the other hand. the persistence of 
thesf:' multiple form s in distinct cell lines maintained in vitro for a long time and 
ha\·ing a different origin and history (like the HeLa BC25 and YArB cell lines) 
and. in the case of the mouse DHFRase mRI\A. the observation of the same 
multiplic it~· of species in cultured cells and in liver strongly suggest that this 
plurality of R~A species has a functional significance. What this possible sig-
nificance is . and whether the different species of DHFRase mR~A are transcribed 
from different genes or. on the contrar~·. derive from alternative pathways of 
transcription or processing of R~A transcripts of the same gene. remains to be 
established . 
The multiple DHFRase mR~A species were found tD be greatly increased in 
amount in the poly(A)-containing RNA fraction from the two methotrexate-
resistant variants 10B3 and 6A3. as compared to their respective parental lines , 
BU25 and V A2-B. This observation is consistent with the previous evidence 
indicating a greatly increased DHFRase activity and content in the 
above-mentioned methotrexate-resistant cell lines , as compared to the parental 
lines (Masters eta! .. 1982), and with more recent findings (unpublished) concerning 
a large increase in DHFRase-specific DNA sequences in their genome: taken 
togPther . the available evidence points to a DHFRase gene amplification as the 
basis for methotrexate-resistance in these cell lines . 
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SLMMARY 
The nucleotide sequence of the human dihydrofolic acid reductase (DHFR) reading frame has been 
derived from the analysis of human DHFR eDNA. This sequence and the corresponding amino acid 
sequence have been compared with those available for the enzyme and its coding segment from other 
organisms. There is an 89% nucleotide sequence homology between the human DHFR reading frame and 
the mouse coding sequence. Furthermore. amino acid-sequence homologies of 74%. 81% and 89% has been 
found between human DHFR and chicken. bovine and mouse DHFR. respectively. 
INTRODUCTION 
DHFR is the enzyme responsible for reducing 
dihydrofolic acid to tetrahydrofolic acid in an 
NADPH-dependent reaction. It is the target en-
zyme of 4-amino analogs of folic acid. like 
amethopterin (Mtx), which have been used exten-
sively in cancer chemotherapy (Bertino and Johns. 
1972) and in the selection of cell lines with DHFR 
gene amplification (Schimke, 1981 ). We have pre-
viously described the cloning of the human DHFR 
eDNA from Mtx-resistant cells (Morandi et aL, 
1981). 
Abbreviations: bp, base pairs; eDNA. DNA complementary to 
mRNA; DHFR. dihydrofolic acid reductase; Mtx, methotre-
xate; SDS. sodium dodecyl sulfate. 
In this communication we report the nucleotide 
sequence of the human DHFR reading frame de-
rived from eDNA analysis and the corresponding 
amino acid sequence. and we compare these se-
quences with those available for the enzyme and 
its coding segment from other organisms. 
MATERIALS AND METHODS 
The isolation of pHD80, pHD83 and pHD84 
plasmids containing as inserts segments of the 
human DHFR eDNA was carried out as described 
previously (Morandi et aL, 1981 ). The method of 
Maxam and Gilbert ( 1980) was used for sequenc-
ing. The strategy followed is described in the legend 
of Fig. 1. 
60 
AUG EcoRI 






------ . pHD80,83 
3 
Fig. I. Strategy used for sequencing the coding segment of 
human DHFR cDNAs. The single restriction sites of the 
inserts of pHD84. pHD80 and pHD83 which have been used 
are indicated. The plasmid DNAs were cut at one of the si tes 
indicated above. and either 5'-end labeled with [ y- 32 P]A TP and 
polynucleotide kinase after alkaline phosphatase trea tment. and 
then digested with Pst I (there is one such site at each end of the 
insert in the three plasmids; Morandi et al. . 1982). or digested 
with Pstl and then fill-in labeled at the 3'-ends with the 
Klenow fragment of E. coli DNA polymerase I. and [a-
32 P]dNTPs, as previously described (Morandi et al.. 1982): in 
both cases. the fragments of interest. labeled in only one 
strand. were isolated by electrophoresis on a polyacrylamide 
gel. The arrows indicate the direction and extent of sequence 
determined. 
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RESULTS AND DISCUSSION 
Fig. I shows a portion of the physical map of 
the DHFR eDNA illustrating the positions of the 
restriction sites used for DNA sequencing relative 
to the translation mtliation and termination 
codons, and the sequencing strategy employed here. 
Either 5'- or 3'-end labeling, or both, were per-
formed at the sites indicated. We used three 
plasmids expressing the DHFR coding sequence in 
E. coli: pHD84, which confers resistance to > I 
mgj ml trimethoprim upon the host , and whose 
insert ends just before the Bglll site in Fig. I: 
pHD80 and pHD83, which confer upon E. coli 
cells resistance to 25 ,ugj ml and 4 ,ugj ml tri-
methoprim, respectively, and which contain inserts 
extending past the Bglll site. No sequence dif-
ferences were found in the overlapping coding 
regions of these plasmids. 
The nucleotide sequence of the human DHFR 
eDNA coding region is shown in Fig. 2, in parallel 
10 20 30 40 50 60 
ATGGTTGG~fC~ETTAACTGCATCGTCGC~GTGTCCCA~AA~ATGGG~AT~GGCAAGAAC 
AT G G T T i<. GJ._Q_C~ T QA ACT G CAT C G T C G C lg, G T G T CCC A~A A:.Ii AT G G Gi.Qj A T i.I)a G C A A G A A C 
70 80 90 !00 110 120 
G G G G A C C TG' c C C T G G C C~C C G C T C A G G A Ar'f! G A~T T C ARfA1 T A'f1 T T C C AiGlA G A AT G A C C A C A 
G G_!._G A C C T ~CCC T G G C CJ:JC C G C T C A G G A A~G AIQ) T T C A~T A[g T T C C A~A G A AT G A C C A C A 
130 140 !50 160 170 180 
ACCTCTTCAGT~GAAGGTAAACAGAATCTGGTGATTATGGGTA~GAAiGlACCTGGTTCTCC 
ACCTCTTCAGT~GAAGGTAAACAGAATCTGGTGATTATGGGTA~GAA~ACCTGGTTCTCC 
190 200 210 220 230 240 
ATTCCTGAGAAGAATCGACCTTTAAAGG~AGAATTAAT~TAGTTCTCAG~AGAGAACTC 
ATTCCTGAGAAGAATCGACCTTTAAAGG~AGAATTAAT~TAGTTCTCAGmAGAGAACTC 
250 260 270 280 290 300 
AA~GAACC~CCAC~AGGAGCTCATTTTCTT~CCA~AAGT~T~GATGATGCCTTAA~ACTT 
AA~GAACC~CCACQAGGAGCTCATTTTCTT~CCA~AAGT~T~GATGATGCCTTAA~ACTT 
310 320 330 340 350 360 
A~TGAACAACC~GAATT~GCAA~~TAAAGTAGACATGGT~TGGATAGTMGG~GGCAGTTCT 
A_LTGAACAACC IQ, GAATT~GCAA [QjTAAAGTAGACATGGT l:!:jTGGATAGT[gGG~GGCAGTTCT 
370 380 390 400 410 420 
G T T T A :>fA' A G G A A G C CAT G A AT C Afc: C C A G G C C AfTl C T T A~A C T[AjT T T G T G A C A A G GAT CAT G 
G T T T A.C c'A G G A A G C CAT G A AT C A~C C A G G C C Al.QJC T T A[QJA C Tl.QJT T T G T 0 A C A A G GAT CAT G 
430 440 450 460 470 480 
CA~GA~TTTGAAAGTGACACGTTTTTffiCCAGAAATTGATTTGG00GAAATATAAACTTCT~ 
CA~GA~TTTGAAAGTGACACGTTTTT~CCAGAAATTGATTTGG~GAAATATAAACTTCT~ 
• ~ m ~ ~ ~ 





Fig. 2. Nucleotide sequence of the human DHFR eDNA coding region (top lines). The sequence of the coding segment of DHFR 
derived from Sl80 M50 mouse cells (Chang et al. , 1978; Nunberg eta!. , 1980; Crouse et al. , 1981) is shown for comparison (bottom 
lines). The non-homologous regions are boxed. 
with the nucleotide sequence of the DHFR coding 
region of a eDNA clone and genomic clones de-
rived from Mtx-resistant Sl80 M50 mouse cells 
(Chang eta!. . 1978: Nunberg et al.. 1980 ; Crouse 
et a!.. 1982). 
The human DHFR reading frame is 564 
nucleotides long and exhibits an 89% homology 
with the mouse DHFR coding stretch. Of the 64 
nucleotide differences, 45 represent silent changes 
and 7 produce codons specific for analogous or 
isosteric amino acids . Therefore. there is a func-
tional homology of 98 % between the human and 
mouse coding sequences. 
The nucleotide sequence codes for a protein of 
186 amino acids (excluding the initiator methionine 
which has not been detected in the DHFRs se-
quenced so far) (Kumar et a!. , 1980). with a calcu-
lated Mr of 21297; this value agrees well with the 
Mr of 21 000 estimated for the enzyme from its 
electrophoretic mobility on an SDS-polyacryla-
mide gel (Morandi and Attardi. 1981). Fig. 3 shows 
the human DHFR amino acid sequence and the 
64 
61 
positions where the sequences of the enzymes from 
chicken liver (Kumar et al. , 1980), bovine liver 
(Lai et al. , 1979), and mouse lymphoma L121 0 
cells (Stone et al., 1979), differ. The homologies 
between the human DHFR and the enzymes from 
chicken, bovine and mouse are 74, 81 , and 89%. 
respectively. It is interesting to note that the eDNA 
derived amino acid sequence of the S-180 cells 
DHFR differs from the directly determined se-
quence of the lymphoma cell enzyme in four amino 
acid residues (122-Gln, 123-Glu, 127-Gln and 173-
Lys), this representing a homology of 97 %. 
Matthews eta!. ( 1978. 1979) have recently solved 
at 2.5 A resolution the X-ray crystallographic 
structure of the ternary complex of the L. casei 
DHFR with Mtx and NADPH, identifying the 
amino acid residues involved in the three-dimen-
sional binding of these molecules to the enzyme. 
More recently, the X-ray structure at 2.9 A resolu-
tion of the ternary complex of the chicken liver 
DHFR with NADPH and a phenyltriaz.ine inhibi-
tor has similarly been determined (Voltz et al.. 
10 20 3() .;() 50 60 
Hum•n V G S L N C I V A V S Q N M G I G K N G 0 L P W P P L R N E P R Y P Q R M T T T S S V E G K Q N L V I M G K K T W F S I 
\ louse RP K R 
Bovine RP N Q v z R 
Chicken R s c 0 N YK s H A 
70 80 90 100 110 120 
Hu man P E K N R P L K G R I N L V L S R E L K E P P Q G A H P L S R S L D 0 A L K L T E Q P E L A N K V 0 M V WI V G G S S V 
.\'louse 0 R AK R I s 
Bovine N K AK N E I Q 0 T B(M) X 
Chicken 0 A K y K A LOS KS TA 
130 140 150 160 170 180 
Humnn Y K E A M N H P G H L K L P V T R I M Q 0 F E S 0 T F F P E I 0 L E K Y K L L P E Y P G V L S D V Q E E KG I K Y K F E 
\1ousc EQ I! R E G I! D 
Bovi ne z OK VR E (A) (A) p PL I! (D Q) 
Chicken A I! K I N H R LHI! YKOF T P A I 0 Q 
llu m<>n V Y I! K N D 
\ l ouse K 
Bov i ne 
Chicken Q SVLAQ 
Fig. 3. Amino acid sequence of the human DHFR derived from the nucleotide sequence of Fig. 2. The nonhomologous amino acids in 
the sequence of the enzymes from mouse L120 cells (Stone et al., 1979). bovine liver (Lai et al., 1979) and chicken liver (Kumar et al.. 
1980) are indicated. 
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1982 ). This investigation has revealed that the 
overall backbone chain folding of the chicken en-
zyme is very similar to that of the bacterial en-
zyme. and that the binding of NADPH to the 
chicken DHFR involves interactions analogous or 
identical to those occurring in the L. casei 
DHFR-NADPH-Mtx ternary complex. Interest-
ingly. an alignment of the L. casei DHFR amino 
acid sequence with the sequences of the homolo-
gous enzymes from other bacteria and from three 
mammali an sources (chicken liver. bovine liver 
and mouse L 1210 cells) has revealed a high degree 
of conservation throughout the evolution of the 
amino acid residues involved in Mtx and NADPH 
binding (Kumar eta!.. 1980). Thus. 5 out of the 13 
residues participating in Mtx binding in the L. 
casei enzyme (Ala-9. Phe-34, Leu-67. Arg-70 and 
Thr-136. using the mammalian numbering system) 
were found to be invariant . and two others (Leu-22 
and Ser-59) almost invariant in all enzymes for 
which sequence data were available. Asp at posi-
tion 30. also implicated in Mtx binding. was found 
to be invariant in all bacterial enzymes and re-
placed by Glu in the mammalian enzymes. A 
scanning of Fig. 3 shows that the human DHFR 
does not provide an exception to any of these 
rules. In the same study referred to above. of the 
24 amino acid residues involved in NADPH bind-
ing in the L. casei enzyme. eight (Ala-9, Ile-16, 
Gly-17, Try-24. Gly-53, Thr-56, Leu-75 and Gly-
117) were found to be invariant in the enzymes 
from all species analyzed, three others (Leu-22, 
Ser-59 and Gly-20) appear to be common to the 
three mammalian enzymes and many bacterial en-
zymes. and one (Thr-146) was found in all en-
zymes except in that from bovine liver, where it 
was substituted by Ala. The residues 54 and 55, 
which are also involved in NADPH binding, were 
found to be represented by either Arg or Lys in 
different enzymes. Again , it appears from Fig. 3 
that the human DHFR sequence exhibits the in-
variant or semi-invariant features mentioned 
above, with Lys residues being present at positions 
54 and 55 and Thr at position 146. The striking 
conservation from bacteria to man of the primary 
sequence of DHFR involved in the formation at 
the Mtx and NADPH binding sites obviously re-
flects the strong structural constraints which have 
accompanied the evolution of the enzyme. The 
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knowledge of the primary sequence of human 
DHFR will hopefully be useful for the develop-
ment of improved agents for cancer chemotherapy. 
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CHAPTER 5 
A Human Dihydrofolate Reductase Pseudogene and its Relationship 
to the Multiple Forms of Specific Messenger RNA 
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A Human Dihydrofolate Reductase Pseudogene and its 
Relationship to the Multiple Forms of Specific Messenger RNA 
. I r: I·TH 1·:\ :\:. ~h>'Tt-:1{,.; .• J 1 \<>t·:-.:L K. Y .-\ :-.:c ; . .-\ u~"" -1:-.: llH .\ ('ELLI :-.:1 
.\\ll Clt•,.;EI'I'E .-'\.TT.\1{1)1 
/J/ri.--/rn, 1Jf Hioloi,J.IJ. ('alrfomia /n.<:/i/11/e of Technoloyy 
Pa.wl(le11 11. ('all] . .911:!-5. r·.S . .-1. 
( H ece i n' rl 1 .j /)ere 111 be r 19S:!) 
TIH· prPS!'Il<-t· of dihydrofp);ttf' rf'dudasp (DHFHasP)-sppcific- sPquenr·ps that. in 
c·ontmst to tlw normal TJH FRase• gpm•. arp not amplifipd in a methotrt>xate -
n •s istant c·pll lint' . has hPPil nf'tPdPd in tlw D:\A from human spt>rm and from 
Sf'\·c·ml human (·P IIlim•s. 0:\A fragnwnts ('ontaining some of these sequenC'es ha\·e 
I wen isolatPd from a cosm id I ihra1y of human ~perm !J:\ A .. One of these fragments 
c-ontains a DH FKast' I'Sf'ttdOf!PnP (t/IH ])J ) that ('OmplPtel_,. laC'ks introns. has 92° 0 
sc·quPnl'P homology to t lw c·otTPsponrl ini! reg1on of normal DH FRase 
compiPnH•ntarY ]):\..\ . but exhibits spq•ral altPrations that make it non -
functional. 
Tlw sequencf' a nalYsis of tlw insPrts of four rlifferent plasmids containing the 
rPading franw and \·a r.Ying ]pngth~ of tlw :r non-c·oding regions of human 
DH FKast'-S}'P('itic- c-D:\As has rp\·pa ]pd that tlw 3' non-C'oding spgments all arp 
c·olinPar in their c·oiTPsponding portions . Furthermore . the data indicat.P that thP 
c-ll:\A of onp of tht> plasmid:< is prohabl_,. dPri\·pd from thP smallpst of thP thrPP 
main human DHFRasP mPssPngPr R:\As. thP O·~x 103 hasp (0-~kb) mR:\ .-\. thP 
dl:\A of two otlwr,.; . from tlw 1·11 kb mR:\.-\. and thP cD :\:.-\ of thP fourth. from a 
longt·r mH:\ .-\ . ThesP rPsults arP ('OnsistPnt with thP idpa that tlw multipiP form s 
of DHFRasp mK:\ .-\ in human C'P ih< dpri\·e from thp samp gpnp by different 
transc-ription or R:\ A-proc·pssing en·nt~. ~IorPo\·pr. the spquem·P comparison 
hptwPPn t lw ,PHD I and tlw diffprpnt DH FRase c-D:\ As C'learly indieates that. if an 
mH:\A intprnwdiatp has partic·ipatPd in tht> formation of this pf't>udogf'nf'. a form 
of mH:\A largf'r than tlw HI kh mR:'\.-\ . probably tlw 3·~ kb mR:\A . must ha\·p 
hPPn inn>h·ed . 
1. Introduction 
~tudie>' on eukaryotic· genome organization in sewral laboratories haYe reeently 
re,·ea led the occurreJwe of C'opies of specific· genes that. because of their structural 
alterations. are probably non-func·tional: indeed. they ha,·e not yet been found to 
be transc ribed. The alterations in question range from gross deletions or insertions 
to small deletionsc insertions or single base changes that result in frame shifts. 
formation of stop codons or perturbation of RXA processing. These apparently 
non-functional genes. which are usually referred t.o as pseudogenes. ha,·e been 
23 
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found t>itlwr near the l<wi of the <·orresponding normal genes (.Jaeq el a! .. 1977: 
:\lill<·r el fll.. IHI~: Proudfoot & :\laniatis. 19SO Lary & :'1-laniatis. 19SO: claim el rd .. 
19~11 ('lear~· el fl! .. Hl~l) or dispersed to other regions of the genome. often in 
different <·hromosonws ( Holli:-: PI rd .. 19S2: Leder el a! .. 19SI ). First obsetTed in the 
;) ~ IC\A gem· family of .\enOJill-' lael'l·-' (.Jaeq el a! .. 1911: Miller el al .. 19iS). 
strudmally altered copies ha ,-e subsequently been described for a ,-ariety of 
structural genes. like the 1.-globin (Xishioka el a! . . I9RO: Yanin et a! .. 1980: 
Proudfoot & !\laniatis. 1B80) and ,8-globin genes (Lacy & Maniatis . 1980: clahn et 
rrl .. HlSII: ('lear~- PI nl . . Hl81) of sen'ral mammalian spec-ies . the human ,8-tubulin 
genes (\\'ilde fl fl! .. HIS2a.b). the mou:-:e immunoglobulin genes (Hollis eta!.. 19S2). 
the human metallothionein genes (Karin & Ric·hards. 1982). and the human small 
nu<-lenr RX.-\ genes (\.an .-\r;;dell el al .. 19S1 ). The reeently reported dispersed 
<-<>pies of sea urc·h in histone genes ( orphons) probably also im·lude pseudogenes 
(<'hi Ids PI a! .. I BSI ). 
One intere:-:ting subc·lass of pseudogenes related to structural gene families is 
repre:-:ented b.Y genes from whi<·h one or more of the introns are clearly missing. as 
if they had been exc·ised with the same precision and specificit~- that occurs in the 
splicin[I of the mRXA precursors (Xishioka et al .. 19RO: Yanin el al .. 1980: \\'ilde et 
al .. HlS2a.b: Hollis et al .. 19S2: Karin & Ri chards. 1982). This feature and the 
ohsen·ation that in se,·eral of these genes the homology with their normal 
homologue;; ends preeisel.Y at the pol~·(.-\) addition site. the sequence of the 
pseudogene in some ca:-;es c-ontinuing in a poly(.-\) tract. haYe led to the suggestion 
that an RX.-\ transcript may be an intermediate in their formation. In particular. 
these gene:-:. which ha,·e been de:;ignated "proc-essed .. genes. may ha,-e resulted 
from re,·erse transc-ription of a processed RX.-\ into complementary DXA. 
followed b~· reintegration of this into the genome at a different site from that of 
the o riginal gene. A cDX.-\t intermediate has also been thought to be inYolYed in 
the dispers ion in the human genome of members of the Al11 gene family (Yan 
.-\rsdell et al .. 1981: .Jagadeeswaran el al .. 19S1) and of the small nuelear RXA 
gene fami]~- (\ ' an Arsdell eta! . . 19H1 ). In this paper. we report on the occurrence in 
the human genome of an intronless eop~- of the dihydrofolate reductase gene: this 
pseudogene exhibits multiple alterations that would make it non-functional for 
DHFRase production. 
2. Materials and Methods 
(a) .Urilnial-' 
Rt>~triction enzymes were from :\ew England Biolabs. Escherirhia coli D:\..\ polymerase I 
from Boehringt:'r- }lannheim and :\t:'w England Xuclear. D:\A polymerase I large 
fragmrnt (Klt>now) from :\ew England Biolabs and :\ew England :\uclear. benzoylated-
naphtho~·Jated DEAE(B:\D)-cellulost> and DL-methotrexate (MTX. consisting of50°0 of the 
L-form) from ~igma. 
(b) ( 'p/l/ine8 and methods of growth 
Suspt>nsion cultures of tht:' S3 clonal strain of HeLa cells were grown as pre,·iously 
described (Amaldi & Attardi. 196S). Tht> human cell line \'.-\ 2-B. an azaguanine-resistant 
t Ahhr~\·iation' u"·d : <'D:\ .-\. <'ompiPmentary D:\.-\: DHFRaRe. dihydrofolaU> reductase: kb. 103 
bast'~ or hasp -pairs. 
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~ lll l(' l o rw ( \\' t> i~s PI 11/ .. l !)()S ) of ~i mi a n 1·inr ,; +0-tran sfo rnwd lin!' \\'J.I S-\ ' ..\ 2 (Pont Pn el rd .. 
l!JH:l J a nd it ,; :\ITX·r't's is t a nt d t> ri 1· ati n ' 6 .-\ 3 (:\la~ t P rs PI nl.. 19S:? ) WPI'l' g rown a~ pre1· io usl!· 
d Pst·ril u-d ('.l o randi PI rd .. 1!1~:2 ). 
(<·) /J.\'.--1 JH'r'JJ(Lm lion 
(; t' ll <lllli<· DXA 11 · a~ iso la tPd h.1· tlw nwtlrod of (;ros~ · Bellard PI a/. (1!173 ). ( 'o~mid a nd 
pla ,; mid D:\As 11 prp in g~>ne ralJ>r'e J >arpd from I lite r <· ultures by a lkaline lysi ~ (Birn bo im & 
Do ly. 19-;'H ) f(, Jlmn ·d by ( 's( 'fjt> thidium bromide <·Pntrifugat ion: tlw DXA of pl' ( '9 pl asmid s 
<·ontaining fragnw nt8 of eosmid DX .-\ (SPP ht> low ) wa s purifi ed by alka lirw l.1·sis o f thP 
ha d t'r ia a nd HXD-l'e llul osp r hroma t ogra p h.1· of tlw DX.-\ as desnihed b,Y Ki ge r & 
:-;ins ht ·inr pr (l!Hi!l). Hum a n s pe nn D X .-\ wa~ a g ift fmrn .lay Ellison (<'a lifo rnia In stitut e of 
T t><· hnolog,,·. Pasadena. ( 'a lifo rni a ). 
(d ) !J.\'.--1 lmn .~{N and hyhrid i:a lion 
0:\ .-\ sa mpf p,; we r·p digested to co mple t ion with restric ti o n enz.1·m ps (r·omple tio n of 
d igPs ti o n o f th e genomi <· D:\ .-\ wa~ teste d b.1· adding lambda D:\A t o a po rti on o f tlw 
n •a f'!ion mixtun· a nd continuin!! tlw in<·uha tion until the lambda D:\A ga1·e a co mplet t> 
di i!Ps ti on pa ttt' I'Tl upon aga rost> ge l elt>c tro ph ort>s is ). t> lt>ctropho rest>d thro ug h a n aga rosp gt> l. 
trans ft> rwd t o a nitror·pfful ost> filt e r and h.1·hridized with a pa rti cular pro be . 32 P -Ia belt>d by 
ni<·k -tra nsla ti on a s dese rib t>d bY :\l orandi Pial. (19R2 ). Tht:> l11·bridiza tion was ea rried o ut in 
ti x :-;:-;c (:-;:-;( ' i;; 0 ·1.'1)t·:\ a ('J. <·J·O;j)t-sodium c itrate) . <H 0 0 'sodium doderyl s ulfa t <:>. 0 ·1° 0 
~odium p,nophospha te . 10 x Denhardt 's solutio n (0·2° 0 Fieoll. 0·2° 0 po l!·, ·in.l·lpyrrolido ne. 
11·2" 0 hm·i rw se rum a lbumin ). !0° 0 d ex tra n s ulfa tt> . 50 11-g po lyr·:'·tidyli e a eid/ ml. a nd 100 11-g 
lr t> at-dr naturt>d sa lm on SJ>P rft1 D:\ .-\/ ml. fo r 1.'1 hat 68' ('. The filt <:> r was then washed on ce 
with ti x :-;('( ·. 1<1 x D<:> nh a rdt·s ~olution . 0·1 °0 sodium pyrophos phate . 0·1° 0 sodium d od <:><·!·! 
s ulfa It'. on<·t> with:? x :-;:-;(' _ 0·1 °0 sodium d od Pr-!·1 s ulfate . a nd 3 tim es with O·i'i x SS<'. fo r I h 
Pac h a t tiS ( ·. Th e tilt t> r 11 as finally dri t>d a nd expos<:>d t o K od a k X.-\R-5 film with a Dupont 
Lig h t ning Plus int t>n s ifying s<w en a t -70' (' . 
(!:') ('osmid libm ry scree ning 
.-\ hu ma n cosmi d D:\ .-\ libra r!· (pro ,· id t>d by Jay Ellison and Lero!· H ood . Califo rnia 
I ns tit ut r of T e<·hnology. Pasad <:> na . Ca lifornia ) was constructed by pre paring a partial 
J/IJo ! digP~ t o f huma n s perm D:\A and liga ting it t o tlw Bg!II s ite of pTL.') (H o hn & 
( 'o llin ~. l!lSO). a erording t o pre l'io usly pu b lished procedures (Lund eta/ .. 1982 : :::ite inme tz 
t l rd .. 19S:! ) Thi s library was sc re<:> ned. b1· th t:> nwth od of G ros,·eld eta! . (1981 ). with the 
in~e r1 of pHDS+. 3 2 P - I~lw led by ni ek -tra ;1s la ti on . Eco RI fragments of cosmid D:\A we re 
~uh l' l o rwclus i ng the plas mid plT!l (\'ieira & .\Iess in g. 19R2 ) as a ,·ector. 
(f ) D.\'A. 8equenc ing 
lndi ,·idu a l rpstri etion fra g ments we rt:> labeled at th e ir ;)' o r 3 ' ends . and clea,·pd with an 
appro pria t <:> res tri ct ion e ndonuclease to produce fragments la be led at on! !· one end . wh ieh 
we rt> th en iso la t ed b!· po lyaer!·la mide g <:>l electro ph oresis. as pre1·iuusly d <:>srribt:>d by 
.\l o ra ndi t1 rd . (19S2 ). Tlw mt>th od of :\I a xam & Gilb<:> rt (1980 ) \\·a s used fo r seque neing. 
3. Results 
(a) Distrib11tion of DHFRase-spec ijic .sequences in human DSA 
Fig ure I shows the distribution of DHFRase-specifk sequences in a sample of 
human sperm D:\A and in the DXA from the human cell lines HeLa . ''A2-B 
(Weiss et a!. . 196R). and a MTX-res istant deri1·ati1·e of ,.ArB. 6.-\3 (Masters et 
al .. 19fl:? ). Simila r a mo unts of the Yarious D:\A samples were digested with 








Sptrm Hela VA2 6A3 
• . liP 
F11 :. I Distribution of OH FRasP-spec·ifi<· St>quen('('s in EruRI-digest('(l D:'\.-\ from human sperm and 
fnn11 thP human eell lim•s He La. L\rB and its .\ITX-resistant deri,·atin• ti.-\:3. Samples (lp.!!) of the 
'1*'1"111 and HeLa D:'\.-\s and .5p.g sample,; of \".-\ 2 -B and ti.-\3 0:'\.-\s were digested to completion with 
ErolU. s ubmitted to elec-trophoresis through a 0·/ 0 0 agaroSt' gel. transferr"t'd to nitrocellulose and 
hyhrirlized with th t-> in:;ert of pHI>X-t 32 1'-laht>led by nic-k-translation . The numbers represent the sizes 
(khi of tlw normal DH FRase gene fragments. whi(•h an> amplifierl in \'.-\ 2 -B and. t.o a higher degt"t't'. in 
6.-\ :l eel Is . the letters indi<·ate fragments of putati,·e Yariant DH FRase genes or pseudngenes (see the 
tt>xt ). 
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nitnwellulo::;e and hybridized with the insert of pHDH.J.. 32 P-Iabeled by nick-
translation. This plasmid is a human DH FRa,;e eD:\'A clone. whic·h eonfers upon 
E. roli resistan(·e to trimethoprim at I mg/ ml (Morandi et al .. 1982) .. -\II lanes show 
two set:< of hybridization bands. One set of bands. whic·h eorrespond to fragments 
of size,. 13 . ti . .J.. 1·8 and 1·6 kb. appears to be more intense in the \ ' .-\ 2 -B D:\'.-\ 
sample. and mu('h more so in the 6.-\3 D:\'.-\ . than in the sperm and HeLa D:\'As. 
\\'e int erpret these fragments as belonging to the normal DHFRase gene. which 
appear,; to be moderate!:· amplified in \'.-\ 2 -B c-ells and great!:· amplified in 6.-\3 
eelk The fragments described abo,-e ha,·e been rec-ently isolated from a ('h.J..-\ 
librar.\' of ti.-\3 D:\'.-\ and shown to be fragments of the amplified DHFRase gene 
and to (·ontain the whole or almost tlw whole <'oding sequenc-e (.J. K. Yang. ,J. :\'. 
:\laster':' & G . .-\ttardi. unpublished data). The apparently lower amount of these 
fragment::; in the HeLa D:\'.-\ as compared to the sperm DXA in the experiment 
shown in Figure 1 may be a ronsequenc·e of the heteroploidy of this cell line. The 
other ::;et of bands in Figure I. designat-ed a. b , c. d and e. correspond to fragments 
of sizes of 18. li . 3-H. 3·5 and 2·3 kb. respecti,·ely. and do not show any increase in 
intensity in the \ ' .-\ 2 -B and 6.-\3 D:\'A samples as compared to the sperm and 
HeLa D:\'.-\s. but rather a decrease. (Band a . which is Yery faint here in the \'.-\2' 
B and 6.-\3 D::\A samples . appears elearly in other blots using D:\'A from HeLa 
and two human fibroblast lines (not shown) .) These bands cou ld represent 
fragments of allelic· copies of the DHFRase gene. other ,-ariant DHFRase genes 
or pseudogenes. The strong intensity of some of these bands. i.e. b. c and e. 
suggestect that they c-ould c-orrespond to intronless "procesRed .. genes. Further 
anal:·si". as described below. has shown this interpretation to be correct at least 
for bands d and e . 
(b) I .solation of cosmid clones con/(lining DH F Ra.se-specijic sequences 
During the screening of a rosmid library of sperm DXA (the same as that 
ana l:·zed in Fig . 1) for the purpose of isolating cosmids containing the whole or 
most of the DHFRase gene . se,·eral cosmids were isolated that contained some of 
the non-amplified DHFRase-specifir sequences discussed aboYe. The librar:\' had 
been prepared with a partial J/bol digest of human sperm D::\.-\ using the ,·ector 
pTL5 (Hohn & Collins . 1980) . and screened with the 32 P-labeled insert of pHD8-l. 
Although ten positiYe clones were found. none of the cosmids contained any of the 
amplifiable DHFRase gene fragments shown in Figure I: we haYe no explanation 
for this obsen·at ion . Dot hybridization experiments showed that the DX.-\ of nine 
of these eosmids hybridized with each of three subfragments of the insert of 
pHD8.J. corresponding to the 5' -end proximal. middle and 3' -end proximal 
portions (probes).. f3 andy. respectiYely. in Fig. 2) (not shown). This is in contrast 
to the behaYior of the normal DHFRase gene fragments in the genomic blots: all 
of these. in fact. hybridized with the whole pHD84 probe. while only the 13 kb. 
1·6 kb and 4·0 kb fragments hybridized with the pHD43 probe: therefore , they 
contain sequences from the middle and 3' -end proximal segments of the insert of 
pHD8-l (Fig. 2) . These results indicate that these cosmids contained a segment 
corresponding to the whole or almost the whole DHFRase coding sequence. Upon 
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Ft<; :.! . Representation of the DHFRase cD:\A probes used in the D:\A and R:\A transfer 
hYbridization t>xperiment>; and the strategy used for sequeneing the DHFRase cD:\As. These cD:\As 
wt>re prt>pared from pol,·( .l. 1 -<~ontaining polysomal R:\.l, from tht> MTX -resistant cell line 6:\3 and wt>rt' 
cloned into tht> s ingle P.,tl s it t> of pBR3:.!:? (Morandi eta/.. 19R:? ). Tht> top line rt>presents a portion of 
th<, cD:\A of tlw 3·H kb DHf'Ra;e mR:\A (\torandi el a/ .. 19H:?): the positions of tlw in itiator and 
terminator eodons of the DH FRase reading frame and of the restriction sites used are indicated. Below 
this . tht> indi,·idual cD:\As ust>d and tlwir fragment.:; ha,·e been aligned . and the sequt>ncing strategy 
ha ' ilf'en shown for each done . tht> t>xtent and direction of sequenc-e determined being indi ca ted by 
arrows. bp. base- pairs . 
EcoRI digestion of the DXA from these cosmids and DXA transfer hybridization 
with a pHD8.J. probe. this segment was found to be located. in eYery case, in the 
largest fragment (9 to 28 kb) . 
The tenth cosmid. cosHD37. has a size of .-....41 kb, and its EcoRI-digested DXA 
yielded . among others. a 3·5 kb and a 2·3 kb fragment , both of which hybridized 
with pHD8.J. (Fig. 3(a)). It seemed possible that the 3·5 kb and 2·3 kb fragments 
corresponded to the fragments of similar size designated d and e in the genomic 
blots of Figure 1. The identity of electrophoretic migration of the 3·5 kb and 
2·3 kb fragments of cosHD37 with bands d and e, respectively. was confirmed in 
an experiment in which cosHD37 DXA and HeLa DXA were subjected to 
electrophoresis , alone or in a mixture. through an agarose slab gel , transferred to 
nitrocellulose and subjected to hybridization with a pHD84 probe (Fig. 3(b)). 
cosHD37 was chosen for further analysis. In DXA transfer hybridization 
experiments (not shown) , it was obsen·ed that the 5'-end proximal fragment of 
pHD41 (probe o) hybridized exclusiYely with the 3·5 kb fragment of cosHD37. while 
pHD43 hybridized only with the 2·3 kb fragment of cosHD37. These and the 
pre,·iously discussed data were compatible with the idea that the 3·5 kb and 2·3 kb 
fragments were the two fragments of a Yariant DHFRase gene or a DHFRase 
pseudogene separated by the EcoRI site existing 89 bp downstream from the ATG 
in the cDXA coding sequence. This idea received support from the restriction map 
of cosHD37 DXA (Fig. 4). This showed that the two EcoRI fragments are linked, 
and that the positions of the Accl and HincH sites relative to the EcoRI site , in 
























F11 :. :l. (a ) llt> tPI'!ion of DHFRasP ·SJ~l'ili<- ~eq uerwes in <·osHD37 D:\A. La nE' I. Hindlll-digPsted A 
l>\A lanp :.! . EtoRI-digt>s ted •·o~Hl>:l'i 1.>\.-\ . larw 3. autor·adiogram of lam· :? after transfer of the 
D\A to nitm<·PIIulnst• and hybridization to tlw nic·k·transla!f•d in sert of pHD~~ (b) D:\A transfpr 
hyb ridi za tion analysis uf EroRl-digestpd HPLa D:\A and c·osHD37 D:\ .-\ us ing a DHFRasE' cD \A 
prohP. Err,Hl-digestP<I D:\As were s ubmitted to e lertro phorPs is through a 11·5° 0 a~~:arose ge l. 
transferTPd to nitro<~· llulose. hybridizPd to 31 P -labe1Pd pHDx~ . Lane I. cosHD3i D:\A . 0·6 ng : lanE' :2. 
!'osHI>:li 1>\A . O·fi ng . plus HeLa D\A. 51'-g : lane 3. HeLa D:\A. 51'-f!.· The faint band at I~ kl.J in lane 
:l of (a). a nd la nes I and:? of (b). is due to h~· bridization uf contaminating pBR3:?:2 sequences in the 
probe with thl' pBR:l:!:? sP<JUenc·Ps pn·sent in the l'osmid D\.-\ (see Fig.~) . 
similar to those of the same sites in the insert of pHD8-t . Conrlusi\·e eYidence that 
cosHl>37 <·ontains a human DH FRase pseudogene (designated .jJHDl) has come 
from a DXA sequence analysis of portions of the 3·5 kb and 2·3 kb fragments of 
this eosmid. 
(<') D.YA sequenre analysi8 of 3' non-coding segments of DHFRase cD.YA s 
Figure 5 shows the pre\·iously determined sequence (sense strand) of the 
DH FRase reading frame and the upstream region in the insert of pHD8-t 
(Morandi ef al .. 198:2: Masters & Attardi . 198:2). as well as the newly determined 
:111 
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Fl<. ~ . J{,·st lwtion lllHJ• of•·•"HIJ:!~ 1>:\ ,\ and ,;tratq.!\ ' U'l•d fin· SPIJUPn('ing thp <PH Ill ps<• udogpn p 
•·ontaitll'd in •·o,;HI>:l~ . Till' UJ<J"'r linl' sho11·s tlw n·stri<·tion map of ('o,;HlJ3~ D:\ . .\ . Tlw it' ngths of 
t IH· f.'r·,,l{ I i'ntglnt·nts an· shown hPio11· tlw mal' in khJ• ( 111 3 hasP -pairs). Tlw wa,·y lint• indi .. atl's pTL.~ 
, .,.d11r ·"''' lj\ H'IH't'.' · Tilt · lttWP!' lint· :-;how;-.; tht· df'tailt-•d !'t'~trictio11 mal' of tlw two EcrJR I fra~rn Pnt~ . with 
siz•··' of :!·.'i and :.'<l khp . whi< ·h wpn• sulwlonPd spparately using pl'(~l as a \' Pl'lor . ThP till t>d bar 
lltdi<·att ·, tiH· limits of tlw D:\A SP<JIIPn<·e homologo us to the normal DHF!{aSP t·nding :-;{'IJIIPn<·P. as 
sho11n in Fig . . ; . Tlw rP>ll'il'!ion PllZ,\'tll!'s U:-;(•d arP dt>s ignatl'd a,; follow,; Ac·. A crl : H. Hy/11 : ( '. f'/ai . 
H. ll u«· II . K A' tml · 1' . 1'-<11 : R . Err. !{ I . ~a. Soli · ~ . -'Jrhl : \ . .\hoi. In th!' lowc>r part of tlw tigun•. 
till · <IITows s ho11· till' dirPc-tion and extPnt of sP<JIIl' ll <·f' dPtt'rmined. (..\) is an A/ul s itt•. whi c·h wa,; 
d<·rl<w<"d fron1 " '' JII Pn< ·e da ta and was ust>d to ""'lii!'IH'l' through the Hinc-11 s it<' irnrnediat<"ly upstrPa rn 
:-<!:'(jllt:'ll<'t:' of the D.:\ .\ segment:< l~ · ing downstream from the reading frame present 
in pHD~-+. pHD~o . pHD~3 and pHD-+1. The segments sequenc·ed and the 
:-<eq uenl'ing ,;t ra tPg_Y u,;ed a rP shown in Figure l. As shown in Fig me 5 . the 
,.;equPnl'P:-< of the inserts of pHl>K-t. pHD~o. pHl>K3 and pHD-tl were found to be 
l'olinear in tlwir l'orrespond ing segment~- as determined relatiYe to the reading 
franw thi,.; . in all the in,;erts . lies near the 5' end (~lorandi et a! .. 19~:.? ). 
Furtlwnn or!:'. tlw sequen(·e of the insert of pHD~+ was found to (·ontain a s tretch 
of I:?.\ re:-<idu!:'s. ~tartinl! at pos ition 6-J.H (just preeeding the pol~·((') tail used for 
c·loning) . :-;imilarl.\·. the in::;erb of both pHDHO ami pHDH3 were found to eontain a 
st ret<·h of.\ residue:-< starting at pos ition 900 (5:.? residues long in pHD80 and > iO 
rt:'sidue:; long in pHD83. just pret·eding the poly((') tail of these plasmids). A 
reasonable inte rpretation of these results is that the cD:\A of pHD8-+ is deriYed 
from re\·erse transeription of the 0·8 kb mR:\A. while the cD:\As of pHD80 
and pHDI'i:3 are deri\·ed from the I ·Okb mR:\A (Morandi eta! .. 1982) . The 
eD:\A of pHD-+1 must haYe been deri\·ed from rewrse trans(·ription of a 
longer mR:\ .\ . probably the 3·~ kb mR:\A (Morandi el a! .. 1982). The aboYe 
condu,;ion and the colinearity of the eorresponding segment; of the three types of 
c·D:\.\s support the idea that the three main forms of mR:\A pre\·iously detected 
are deriYed from transc-ription of the same sequenee (although not necessaril~· of 
the same templ ate) extending o\·er different length,;. In agreement with this idea 
are the re;;ults of R:\A transfer h,\·bridization experiments using the polysomal 
poly(A )-eontaining R:\A from 6.\3 eells. \\"hen the whole plasmid pHD-tl was 
used as a probe. all three spec-ies of mR:\A hybridized. When a 3'-end proximal 
subfragment of this plasmid was used (probe € in Fig. 2). beginning at the Bglll 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.1. :\ :\1.-\~TE R~ ET .H. 
the c·D:\.-\ of pHDS-L and terminating at the pBR322 EroRI restriction site 
(whil·h liPs downstrPam from the DH FRase coding sequen(·e). thP O·R kb mR:\.-\ 
did not hybridizP. while the HI kb and the 3·R kb mR:\.-\s did. When a different 
suhfragmPnt was w:wd (probe¢> in Fig. :2). beginning at the Hindiii site of pHD-+! 
and ending at the pBR:322 EcoRI site. only the 3·8 kb mR:\.-\ hybridized (not 
shown). 
Pre,·ious work has shown that the human DHFRase coding sequence has an 
S!l"o nuc·leotide sequem·e homology and an H!l 0 0 amino acid sequence homology to 
tlw mousP DH FRase reading frame (Masters & Attardi. 19H2). A homology of 
:2;)" 0 exists hetwepn the 3' non-c·oding region of the mouse 1·6 kb mR:\A (~etzer et 
of .. IBS:2) and the aYailable 3' non-coding se4uenc·e of the human gene. 
(d) ldentifiration of a human DHFRase pseudogene (l/JHDJ) 
Figurp 5 also shows the comparison of the cD:\.-\ sequence described aboYe with 
the homologous region of tj;HDI. Gaps ha,·e been introduced into the cD:\.-\ 
sequence and the t/;HDI sequence to maximize the homology between them. The 
sequence of t/;HDI begins in the 3·5 kb EroRI fragment and continues in the 2·3 kb 
EroRI fragment. extending beyond the poly(.-\) addition site identified in the 
eD:\.-\ of pHDHO and pHDH3. It exhibits an oYerall 92° 0 homology with the 
cD:\A se<.JUPnee. with no significant difference in the degree ofdi,·ergence between 
the region corresponding to the DH FRase coding sequence (93° 0 homology) 
and the 3' non-coding segment (90°0 homology). Se,·eral small insertions. 
ciPletions and single base changes are obserYed. distributed fairly uniformly 
throughout the sequenre. In particular . there are fi,·e insertions. between 
nueleotides -16 and -15. 36-l and 365. 6-4-0 and 6-+1. 65R and 659 . and 920 and 
9:21. of the eD:\ A sequence: and two deletions. corresponding to nucleotides 243 
and 301 to 30-+ of the cDXA sequence. The deletion of nucleotide 243 causes a 
frameshift in the DHFRase coding region. which results in an ochre termination 
codon beginning at a position conesponding to nucleotide 293 in the cDXA 
sequence. 
The deletion of nucleotide 243 in tj;HD1 is particularly interesting since this is 
the first nueleotide of the fourth exon of the mouse DHFRase gene (('rouse et al .. 
19S:2). In order to determine whether the missing nucleotide also corresponds to a 
splice junction of human DHFRase gene. the exon region of the cloned 1·6 kb 
fragment of the human gene (Fig. I) . whic·h from restriction mapping data was 
expected to contain the coding sequence corresponding to the fourth exon in the 
mouse gene (Yang et al .. unpublished data). was sequenced. The sequence data 
clearly confirmed this expectation. thus indicating that the 3/4 and 4/5 exon 
junctions of the mouse gene correspond precisely to splice junctions in the human 
gene (Yang et al .. unpublished data). The sequence data of Figure 5 show that . 
apart from the missing nucleotide 2-+3. the region immediately surrounding the 
two splice junctions in the human gene (indicated by long, unbroken arrows) 
shows perfect homology to the corresponding segments of the t/;HDI pseudogene. 
The normal gene and the tj;HDI sequences also show perfect homology to each 
other in the sites corresponding to the other exon junctions identified in the 
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mousE' gPnP (Sptzer et rd .. 19H:2: ( 'rousp eta! .. 198:2) (indicatpd by broken arrows in 
Fig 5) 
4. Discussion 
Tlw DH FRast> psPudogt>nt> idt>ntifipJ in tlw presPnt work in tlw sperm D.\'.-\ 
from a human indi,·idual and in tlw genomt>s from two human estab li shed f'ell 
I inP>' has rp,·palt>d t hP typic·al strud ure of an intronless genE' . The interYen ing 
sequerH·Ps that interrupt tlw rPading frame oft lw human DHFRase gene (Yang et 
rd .. unpuhli,.;hed data) art> missing. The precise positions of two of thE'S!:' 
inten·ening st>qtH' nc·e;; ha,·p been idPntitied (Yang et a! .. unpublished data). and 
tht>y appt>ar to ('Oin('iclt> with tlw sites of two introns in the mouse gene (Crouse et 
a! .. HlH:2) . .-\s,.;uming that the other introns a lso occur at the same positions in the 
human DHFRase reading frame as in the mouse DHFRase coding sequence . as 
seem,.; like!~·. it appears that the apparent "excision" of introns from !j~HDI has 
been absolutPI .\· prt>c·ise. Tht> exon junction at nucleotides 2-+:2/ :2-4-3 of the pHDS..f 
eD.\'.-\ insPrt is a possible eX<'t>ption. sinc·e a deletion of the first nucleotide of the 
downstream exon (nuf'leotide :2-4-3) appears to ha,·e occurred in the pseudogene. 
The portion of tlw !j~HDI sequen<·e corresponding to the DHFRase reading 
frame has a ,·er~· high degree of homology to it ( ~ 93°0 . ex eluding the deletions 
and insertions). Howp,·pr. the presence of small delt>tions and insertions in the 
pst>udogenP has introduced frameshift s. the first one beginning at a position 
correspond ing to nucleotide :2:2:2 of the normal reading frame . and stop codons. the 
first of whieh is at a position rorrPsponding to nucleotide 271 of the normal 
reading framE:'. ThesE' a ltprations would make !j~HDI non-functional. at least as a 
DH FRasE:' coding gPne . 
Partic·ularly interesting is tlw relationship of !j~HDI to the three main human 
DH FRasE:' mR\'As JWe,·iuusly identified. whic·h differ in the length of their 3' 
untranslat.ed r·pgions (:\lorandi et a! .. 19R:2). The sequence analysis of tlw 3' non-
coding segments of tlw cD\'.-\ insprts of plasmids pHDR..f. pHD80 and pHD83 has 
pro,·ided e,·idence indicating that the first cD\'A is deri,·ed from the 0·8 kb 
mR\'A . and the other two from the 1·0 kb mR\'A . Furthermore . thE' sequences of 
these cD.\'As and of the pHD-+1 cDXA were found to be eolineat in their 
corresponding segments. These obserYations and the results of RX.-\ transfer 
hybridization experiments are consistent with the idea that the two forms of 
mRXA. and probably also the largest (the 3·8 kb mRXA). are deriYed from the 
sanw gene by different transcription or R.\'.-\ -processing e\·ents. A similar 
conelus ion has been reached concerning the origin of the multiple DHFRase 
mR.\'As in the mouse system (Setzer et al .. 1980, 1982). The hexanucleotide .-\-A-
l'-A-A-A. which is found 15 to 20 nucleotides upstream from the polyadenylation 
sit!:' in most eukaryotir mR\'As (Proudfoot & Brownlee. 1976) and is considPred 
to be a rerognition site for polyadenylation (Fitzgerald & Shenk. 1981 ). is absent 
in the 0·8 and 1·0 kb mR.\'As. although possible ,-ariants of this sequence are 
present at the expected positions. This obsen·ation indicates that. as preYiously 
suggested for the mouse system (~etzer et al. , 1982). the hexanucleotide A-A-l'-A-
A-A is not required for polyadenylation of at least two of the human DHFRase 
mR.\'As. 
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Tl](' "<'<Jll<' ll<"t' of <bH 1>1 dml·n,-trP<ll ll from tlw segnwnt <·on·psponding to th e 
I >H 1-'J:a,-<· rt'<l ding franw aJ,-,, p:o; hihih a high dt>grPP of homology (- ~)11" 11 ) to thP 
:r tllll r<t li"l 'tlt ·d n•gion of tlw I'll\.-\,- ,.wqtiP!l<-Pd lwrP. up to a po,.: ition pa,.:t tlw 
ptlt <tlin· )'"h·(.·\ I addition ,-it<· of th f' ) ·() kh 1nH\.-\ . Hoii-P'.·P r. it dop,.: not rp\·pa ) 
an1· Pl·idPn< ·t• fort)](' prp,.:(' n<T of a pol_1·(.-\) tm<·t. although it l'Hnnot be pxdudt>d 
that a poh·(.-\ ) tnu·t may lw prp,.:pnt somp1rhpre downstrea m. In the 5' Hanking 
rPgion of l/I HI>l . \I 'P lliln• likPwisP no e1·idP11l'e. as yet. as t o t lw existPn<·P of 
homolog_\' to tiH· initiation point(,: ) of trans<·ription of the DH Fl{ase mH.\.-\s. In 
,:pit<• of thi,; . tlw ,.:tilldun· of l/IHD I stron1-d.1· ,.:uggpsts that an K\ .-\ intprmediatP 
Ita" parti< -i J ~<l l< · d in ih formation. a,; s ttggp,.;ted Jll 'e Yiousl .Y for o ther intron!Pss 
p,.:t· ttdogPnP,.: (\ishioka et rd .. l\1:-10: \ 'anin e/ a/ .. HlHO: \\'ilde et rd .. l!lH2a.b: Hollis 
rt ul .. 1 \t~~ : Karin S.: Hichank 1!1:->2 ). lftlw l{\ _-\ intermediate po,.;tulated herE' i" 
dt·riu·d h·o1n rP\·p rsP transt ·ription of a DHFHa,.:p mH.\A. a form ofmH\.-\ larger 
than tiH-· J·tl kl, mH\.-\. pmhably the :3-S kh mR\ .--\. must han• been i111·oh·ed. 
H<·<·Pnt prPiiminary el·idPn<·P indil'atp,.; that l/IHDI is IO<·ated in a different 
l'hronlu,.;om<· from that l'ontaining thP normal DH FH.a,.;e gene (B. Maurer. 
1'. HarkPr . . 1. ~last Prs. J> . d'Eu,.;ta('hio . F . H.uddlf' & G. Attardi. unpublished 
o h,.:pn·a tion,.; l. a re,.;ult that i,.; <·onsistent with the idea that an H.\.-\ intermediate. 
,,·JwthPt· an mH\A or a re tro1·iru,.: genotnf' eopy. was responsible for its fo rmation 
and tr<tn,.: lo<·ation. \\ ' hatpi·P r p1·ent IPd to thP formation of l/IHDI.. the limi ted 
dPgrPP of dil·prgPnl'e from tlw DH FHa,.:e <·odin!£ sequen('e suggests that it must 
ha n · ), f'P n a rP< ·Pn t one. Th f' great di1·ergenl'e between human and mouse 
DH FHa,-t· in tlw :r non-l'odinf! sPquen('e plaee,.: the origin of thi s pseudogene in 
(' Yolution<lry tim l:' after tlw separati on of tlw lines leading to primates and 
rod Pnh . 
l/IH Ill i,- J'rohably not tlw on ly DH Fl~asl:' p,.;<:>uciogene present in tlw human 
gf'noml:'. Th l:' pre! imina r_,. Pl·idl:'n<·e ob tained on the stru<·t ure of seYeral cloned 
fragnwnt,.: i,.;olated from tlw <·osmid library ,.;uggl:'sts that the otlwr bands gi 1·ing a 
hybridization ,.:ignal ,,·ith a pHDH~ prolw in tlw genomie blots ana lyzed here (a. b 
and <· in Fig . I ) l'Oll ld repre~ent all<:>lic DH FH.asp genes. other Yariant genes or 
psl:'udogl:' rw,.: . Til(:' existem·e of a llelie DH FRase genes with different restriction 
patt <:> m,.: and specif~·ing protein produc·ts of different elec-trophoretic· mobilitie~ has 
bef'n demonstrat<:>d in ( 'hinesf' hamster c-ell s (Flintoff eta/ .. 1 9~2: Lewis et a/ .. 
1\1:-12 ) 
Tlu· ,- i_gniticanc·p of the moderate DH FRase genE' amplifieation that has 
o<·<·urwd in thl:' human ('ell line \ '.--\ 2 -B in the absenee of methotrexate selec·tion is 
unknown . Thi,.; <·ell line is a subdone resistant to H-azaguanine (\\'eiss et al .. 1968) 
dPri1·ed from the line \\'I -IH-\'.-\ 2 transformed by s imian 1·irus -W (Ponten el a/ .. 
H-lli3 ). The I>H FRa~e gen<:> amplific·ation eould ha1·e oc·<·urred at an~- time during 
the life of this <·e ll line . Besides the DHFRas<:> gene dosag<:> . the le1·el of the three 
DHFRase mR\.--\s is abo incr<:>ased in thesf' cell s (Morandi et al .. 1 9~2): b~­
<·ontrast. tlw DHFRase aetiYity appears to be only slightly in('reased (Masters 
el ol .. I !ll'\2). 
Tlw~<· inl't·~tigations wpn:• ~u pportPd h~· :\'ational Institutes of Health grants (;MJJ72ti 
and T:l:.? ( ;:\)11/lilti . \\' p arP \'Pr~· gratpful to A. ('homyn fur hPipful di sc- ussions and to .J. 
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Elli>'o n fur a gift of human sp<· rm D :\ .-\ and to .1 . Ellison a nd L. H ood for pro,· iding us with 
tlw human D:\A !'Osmid librarY . 
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Abstract 
The complete human dihydrofolate reductase (DHFR) gene has been cloned from four 
recombinant lambda libraries constructed with the DNA from a methotrexate resistant 
human cell line with amplified DHFR genes. The detailed organization of the gene has 
been determined by restriction mapping of the cloned fragments and DNA sequencing of 
all the protein coding regions and adjacent intron segments, and shown to correspond to 
that of the native human DHFR gene. The gene spans a length of approximately 29 kb 
from the A TG initiator codon to the end of the 3' untranslated region, and contains 5 
introns which interrupt the protein coding sequence. The number and positions of introns 
are identical to those found in the mouse gene. By contrast, the size of the homologous 
introns, with the exception of the first one, varies greatly, up to several fold, in the 
genes from man, mouse and Chinese hamster; the intron sequences also exhibit a great 
divergence, except in the junction regions. A striking sequence homology, extending over 
several hundred nucleotides, exists between the human and mouse gene 5' non-coding 
regions. These regions are characterized by an unusually high G+C content, 72 and 66% 
in the human and mouse gene respectively, which is maintained in the first coding 
segment and first intron, and sharply contrasts with the relatively low G+C content, 
-40%, of the remainder of the gene. 
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Introduction 
Recent work from this laboratory has led to the isolation of several human cell variants, 
derivatives of the cell lines HeLa BU25 and VA2-B, which are resistant to high 
concentrations of methotrexate (MIX) as a result of the hyperproduction of 
dihydrofolate reductase (DHFR), the target enzyme of the drug (Masters et al., 1982). 
These variants have been characterized as to the stability of their phenotype in the 
absence of selective pressure and to their chromosomal constitution (Masters et al., 
1982), and two of the variants, 1 OB3 and 6A3, in the physical and enzymatic properties of 
the hyperproduced DHFR (Morandi and Attardi, 1981) and in the pattern of transcription 
(Morandi et al., 1982). Furthermore, the cloning and characterization of the DHFR-
specific cON As derived from the 6A3 cell line (Morandi et al., 1982; Masters and A ttardi, 
1983; Masters et al., 1983) have permitted an analysis of the distribution of the DHFR-
specific sequences in the human genome by DNA transfer-hybridization experiments, the 
identification of a DHFR pseudogene (Masters et al., 1983), and the chromosomal 
localization of the human native DHFR gene and three pseudogenes (Maurer et al., 1983, 
and unpublished data). 
In this paper, we describe the organization of the complete human DHFR gene and 
compare it to that of the homologous genes from mouse (Crouse et al., 1982) and Chinese 
hamster sources (Carothers et al., 1983; Milbrandt et al., 1983). Although the three 
mammalian genes have a similar size and a similar overall structure as concerns the 
number and positions of the introns, there has been a strong divergence in the size and 
sequence of the introns, especially marked for the fifth intron. By contrast, a striking 
sequence homology has been detected in the 5' non-coding regions of the human and 
mouse genes, which have an unusually high G+C content: this homology extends up to at 
least 327 bp upstream of the initiator codon. 
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Materials and Methods 
(a) Materials. 
Restriction enzymes and Bal31 were from New England Biolabs, Bethesda Research 
Laboratories, or Boehringer Mannheim; T4 DNA ligase from Bethesda Research 
Laboratories; Escherichia coli DNA polymerase I from Boehringer Mannheim; DNA 
polymerase I large fragment (Klenow) from New England Biolabs or New England 
Nuclear; (a32P)-dNTPs from Amersham; BND-Cellulose from Sigma. 
(b) Cell Lines and Chromosome Isolation. 
The human cell line 6A3 is a MTX-resistant variant derived from VA2-B cells (Masters 
et al., 1982). Suspension cultures of 6A3 cells were grown as previously described 
(Morandi et al., 1982), and arrested in metaphase by treatment with vinblastin sulfate (50 
ng/ml) for 20 hr. Chromosomes of normal size range (referred to in this paper as 
"normal" chromosomes) and large and small double minute chromosomes (indicated as 
large and small double minutes) were separated by differential centrifugation at 4,100 xg 
for 30 min, at 16,300 g for 30 min and at 70,000 g for 60 min, respectively, in a high pH 
buffer system (Wray et al., 1972). 
(c) Preparation of Cot Fractionated DNA. 
HeLa cell DNA was isolated by the method of Gress-Bellard et al., (1973), sheared to an 
average size of -600 nt using a Virtis homogenizer (Britten et al., 1974), denatured, 
allowed to reanneal to Cot 100 to renature the bulk of the repetitive sequences (Schmid 
and Deininger, 1975), and then subjected to hydroxylapatite chromatography to separate 
the dsDNA fraction, which represented 44% of the total, as measured by the absorbance 
at 260 nm. This DNA was then tested to determine the minimum amount needed to 
quench the signal from 32P-labeled probes containing repetitive elements. It was found 
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that addition of 10 ~g/ml of Cot 100 DNA to the hybridization mixture m the plaque 
screening assays was sufficient to obtain this effect. 
(d) A Library Construction and Screening. 
Cha4A libraries were constructed as previously described (Maniatis et al., 1978), using 
sucrose gradient fractionated partial EcoRI digests of DNAs from 6A3 chromosomes or 
from large double minutes or small double minutes. AJ 1 (kindly provided by J. Mullins) 
was derived from :>..L47 .1 (Loenen and Brammar, 1980) by replacement of the 1.37 kb and 
2.83 kb EcoRI-BamHI fragments with the 100 bp EcoRI-BamHI polylinker sequence 
[derived from nVX; (Maniatis et al., 1982)]. A partial Mboi digest of 6AJ chromosomal 
DNA was fractionated by sucrose gradient centrifugation and cloned into the AJ 1 arms 
generated by BamHI. The libraries were screened by in situ plaque hybridization (Benton 
and Davis, 1977) with pHD84, a plasmid which contains a human DHFR eDNA segment 
comprising the whole coding sequence (Morandi et al., 1982), or with pBH31R1.8 or 
pUH112PR1.3 (two plasmids carrying human DHFR gene fragments), 32P-labeled by nick-
translation. The recombinant phages were grown in DP50supF (Blattner et al., 1977), and 
DNAs were prepared as previously described (Williams et al., 1977). 
(e) Subcloning into Plasmids. 
DNA fragments were isolated by electrophoresis through a low melting (Seaplaque) 
agarose gel, and subcloned into pBR325 (Bolivar, 1978) or pUC9 (Vieira and Messing, 
1982), using as a host the E. coli B derivative HB 101 (Boyer and Roulland-Dussoix, 1969) 
or, respectively, TBl [a JM83 (Messing, 1979) derivative deficient in the host restriction 
system and cured of a P1 prophage, T. 0. Baldwin, personal communication]. The 
plasmid pUHJlPR0.8 was constructed by ligating a Psti-EcoRI digest of pBH31R1.8 to a 
Psti-EcoRI digest of pUC9 [which had been spermine precipitated (Hoopes and McClure, 
1981) to remove the small linker fragment]. A Pstl digest of pUH31PR0.8 was digested 
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for various lengths of time with the exonuclease Bal31 (Lau and Gray, 1979), treated with 
the large fragment of DNA polymerase I to make blunt ends (Maniatis et al., 1982), then 
digested with EcoRI and ligated to a Smai-EcoRI digest of pUC9 to produce pUH3lll7 
and pUH3llll6. The recombinant clones were screened either by restriction enzyme 
analysis of DNA rapidly isolated from randomly picked colonies (Birnboim and Doly, 
1979) or by colony hybridization (Grunstein and Hogness, 1975). Large-scale preparations 
of plasmid DNAs were made by the alkaline lysis method (Birnboim and Doly, 1979), 
followed by benzoylated-naphtoylated-DEAE (BND)-cellulose chromatography (Kiger and 
Sinsheimer, 1969) or by CsCl-ethidium bromide gradient centrifugation. 
(f) DNA Transfer and Hybridization. 
DNA samples were digested with restriction enzymes as suggested by the vendors, 
fractionated by agarose gel electrophoresis, transferred to a nitrocellulose filter and 
hybridized with an appropriate 32P-labeled probe as previously described (Masters et al., 
1983). Cot fractionated HeLa cell DNA was used in some experiments as carrier DNA to 
quench the signal given by repetitive elements in particular probes. 
(g) DNA Sequencing. 
Individual plasmid DNAs were digested with a restriction enzyme cutting within the 
region of interest, and the ends thus generated were either 5'-labeled, using T4 
polynucleotide kinase and (y-32P) ATP following treatment with calf intestinal alkaline 
phosphatase, or 3'-labeled, using the large fragment (Klenow) of E. coli DNA polymerase 
I and an appropriate (a-32P)-dNTP: this approach allowed the sequencing of both strands 
from the same end of the fragment. The DNA was then digested with a second enzyme 
to produce the fragment of interest labeled at only one end. The 32P-labeled fragments 
were in general purified by polyacrylamide gel electrophoresis (Maxam and Gilbert, 
1980); however, when the second digestion resulted in an unwanted 32P-labeled fragment 
89 
less than 50 bp long, the DNA was spermine precipitated (Hoopes and McClure, 1981) to 
remove the bulk of the small fragment, and then sequenced directly. The sequencing 
reactions were carried out as described by Maxam and Gilbert ( 1980). 
Results 
(a) Construction and Screening of DNA Libraries from a Human Cell Line with Amplified 
DHFR Genes. 
6A3, a MIX-resistant human cell line derived from VA2-B cells (Masters et al., 1982), 
contains amplified DHFR genes which are in part associated with "normal" chromosomes, 
in part with double minute chromosomes (Maurer and Attardi, unpublished data). 
Because of the existence of amplified genes in the two types of chromosomal structures, 
the "normal" chromosomes, the large double minute chromosomes and the small double 
minute chromosomes were separated by differential centrifugation and utilized 
independently to construct :\Cha4A libraries. About LOx 106 recombinant phages from 
the library of chromosomal DNA, 1.7x105 phages from the library of large double minute 
DNA and 7.5x104 phages from that of small double minute DNA were screened with 32P-
labeled pHD84, a plasmid containing a eDNA segment comprising the entire human 
DHFR coding region (Morandi et al., 1982), by in situ plaque hybridization; -0.2% of the 
phages from each of the three libraries gave positive signals with the probe. Ninety-
eight positive clones (62 from the chromosomal DNA library, 22 from the large double 
minute DNA library and 14 from the small double minute DNA library) were analyzed by 
DNA transfer hybridization experiments using the pHD84 probe for the presence of the 
EcoRI fragments containing the DHFR coding sequence, which are found in digests of 
human DNA and which are amplified in 6A3 cells (Masters et al., 1983): these fragments 
have sizes of 13, 6, 4, 1.8 and 1.6 kb. Ten groups of phages differing in the inserts were 
found among the 98 positive clones. Seven of the 10 groups of phages could be shown to 
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contain m their inserts one or two of the above listed EcoRI fragments reactive with 
pHD84, and could be classified as follows: 13 kb, 13 kb and 4 kb, 4 kb and 1.6 kb, 1.6 kb, 
6 kb, 6 kb and 1.8 kb, and 1.8 kb. The remaining three groups of recombinant phages 
contained rearranged DHFR gene fragments producing abnormal EcoRI digestion 
products, and will be described below. The recombinant phages which contained the 6 kb 
or the 6 kb and 1.8 kb EcoRI fragments turned out to be very unstable and to undergo 
rearrangement during phage growth, so that they could not be analyzed further. 
Figure 1A shows the alignment of the phage DNA inserts containing EcoRI 
fragments of the amplified DHFR gene. One can see that the inserts cover a stretch of 
>35 kb interrupted by a gap. We were unable to identify any stable recombinant phage 
whose insert overlapped the inserts of A.Cha4A-DML31 and A.Cha4A-DML29 among a total 
of 1.3x106 recombinants analyzed. It was conceivable that by a partial digestion of 
genomic DNA with a more frequently cutting enzyme, one might split the sequences in a 
way that would allow their cloning (a situation which has indeed occurred in the case of 
human mtDNA, unpublished results). Therefore, we partially digested the chromosomal 
fraction of 6A3 DNA with Mbol, fractionated the DNA on a sucrose gradient and ligated 
the 15-20 kb fraction to the purified arms of Bam HI digested A.J 1 DNA. About 5x 104 
recombinant phages were screened first with 32P-labeled pBH31 R 1.8, a plasmid carrying 
the 1.8 kb EcoRI genomic fragment which lies next to the gap between the inserts of 
A.Cha4A-DML31 and A.Cha4A-DML29 (Fig. 2A), and then with 32P-labeled pHD84. The 
DNA from two phages gave positive signals with both probes [AJ l-CM15, Figure 1B, and 
A.Jl-CM12, a phage containing rearranged DHFR gene sequences (see below)], the DNA 
from 13 phages hybridized only with pBH31Rl.8 (not shown), and the DNA from 12 
phages hybridized only with pHD84 [three phages containing normal DHFR gene 
sequences (AJ1-CM112, AJ1-CM113, AJ1-CM114, Fig. 1B), four phages containing 
rearranged DHFR gene fragments, to be described below, and four unstable phages (not 
shown)]. The inserts of AJ1-CM15 and AJ1-CM112 reduced somewhat, at each end, the 
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gap existing in the restriction map of the DHFR gene. In a final attempt to bridge the 
remaining gap, -l.2x l 05 recombinant AJ l recombinant phages were screened with a probe 
containing the 1.3 kb 5'-end sequences of AJ 1-CM 112 subcloned in pUC9 (pUH ll2PR 1.3, 
Fig. 2A). The 1.3 kb fragment was shown to contain repetitive sequences by its 
hybridization to nick translated Hela DNA (data not shown). However, by using Cot 
fractionated Hela DNA in the hybridization mixture, as described in Materials and 
Methods, we were able to quench the signal from the repetitive DNA. Among the 
recombinants, 25 phages gave a hybridization signal with the pUHll2PRl.3 probe. 
Analysis of the DNA from these phages enabled us to find one clone (AJ l-CM2ll) whose 
insert overlaps that of AJl-CM15 by 275 bp, as determined by DNA sequencing (see 
below), thus bridging the gap in the restrictiom map of the DHFR gene (Fig. l B). 
(b) Organization of the Amplified DHFR Gene. 
The inserts of five recombinant phages from the A.Cha4A libraries and five phages from 
the All library (Fig. l) were aligned and analyzed in detail by restriction enzyme 
mapping and DNA transfer hybridization experiments using 32P-labeled pHD84. Their 
orientation was determined by dot hybridization experiments with 5'- and 3'-specific 
probes from eDNA clones (Morandi et al., 1982; Masters et al., 1983). 
The precise location of the protein coding regions in the DHFR gene was further 
investigated by subcloning the various fragments containing these regions (Fig. 2A), by 
analyzing these fragments by restriction enzyme digestion and DNA transfer 
hybridization experiments, and finally by DNA sequencing (see below). As observed in 
the cloning of the 6 kb EcoRI fragment of the DHFR gene into A. vectors, difficulties 
were experienced in the subcloning of this fragment. Thus, the region of the fragment 
containing the coding region III was particularly resistant to subcloning into pUC9 using 
JM83 or a restriction deficient and P l cured derivative of this strain (TB l, kindly 
provided by T. 0. Baldwin) as a host. As another approach to solve this problem, the 6 kb 
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EcoRI fragment from AJ l-CM211 was digested with several blunt-end cutting enzymes 
(Smal, Pvull, Hincll, or Hpal) and ligated to Smal and EcoRI digested pUC9. One of the 
subclones (pUH211 RS 1.2), containing an EcoRI-Smal fragment, was mapped near the 
5'-end of the 6 kb EcoRI fragment and utilized for DNA sequencing (Fig. 2B). Another 
subclone was found to contain the coding region III and was utilized to localize this 
region by restriction mapping (pUH211PvR2.1, Fig. 2B). In another experiment, the 6 kb 
EcoRI fragment was completely digested with Mbol, the mixture was ligated into the 
BamHI site of pUC9, and the recombinants were screened by colony hybridization using 
the pHD84 probe. One such clone, pUH211M0.6, containing the coding region III (Fig. 2B) 
was utilized for DNA sequencing. 
(c) DNA Sequencing. 
Figure 2B shows the segments of the DHFR gene and of the 5' non-coding region which 
were sequenced and the sequencing strategies. The sequences of all the protein coding 
regions, starting at the A TG, of the adjacent intron regions, including the whole first 
intron, and of the 3' untranslated region up to the Bglll site are shown in Figure 3, 
together with the homologous regions of the mouse DHFR sequence (Crouse et al., 1982; 
Setzer et al., 1982). Sequencing of the whole human DNA insert of pUH15R0.5 (Fig. 2B) 
yielded the sequence of the major portion of the second coding region and of the adjacent 
segment of the second intron (position 457 to 881) (Fig. 3). The sequence from position 
607 to 881 was also found in the 5'-end proximal segment of the insert of pUH211RS1.2 
(Fig. 2B). The overlap by 27 5 bp of the two sequences thus appeared to bridge the gap in 
the restriction map of the DHFR gene, strongly suggesting that the whole gene had been 
cloned. This conclusion was corroborated by the results of genomic blotting experiments 
(see below). 
The protein coding sequence is complete, and is identical to that determined from 
the human DHFR eDNA (Masters and A ttardi, 1983). Also the sequence of the 3' 
93 
untranslated region, up to the Bglii site, matches perfectly that of the eDNA (Masters 
et al., 1983). The perfect alignment of the restriction sites of this region in AJ 1-CM 113 
(Fig. 2B) with the restriction sites in the eDNA (Morandi et al., 1982) indicates that 
probably there are no introns in this portion of the gene at least up to the BamHI site 
(pUH 113Sm5.6, Fig. 2B). The intron-exon junctions are conserved as compared to the 
mouse sequence; their positions follow the GT -AG rule (Breathnach et al., 1978), 
although the only unambiguous junction is between coding regions V and VI. 
The available human and mouse gene sequences show, as previously reported 
(Masters et al., 1983), high homology (89%) in the protein coding regions; the homology 
drops to less than 30% in the introns at 15 to 35 bp from the splice junctions in all cases 
where both the human and the mouse sequences are available. A dot-matrix plot of the 
intron sequences did not show any obvious homology of these regions in the two genes 
(not shown). 
The 5' non-coding sequence of the human DHFR gene, ending with the ATG 
translation initiation codon, is shown in Figure 4, together with the available 5' non-
coding sequence of the mouse gene (Crouse et al., 1982), as well as with the homologous 
regions of two recently isolated human pseudogenes, I(JHD1 (I(! b Masters et al., 1983) and 
hDHFR-1(!2 (t!Jz, Chen et al., 1982). The homology to the mouse 5' non-coding region is 
65% and extends to at least -327 bp from the ATG initiator codon. Both pseudogenes 
exhibit good homology, upstream of the initiator codon, to the human 5' non-coding 
region up to position -61 (79% for I(JHDl and 85% for hDHFR-ljJ2), and then rapidly 
diverge. \jJHD 1 has an additional 176 nt at the 5' end which shows no homology to the 
available 5' non-coding sequence of the human gene (data not shown) 
The alignment of the first coding segment and 5' non-coding region of the human 
and mouse DHFR gene was determined by the best-fit plotting program ofT. Hunkapiller 
and L. Hood (manuscript in preparation) and is shown in Figure 5. This plot best 
illustrates the extensive nucleotide homology of the human and mouse 5' non-coding 
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sequences. In particular, it shows clearly that the human 5' non-coding region contains a 
45 bp stretch at position -91 to -135, which is homologous to the fourfold 45-48 bp repeat 
of the 5' non-coding region of the mouse sequence (also shown in Fig. 4). This 45 bp 
human sequence is not repeated; however, a portion of it, from position -127 to -110 
(GGGGCGGGGGGGCGGGGC), has a 16 out of 18 homology to the sequence from 
position -93 to -76 (GGGACGAGGGGGCGGGGC). 
Figure 4 also shows that the human 5' non-coding sequence is particularly rich in 
G+C (-72% G+C from position -395 to the A TG codon). In order to compare the 
distribution of G+C in the available sequences of the human and mouse DHFR genes, the 
variation in % G+C along the two genes was plotted as shown in Figure 6. The high G+C 
content found in the 5' non-coding region of the human gene is maintained in the first 
coding region and almost the entire first intron (67% G+C), whereas the rest of the 
available human sequence, including the 3' non-translated region, is A-T rich (36% in 
coding regions II to VI and adjacent intron segments, and 41% in the 3' non-coding 
region). This unusual pattern of G+C distribution appears to be conserved in the mouse 
gene (66% in 5' non-coding region, 60% in first coding region and first intron, 37% in 
coding regions II to VI and adjacent intron segments, and 41% in the 3' non-coding 
region). 
(d) The Organization of the Amplified DHFR Gene is Identical to That of the Native 
Gene. 
In order to test whether the complete DHFR gene had been cloned, and to investigate 
whether the organization of the human DHFR gene isolated from the MTX-resistant 6A3 
cells had been altered during amplification, genomic blot hybridization experiments were 
carried out using EcoRI, Hindiii, Ssti, and Kpni digests of HeLa cell DNA and 6A3 cell 
DNA with the pHD84 probe. As shown in Figure 7 A, all the restriction fragments which 
were expected to hybridize to pHD84 on the basis of the restriction map of the cloned 
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gene (Fig. 7B) were found in both the 6A3 cell DNA and the Hela cell DNA samples. The 
8.8 kb Ssti fragment hybridized very weakly to pHD84 because it contains only 19 bp of 
coding sequence. These results clearly confirmed the conclusion of the restriction 
mapping studies indicating that the whole amplified DHFR gene had been cloned, and 
furthermore indicated that the gene organization determined here is identical to that of 
the native DHFR gene. The extra fragments present in Hela cell DNA probably 
represent pseudogenes or other DHFR-related sequences (Masters et al., 1983), which are 
unlinked to the DHFR gene in chromosome 5 (Maurer et al., 1983). 
Blot hybridization of EcoRI digested DNAs from Hela and 6A3 cells with 32P-
labeled AJl-CMl5 (Fig. 1B) showed that the 5' flanking sequences of the amplified gene, 
over at least 30 kb upstream of the coding sequence, are also present upstream of the 
native gene in Hela cells (Figs. 7 A and 7B). It appears, therefore, that in 6A3 cells, these 
upstream sequences had been amplified together with the DHFR gene without any 
significant rearrangement during selection in the presence of MTX. 
(e) Phage Recombinants Containing Rearranged DHFR Gene Fragments. 
In the course of this work, some ACha4A and AJ1 recombinant phages were isolated, 
whose DNA hybridized with pHD84, but which contained EcoRI fragments not found in 
the normal DHFR gene. The constitution of the inserts of these clones is shown m 
Table l. The 1.8 kb and 6 kb EcoRI fragments of AJl-CM12 hybridized with pHD84, and 
were thought to be the 1.8 kb and 6 kb EcoRI fragments of the native and the amplified 
gene observed in genomic blots (Fig. 7). However, a detailed analysis of the subcloned 
6 kb EcoRI fragment of AJ 1-CM 12 revealed that this fragment differs in restriction 
pattern from the 6 kb EcoRI fragment of the normal DHFR gene (Fig. 7B and unpublished 
data). Whether the 1.8 kb EcoRI fragment of AJ1-CM12 and ACha4A-CM95 represents 
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the 1.8 kb fragment of the normal gene has not been determined in this study. 
f.Cha4A-DMs6 contains normal DHFR gene sequences except for the insertion of a 
3.5 kb EcoRI fragment between the 2.5 kb and 1.6 kb EcoRI fragments (Fig. 7B). The 
3.5 kb fragment is apparently derived from fusion of the adjacent 2.5 kb and 1.6 kb EcoRI 
fragments with a small deletion, as indicated by restriction mapping of the three 
fragments (unpublished data). The other recombinant phages containing rearranged 
DHFR gene fragments which are listed in Table 1 have not been analyzed in detail in this 
study. 
Discussion 
The complete human DHFR gene amplified in 6A3 cells has been cloned usmg four 
different lambda phage libraries, and its organization determined and shown to 
correspond to that of the native human DHFR gene. This gene spans approximately 29 kb 
beginning at the A TG translation initiation codon and extending up to the end of the 3' 
untranslated region represented in the 3.8 kb mRNA (Morandi et al., 1982). The 
intron/exon junctions of the gene are at positions identical to those found in the mouse 
gene, and the corresponding sequences show good homology to the consensus donor and 
acceptor sequences of the majority of nuclear protein-coding genes of higher eucaryotes 
(Mount, 1982). The data of Chen et al., ( 1982) on the structure of the 3' portion of the 
human DHFR gene agree with our results, as concerns the size of the fourth and fifth 
introns and the probable absence of introns in the 3' untranslated region. 
(a) Intron Divergence. 
In contrast to the conservation of the intron-exon junction positions, a comparison of the 
human, mouse (Crouse et al., 1982) and Chinese hamster genes (Carothers et al., 1983; 
Milbrandt et al., 1983) shows a strong divergence of the lengths of the introns in these 
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species, except for intron I (Fig. 8). Especially striking is the difference in size, which is 
almost fourfold, between human intron V and the homologous intron of the mouse and 
Chinese hamster genes. This degree of divergence in intron size is much more marked 
than previously observed among homologous globin genes in man, mouse and rabbit 
(Van Ooyen et al., 1979; Nishioka and Leder, 1979; Liebhaber et al., 1980). In spite of the 
variation in intron size, the overall length of the DHFR gene is very similar in man, 
mouse and Chinese hamster. 
Previous work (Masters and Attardi, 1983) had shown that the human and mouse 
DHFR reading frames have -89% nucleotide sequence homology. By contrast, in the 
present study, the analysis of the available intron sequences of the human and mouse 
genes have revealed a strong divergence of these sequences, as previously observed for 
the introns of other split genes (Breathnach and Chambon, 1981). In fact, no significant 
nucleotide sequence homology has been detected between corresponding DHFR introns in 
mouse and man, except in short (15 to 35 bp) stretches adjacent to the coding sequences 
at the 5'-end and 3'-end. 
(b) G+C Distribution Pattern. 
Another feature of considerable interest revealed by the present work is the unusual G+C 
distribution along the human DHFR gene. According to G+C content, the gene appears 
to be divided into two portions: a 5'-end portion rich in G+C ( -70%), which includes 
-400 bp of non-coding sequences, the first coding region and almost the whole first 
intron, and the main body of the gene, including the 3' untranslated region, with a low 
G+C content (-40%). This G+C distribution pattern is conserved in the mouse gene, 
pointing to the existence of different evolutionary constraints in nucleotide substitution 
rates in different portions of this gene. This marked unevenness of G+C content within 
the DHFR gene may reflect the subdivision of the genome in blocks of different G+C 
content, without correspondence to gene organization and without direct functional 
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significance. A more interesting possibility is that the G+C distribution observed here 
has its functional correlate in the existence of different chromatin domains within the 
DHFR gene, possibly important for the regulation of gene expression. In view of the 
proposed role of methylation in gene regulation, it is interesting that the CpG 
dinucleotides represent 11.7% of the dinucleotides in the 5' non-coding region of the 
human gene, a figure which is fairly close to the frequency of 12.7% expected from the 
base composition. By contrast, in the (A+ T)-rich portion of the gene (including the 
3' noncoding region), the CpG frequency drops to 0.8%, a value which is significantly 
lower than the expected one of 3.5%. The latter frequencies of CpG are similar to the 
averages observed and expected in the mammalian genome (1 and 4%, respectively) 
(McClelland and Ivarie, 1982). Whether the lack of selection against CpG in the 5' non-
coding region of the DHFR gene is significant from the point of view of control of gene 
expression remains to be determined. 
(c) 5' Noncoding Region. 
Previous work (Morandi et al., 1982) has led to the identification in human cells of three 
main DHFR mRNAs which differ in the length of their 3' untranslated regions. We do not 
know yet where the 5' ends of these DHFR mRNAs map. It seems possible that at least 
one transcription initiation site is located around position -61 of the human sequence, 
i.e., the position where two human pseudogenes, which are likely to derive from mRNA 
intermediates (Chen et al., 1982; Masters et al., 1983), start diverging in sequence. This 
region lies immediately downstream of the mouse fourfold repeat which has been 
suggested to contain a DHFR mRNA 5' end (Crouse et al., 1982). In the human system, 
preliminary primer extension experiments using reverse transcriptase and polysomal 
poly(A)-containing RNA from 6A3 cells have mapped a putative 5' end of DHFR mRNA 
around position -65 (Masters, unpublished observations). A possible TAT A-like sequence, 
CACAAATA, exists 32 bp 5' to position -61. This sequence lies within and near the 3' end 
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of the 45 bp stretch which is homologous to the fourfold 45-48 bp repeat present in the 
mouse 5' non-coding region (Crouse et al., 1982). The 125 bp upstream of this putative 
TAT A box have an extremely high G-C content (84%). The significance of the very 
biased base composition of this region is not known, but it may play a role in the possible 
cell cycle dependent (Hendrickson et al., 1980; Mariani et al., 1981) and other types of 
regulation of this gene. (G+C)-rich sequence motifs, which play an important role in 
transcription, have been detected in the 5' flanking regions of the herpes simplex virus 
thymidine kinase gene (McKnight and Kingsbury, 1982) and the SV40 large T antigen gene 
(Benoist and Chambon, 1981; Fromm and Berg, 1982; Everett et al., 1983); mutation of 
these regions have been shown to reduce transcription efficiency up to ten- to 
twentyfold. 
The 5' non-coding region shows considerable homology (- 65%) in the two human and 
mouse genes up to at least 327 bp upstream of the initiator codon. However, the 
45-48 bp fourfold repeat of the mouse gene (Crouse et al., 1982) is present in only one 
copy in the human sequence. The significance of this difference is not clear. A sequence 
conservation of the 5' non-coding region has been previously observed in several 
eukaryotic genes, although not so extensive as that reported here (Van Ooyen et al., 
1979; Breathnach and Chambon, 1981). The only exception is the -365 bp nucleotide 
sequence homology of the 5' non-coding region in the human and rat insulin genes (Bell 
et al., 1982). It is generally believed that the sequence conservation in the 5' non-coding 
region underlies the importance of this region in the control of gene expression. In 
several systems, such as the SV40 early region (Benoist and Chambon, 1981), the sea 
urchin histone H2A gene (Grosschedl and Birnstiel, 1980), the globin genes (Efstratiadis 
et al., 1980), the ovalbumin gene (Mulvihill et al., 1982; Compton et al., 1983), and the 
yeast CYCl (Guarente and Ptashne, 1981), HIS4 (Donahue et al., 1983), and GALlO 
(Guarente et al., 1982) genes, besides the signals close to the initiation sites of 
transcription, regulatory sequences further upstream have been described. In the case of 
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the CYCl promoter region, the heme regulatory site is located at about 275 bp upstream 
of the transcription initiation site (Guarente and Mason, 1983). Specific binding sites for 
progesterone receptor have been located at 135 to 300 bp upstream of the mRNA stating 
site for the ovalbumin gene (Mulvihill et al., 1982; Compton et al., 1983). It seems 
possible that conserved sequences located in the region extending up to several hundred 
bp upstream of the DHFR reading frame play an important regulatory function in the 
expression of this gene. 
(d) 3' Untranslated Region. 
In contrast to 5' non-coding region, the 3' untranslated region of the DHFR gene shows no 
obvious homology in the human and mouse genes over at least 770 bp downstream of the 
coding sequence (Masters et al., 1983, and unpublished data). It is, therefore, 
particularly intriguing that there is evidence that the 3' untranslated region of the DHFR 
gene is at least partly responsible for the regulation of the DHFR mRNA level in growth-
stimulated cells vs. stationary cells (Kaufman and Sharp, 1983). Whatsoever the 3'-end 
signals involved in this growth-dependent regulation may be, it would appear that, in this 
case, a high rate of nucleotide sequence divergence is compatible with their functional 
conservation. 
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Table 1 
Recombinant phages containing rearranged DHFR gene sequences. 
Recombinant phages Sizes (kb) of EcoRI fragments in the insert+ 
* * AJl.CM12 4.7, 1.5, 0.8, 1.8 ' 6.0 
* f.Cha4A.CM95 8.0, 4.0, 1.8 
* * * f.Cha4A.DMs6 0.5, 2.4, 3.5 ' 1.6 ' 4.0 
* f.Cha4A.DML3 12 
* AJl.CM104 1 0.5, 2.3 ' 1.6, 1.3 
* AJl.CM107 16 
* AJl.CM108 14.5 
* * AJl.CM109 11.5 ' 2.5, 1.6 
* AJ1.CM224 14.5 ' 2.2 
* AJ1.CM233 10, 4.2, 2.1 ' 0.68 
The asterisked numbers represent fragments which hybridized with pHD84. 
The numbers in bold italic type indicate EcoRI fragments also found in the normal 
gene; those underlined by a single line have a size very similar to that of normal 
fragments but they were not analyzed further. 
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Figure 1 
Construction of the Human DHFR Restriction Map. 
The human DHFR gene and its flanking sequences were isolated from four different A 
libraries [three ACh4A (A) and one AJ 1 (B)] constructed with the DNA from the "normal" 
chromosomes (CM) or the large double minutes (DML) or the small double minutes (OMs) 
of the MTX-resistant human cell line 6A3, as described in Materials and Methods. The 
restriction map was constructed by analysis of the DNA from ten overlapping 
recombinant A phages by single or double digestion with 5 different restriction enzymes, 
and by Southern blot hybridization of restriction digests with 32P-labeled pHD84. The 
coding sequences are indicated as solid boxes and the 3'-untranslated sequences, as a 
cross-hatched box. Sequence data show that AJ1-CM15 and AJ1-CM211 contain 275 bp of 
overlapping sequences at the 3'- and 5'-end of the insert, respectively. The orientation of 
the inserts with respect to A vector arms is indicated as r (right arm) and 1 (left arm). 
The restriction enzymes used are indicated as follows: R, EcoRI; H, Hindiii; K, Kpnl; S, 






















































































































































































































































































































































Organization of the Human DHFR Gene (A) and Sequencing Strategy (B). 
A. The various segments of the human DHFR gene are represented as boxes: solid 
boxes, DHFR coding sequences; empty boxes, intervening sequences; hatched box, 3'-
untranslated sequences. The positions of the initiation codon (ATG), termination codon 
(T AA), and EcoRI sites (R) are shown on the top of sequences. The coding regions are 
designated by Roman numerals (I to VI), and the sizes of the introns are indicated in kb. 
Also shown are the subcloned fragments, which were utilized for the screening of AJ 1 
library, fine restriction mapping, and the sequencing of the protein coding regions. In 
each designation, the first number represents the number of the recombinant phage from 
whose DNA the cloned fragment was derived, and the last number, the size of the 
fragment; the letters between the two numbers represent the restriction enzyme site(s) 
utilized for cloning (R, EcoRI; P, Pstl; Pv, Pvull; M, Mbol; Sm, Smal). B. Fine restriction 
maps of the subcloned gene fragments containing coding regions, and sequencing 
strategies. The extent and direction of the sequences determined are indicated by 
arrows. In each case, both strands of a given segment were sequenced. Restriction 
enzyme designations are as follows: A, Accl; Av, Aval; B, BamHI; Bg, Bglll; H, Hindiii; 
He, Hincll; Hp, Hpal; K, Kpnl; M, Mbol; P, Pstl; Pv, Pvull; R, EcoRI; Rv, EcoRV; S, Sst!; 
Sm, Smal; Sp; Sphl; X, Xhol. The restriction sites in parentheses belong to the plasmid 
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DNA Sequence of the Protein Coding Segments and Adjacent Intron Regions and of the 
3'-Untranslated Segment of the Human DHFR Gene and a Comparison with the 
Homologous Mouse Gene Sequence. 
The portions of the human gene (H) sequence shown correspond, m the order, to coding 
regions I and II with the complete first intron and 5'-end proximal segment of second 
intron, then to the individual coding regions III to VI with their respective flanking intron 
regions, and finally to the 3' untranslated region up to the Bglii site. The coding 
sequences are underlined and delimited according to the GT -AG rule (Breathnach et al., 
1978). The portions of the mouse DHFR gene (M) which are shown (coding regions and 
adjacent intron segments) are numbered according to Crouse et al., (1982) and Setzer 
et al., (1982). Arrows at the 3'-ends of the mouse gene segments indicate that the 
corresponding sequences continue but are not shown. Dots (.) indicate nucleotides 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Comparison of the 5' Non-coding Sequences of the Human and Mouse DHFR Genes and of 
the Homologous Regions of Two Human Pseudogenes. 
The human DNA sequence (H) is indicated with progressive negative numbers relative to 
the initiator codon A TG. The available mouse sequence (M) is aligned below and 
numbered according to Crouse et al., (1982). The first nucleotides of the four 45-48 bp 
repeats of the mouse 5' non-coding sequence are indicated by circled numbers under the 
mouse sequence. The homologous segments of two recently isolated pseudogenes ljJHD 1 
(ijJl) (Masters et al., 1983) and hDHFR-IjJ2 (1jJ2) (Chen et al., 1982) are also shown. Dots 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































Best-fit Plot of the 5' Non-coding Regions of the Human and Mouse DHFR Genes. 
The human sequence is along the x-axis and the mouse sequence, along the y-axis; the 
diagonal lines represent the best alignment of the two sequences achieved by a computer 
program developed by T. Hunkapiller and L. Hood (manuscript in preparation). In this 
plot, the alignment is based on scanning one sequence with successive 50 nt blocks, with 
l nt steps, of the other sequence, a dot being placed where a homology of >50% exists. 
The positions of the first coding regions of the human and mouse genes are indicated. 
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Figure 6 
The Conservation of the of G+C Distribution Pattern Along the Human and Mouse DHFR 
Genes. 
The variation in G+C content along the sense strand of the human and mouse DHFR 
genes was determined by analyzing the % G+C of the two sequences in successive 50 nt 
stretches with 1 nt steps. The human sequence is indicated by a solid line and the mouse 
sequence (Crouse et al., 1982; Setzer et al., 1982), by a dotted line. The positions of the 
protein coding regions are indicated by horizontal bars and identified by Roman 

























































Patterns of Hybridization with Human DHFR Specific Probes of Restriction Enzyme 
Digests of Genomic DNA from HeLa Cells and 6A3 Cells. 
A. Samples of 10 ~g of HeLa 53 DNA (except in the experiment with the U l-CM15 probe, 
where -2 ~g were used) (lanes a), and 0.5 ~g of 6A3 DNA (lanes b) were digested with the 
indicated restriction enzyme and fractionated by electrophoresis through an agarose 
gel. The DNAs were transferred to a nitrocellulose paper and hybridized to 3 zP-labeled 
pHD84 or AJl.CMl5 (using Cot fractionated DNA as a carrier in the latter case), as 
previously described (Masters et al., 1983). B. Restriction maps of the human 
DHFR gene and adjacent genomic regions, with the sizes of the fragments being 
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Comparison of the Organization of the DHFR Genes from Man, Mouse, and Chinese 
Hamster. 
The coding sequences are indicated as solid boxes and the 3'-untrans1ated sequences, as a 
cross-hatched box. The sizes of the coding sequences in each exon (in bp) and those of 
the human gene introns (in kb) are indicated. The sizes of the Chinese hamster gene 
introns are those reported by Carothers et al., ( 1983). 
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CHAPTER 7 
Dihydrofolate Reductase Gene Related Transcripts Present 
in both Polysomal and Nuclear RNA of Human Cell Lines 
Map with their 5'-Ends Upstream of the Main mRNA Cap Site 
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Abstract 
The 5'-ends of dihydrofolate reductase (DHFR) specific transcripts have been mapped in 
the 5'-flanking region of the DHFR gene of the human methotrexate-resistant cell line 
6A3 by primer extension and 51 protection experiments. The main 5'-end, at position -71 
relative to the first nucleotide of the DHFR reading frame, corresponds to a major class 
of trancripts representing approximately 99% of the DHFR-specific polysomal poly(A)-
containing RNA; in particular, an analysis of this RNA fractionated on an agarose-
methylmercuric hydroxide gel has revealed that the -71 end is associated with the 
previously described DHFR mRNA of sizes 3.8, 1.0 and 0.8 kb, and corresponds to the 
recently identified transcription initiation site of the DHFR gene. Six other minor 5'-
ends have been mapped to nucleotide positions -449 to -480 upstream of the DHFR gene, 
and correspond to approximately 1% of the DHFR-specific polysomal poly(A)-containing 
RNA. Analysis of polysomal RNA from VA2-B cells, the parental line of 6A3, and from 
HeLa cells has shown that the upstream initiating transcripts are not specific for cells 
with amplified genes, although their amount is increased in the cell lines containing 
amplified genes in about the same proportion as the three identified DHFR RNAs. The 
upstream initiating DHFR-specific transcripts are also present in nuclear RNA; in this 
fraction, they are indeed relatively more abundant than in the polysomal RNA, 
representing approximately 11% of the major transcripts initiating at position -71: this 




The analysis of the mode of expression of the dihydrofolate reductase (DHFR) gene 
in mammalian cells, which has been greatly facilitated by the availability of cell lines 
with amplified genes, has revealed an unsuspected complexity both in these and the 
parental cell lines, in the form of the existence of multiple species of DHFR mRNAs. 
Thus, in mouse cells, four major polyadenylated species of DHFR mRNA (Setzer et al., 
1982), in Chinese hamster 3 species (Lewis et al., 1982; Setzer et al., 1982), and in human 
cells, three main species have been identified (Morandi et al., 1982). These multiple 
mRNA species differ mainly in the length of the 3'-untranslated tail (Setzer et al., 1982; 
Carothers et al., 1983; Masters et al., 1983), which can be up to several fold longer than 
the reading frame, as is the case for the major human DHFR mRNA (3.8 kb mRNA). 
Furthermore, there is good evidence indicating that the 3'-end tails of the multiple 
mRNAs are colinear (Setzer et al., 1982; Masters et al., 1983). These observations would 
be compatible with the idea that the same transcript could produce different forms of 
mRNA by processing and polyadenylation at alternative sites. 
The significance of the existence of multiple forms of DHFR mRNA is unknown. 
The conservation of this feature in different mammalian species strongly suggests that 
the multiplicity of mRNAs reflects the existence of a physiologically significant control 
mechanism. For a full understanding of the possible functional role of the multiplicity of 
DHFR mRNA, it would be important to know whether there is any regulation of 
expression of the different DHFR mRNAs at the level of initiation of transcription. In 
the present work, an extensive mapping study of the 5'-ends of DHFR-specific transcripts 
in human cell lines with an amplified or normal DHFR gene complement has revealed, 
unexpectedly, the presence, besides a main transcription initiation point at position -71 
relative to the first nucleotide of the DHFR reading frame, of at least six additional 
minor sites upstream of the DHFR gene, which correspond to 5'-ends of DHFR-related 
transcripts. These upstream initiating transcripts are found both in polysomal RNA and 
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m the nuclear RNA; m the latter fraction, they are enriched about 1 O-f old over the 
transcripts initiating at the main start point as compared to the polysomal fraction. 
While this work was in progress, a report has appeared (Chen et al., 1984) describing the 
identification of a main initiation point at position -71 for human DHFR specific 
transcr ipts, on the basis of primer extension and 51 protection experiments utilizing total 
HeLa cell RNA and of in vitro transcription assays. 
Materials and Methods 
Cell lines and methods of growth. HeLa 53 cells were grown m suspension as 
described (Amaldi and Attardi, 1968). VA2-B, an 8-azaguanine resistant derivative 
(Weiss et al., 1968) of the 5V40 transformed line WI-l8-VA2 (Ponten et al., 1963), and 
its methotrexate-resistant variant 6A3 (Masters et al., 1982) were grown as described 
(Morandi et al., 1982). 
RNA preparation. Polysomal RNA was prepared from HeLa, VA2-B, and 6A3 cells 
(Morandi et al., 1982), and the poly(A)-containing fraction was separated from the non-
poly(A)-containing fraction by oligo(dT)-cellulose chromatography (Amalric et al., 
1978). 
For the preparation of nuclear RNA, nuclei were isolated from 6A3 cells (-8 ml 
packed cell volume) by a hypotonic shock procedure (Jeanteur et al., 1968), resuspended 
by vortexing in 4 ml of 6 M urea, 3M LiCl (Auffray and Rougeon, 1980), 
10 mM Na acetate, pH 5, 0.2 mg/ml heparin, 0.1%505, and sonicated at 4 rnA for 60 sec 
with a Branson sonifier. The RNA was allowed to precipitate overnight at 4°C, and the 
precipitate was washed with 8 M urea, 4 M LiCl, dissolved in water, extracted with 
phenol/chloroform/isoamylalcohol (25:24:1) and ethanol precipitated. The RNA was then 
digested with DNasei (50 ~g/ml) in the presence of CaCl2 (0.0 1 M) and proteinase K 
(10 ~g/ml) (Tullis and Rubin, 1980), phenol extracted, ethanol precipitated and 
fractionated by oligo(dT)-cellulose chromatography. The total nuclear RNA recovered 
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( 1.3 mg) was estimated to be 4% of total RNA (assuming 30 pg RNA/cell (Philipson, 1961) 
1.5 x 108 cells/ml packed cells), and contained an amount of 185 rRNA corresponding to 
approximately 1% of that present in the cytoplasmic fraction, as estimated by scanning 
with a Joyce Loebl microdensitometer a negative from an ethidium bromide stained gel 
(with various amounts of cytoplasmic and nuclear non-poly(A)-containing RNA). 
DNA preparation and labeling. Plasmid DNAs were prepared by alkaline lysis 
(Birnboim and Doly, 1979), followed by CsCl-ethidium bromide centrifugation. For 
production of specific primers or fragments to be used in 51 protection experiments, 
10-50 1-1g plasmid DNA was first digested with a restriction enzyme producing the desired 
end, treated with calf intestinal alkaline phosphatase (Boeringer-Mannhiem), and labeled 
at the 5'-ends with T4 polynucleotide kinase (Bethesda Research Laboratories) and 
( y-
32P)-A TP (ICN); the DNA was then spermine precipitated (Hoopes and McClure, 1981) 
to remove the bulk of unincorporated nucleotides, digested with a second restriction 
enzyme, and the fragments of interest, labeled at only one end, were isolated by elution 
from polyacrylamide gels (Maxam and Gilbert, 1980). When the first restriction digest 
contained many fragments, the fragment of interest was isolated from the rest by elution 
from an agarose (Yang et al., 1979) or polyacrylamide gel (Maxam and Gilbert, 1980). 
DNA was sequenced according to Maxam and Gilbert (1980). 32P-labeled markers were 
prepared by 3'-end labeling Hpaii digests of pBR322 or human mtDNA in 50 mM Tris, 
pH 8.0, 5 mM MgClb 1 mM 8-mercaptoethanol, 0.1 mg/ml B5A, 20 mM dATP and dTTP 
at 20°C for 60 min with the large fragment of E. coli DNA polymerase l and 1.5-fo1d 
molar excess of (a-32P)-dCTP and -dGTP (2000-3000 Ci/mmole, Amersham) over the 
number of available sites to be filled in at the ends. Unlabeled dCTP and dGTP were 
then added to 50 mM, and the reaction was continued for 30 min to ensure complete 
filling of all of the ends. 
Primer extension and Sl protection experiments. RNA-DNA hybridizations in both 
primer extension and 51 protection experiments were carried out in 10 1-1l of 0.1 M NaCl, 
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0.02 M Tris, pH 8.0 (25°C), 0.001 M EDTA at 60-75°C for 1 h, usmg the desired DNA 
fragment from 0.2 JJg of plasmid DNA and polysomal poly(A)-containing RNA from 6A3 
cells (1 JJg), or Hela cells (1 0 JJg), or VA 2-B cells (1 0 JJg), and stopped by quick cooling in 
ice-water. 
The primer extension reactions were performed in 50 JJl of 0.08 M Tris, pH 8.3, 
0.05 M KCl, 0.01 M MgCl, 0.01 M dithiothreitol, 4 mM sodium pyrophosphate, 20 units 
RNasin (Promega Biotec), in the presence of 10 units AMY reverse transcriptase 
(Life Science), at 42°C for 30 min, and were followed by phenol extraction, ethanol 
precipitation and electrophoresis through 20 em, 7 M urea-5% polyacrylamide gels or 
80 em 8.3 M urea-5% polyacrylamide gels; the gels were then dried and exposed to 
sensitized Kodak XAR-5 film with Dupont intensifying screens (Laskey and Mills, 1977). 
The Sl nuclease digestions were carried out in 100 JJl of 0.3 M NaCl, 0.03 M Na 
acetate, 0.001 M ZnS04, using 80-200 units 51 nuclease (Sigma) at 37°C for 30-60 min, 
and were followed by phenol extraction, ethanol precipitation and electrophoresis, as 
described above. 
Results 
Multiple 5'-ends of human DHFR specific RNAs. Figure l shows the DHFR specific 
eDNA and genomic restriction fragments, and figure 2 the experimental strategies used 
in the 5'-end mapping experiments. The first primer extension reactions were carried out 
using 6A3 polysomal poly(A)-containing RNA as a template and the 53 nucleotide 
EcoRI-Hinfi fragment (Fig. 1A) derived from pHD84 (Morandi et al., 1982; Masters et al., 
1983) as a primer (Fig. 2A). When the products of this reaction were electrophoresed on 
a denaturing polyacrylamide gel, a major band corresponding to reverse transcripts 
-210 nucleotides (nt) long (a 1) and a minor band corresponding to reverse transcripts 
10 nt shorter (a2) were seen (Fig. 3A, lane 1 ). The 3'-end of the -210 nt reverse 
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transcript corresponds in the DNA sequence to a position -70 bp upstream of the DHFR 
gene initiator codon (Fig. 2A), where the major transcription initiation site for the human 
DHFR gene of HeLa cells had been recently mapped (Chen et al., 1984); this result, 
therefore, indicated a similarly positioned initiation site for the DHFR mRNAs from 6A3 
cells. 
A longer exposure of the same autoradiogram (Fig. 3A, lane 2) revealed another 
minor band (s) corresponding to a size of -620 nt, as well as other bands migrating below 
the -210 nt band. While the latter bands probably represented premature termination 
products of the reverse transcriptase reaction, the upper band conceivably corresponded 
to reverse transcripts of either DHFR gene-related RNAs of low abundance or an 
unrelated RNA which had hybridized with the pHD84 derived primer. In order to 
distinguish between the latter two alternatives, a large scale primer extension reaction 
using 10 J.lg of 6A3 polysomal poly(A)-containing RNA was carried out to isolate 
component 8 from an agarose-10 mM CH3HgOH gel. This component was used in an 
51 protection experiment with 6A3 polysomal poly(A)-containing RNA. If component s 
had been reverse transcribed from a DHFR gene-related RNA (i.e., containing at least 
part of the DHFR coding sequence), it was expected that hybridization with the highly 
predominant DHFR mRNAs would protect from 51 digestion a segment of s equivalent to 
-210 nt (Fig. 2C) or shorter (depending upon the length of the homologous sequences). 
[The minor portion of s protected by the fully homologous RNA would probably not be 
detected.] Under the alternative hypothesis that 8 derived from an RNA unrelated to 
DHFR, an 51 protected band corresponding to somewhat less than 620 nt was expected. 
The results of this analysis showed a major protected segment corresponding to the 
-210 nt band (cq) and a minor segment corresponding to the a2 band detected in the 
primer extension experiments (compare lanes 2 and 3 of Fig. 3B). 
Detailed mapping of the major 5'-ends of the human DHFR specific RNAs. A 
combination of 51 protection and primer extension analysis was carried out to map more 
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precisely the maJor 5'-ends of the human DHFR specific RNAs, using the 199 nt 
Hpaii-BstNI fragment and the 99 nt Banii-BstNI fragment of pBH31Rl.8 (Fig. lB), 
respectively. These probes were expected to produce extended primers and Sl protected 
fragments -75 nt shorter than those observed with the pHD84 derived 53R-H primer, as 
diagramed in Figures 2C and 20. The actual fragment sizes observed with these probes, 
as determined by electrophoresis on a 20 em 7 M urea-5% polyacrylamide gel, 
corresponded to 130, 140 and 540 nt, i.e., the sizes expected for extended primers and 
Sl protected fragments having the same 3'-ends as a2, a 1 and s, respectively (data not 
shown). [For simplicity, these shortened forms of a17 a2 and s, will also be referred to as 
a 1, a2 and s.] Figure 4A shows the extended primers and Sl protected fragments from 
the same experiment, separated on an 80 em sequencing gel in parallel with the products 
of the sequencing reactions carried out on the 199 nucleotide fragment. Both the 
S 1 protection products (lanes 2 and 4) and the primer extension products (lanes 1 and 3) 
exhibit a pronounced band representing a fragment which falls with its 3'-end slightly 
behind the G at position -72 upstream of the human DHFR reading frame (Fig. 5; Chen 
et al., 1984; Yang et al., 1984): This fragment, therefore, corresponds to a 1 in Figure 3. 
Since the sequencing reaction products lack the 3' base by which they are defined, and, 
furthermore, contain both 5'- and 3'-phosphates, in contrast to the extended primer and 
the 51-resistant fragment which have 3'-hydroxyls, the alignment of the sequence with 
these fragments is off by 1 t nucleotides (Sollner-Webb and Reeder, 1979). Therefore, 
the 3'-ends of the extended primer and of the S !-resistant fragment map in 
correspondence to the T at position -71 upstream of the human DHFR reading frame. 
The band corresponding to a fragment one nucleotide longer than a 1 in Figure 4, lane 3, 
may derive from reverse transcription of a minor portion of the DHFR mRNAs starting 
one nucleotide upstream of the major initiation point; however, the lack of a significant 
51-resistant fragment of corresponding size would argue against it. For the same reason, 
the bands corresponding to fragments migrating below a 1, of which those 2, 3, and 9 nt 
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shorter than cq are particularly strong, probably represent premature termination points 
of the reverse transcriptase reaction, rather than reverse transcripts of RNAs starting 
downstream of the main initiation point. One exception may be the band corresponding 
to a2 in Figure 3, which represents a fragment 9 nt shorter than a1. There is, in fact, an 
51-resistant fragment moving one nucleotide behind this extended primer; the production 
of this 51-resistant fragment in the 51 reactions carried out both at 20°C (lane 1) and at 
3]0C (lane 3) would argue against its being due to nibbling of the RNA-DNA hybrids in a 
region which is AT -rich (see below). (Such nibbling, on the contrary, probably accounts 
for the weaker bands between at and a21 which are clearly more pronounced at 3JOC 
than at 20°C). A possible explanation for the 1 nt difference between the a2 extended 
primer and the putatively corresponding S !-resistant fragment is the presence of cap 
structure at the 5'-end of the mRNA which may prevent, under the conditions of 
S 1 digestions used here, the complete trimming of the hybridized DNA strand. Further 
work, however, will be needed to determine whether the band corresponding to a2 
corresponds to a true initiation point. 
Detailed mapping of the minor 5'-ends of the human DHFR specific RNAs. The 
same analysis as described above was carried out to map the minor, upstream 5'-ends of 
the human DHFR specific RNAs, using the 1125 nucleotide EcoRI-BstNI fragment and 
the 60 nucleotide Pvuii-BstNI fragment of pBH31Rl.8 (Fig. lB) for 51 protection and 
primer extension experiments, respectively (diagramed in Figs. 2E and 2F). When the 
products of these reactions were separated on a short denaturing polyacrylamide gel 
(Fig. 4B), a series of six major bands were observed both in the lane containing the 
extended primer (lane 1) and in that containing the 51-resistant fragments (lane 2). 
These bands, which are labeled 6 b 62, 63, 64, 65 and 66, represent fragments with sizes 
of 54, 59, 63, 68, 72 and 80 nt, and correspond to band 6 in Figure 3: in fact, the range of 
sizes of the fragments is reasonably close to that expected from the use of restriction 
fragments which should give extended primers and 51-resistant products -520 nt shorter 
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than those obtained usmg the pHD84 derived 53R-H primer (Fig. 2). Separation of the 
extended primers and 51-resistant fragments from the same experiment on a thin 
sequencing gel in parallel with the products of the sequencing reactions carried out on 
the 1125 nucleotide fragment (Fig. 4c) showed that the bands 131 to 136 correlate with 
bands at positions -449, -456, -460, -466, -470, and -480 upstream of the human DHFR 
reading frame (again correcting for the one and a half nucleotide difference, as described 
above). 
Further characterization of the major and minor 5'--ends. In order to determine 
whether the upstream 5'-ends of DHFR specific RNAs identified above are specific for 
the cell lines 6A3 with amplified DHFR genes or are general features of all cell lines, 
poly(A)-containing RNA samples from HeLa cells, VA2-B cells and 6A3 cells were 
hybridized with the l35l nucleotide EcoRI-SfaNI fragment of pBH3lRl.8 (Fig. lB) and 
digested with Sl (Fig. 2G). The bands corresponding to ab a2 and 13 were observed with 
the RNA from all three cell lines (Fig. 6). Furthermore, it is clear that the RNAs with 
upstream 5'-ends are 5-10 times more abundant in VA2-B cells than in He La cells, and 
-20 times more abundant in 6A3 cells than in VA2-B cells, thus behaving like the three 
DHFR mRNAs (Morandi et al., 1982). 51 protection and primer extension experiments 
using 6A3 cell poly(A)-containing RNA fractionated on an agarose-CH3HgOH gel showed 
that the major 5'-end (corresponding to at) is associated with the three previously 
identified DHFR mRNAs (3.8, l.O and 0.8 kb; Morandi et al., 1982); by contrast, the 
minor 5'-ends (corresponding to the 13-bands) appear to be associated with RNAs of 
different sizes, in the range of 1 to 4.5 kb (data not shown). 
A primer extension analysis of nuclear RNA from 6A3 cells using the 53 nucleotide 
EcoRI-Hinfl fragment of pHD84 as a primer (Fig. lb) is shown in Figure 7 (lanes l and 3), 
in parallel with the same type of analysis carried out on the polysomal RNA fraction 
(lanes 2 and 4). The results show that the upstream 5'-ends are primarily present in the 
poly(A)-containing fraction of both polysomal and nuclear RNA, that the RNA species 
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with the upstream 5'-ends are enriched in the nuclear fraction relative to the RNA 
species exhibiting the major 5'-end, and that the nuclear RNA preparation exhibits other 
minor bands which may or may not result from the occurrence of DHFR specific RNAs 
with different 5'-ends. A quantitation of the results made by cutting out and eluting the 
32P-labeled bands corresponding to a 1, a2 and 13 and measuring their radioactivity showed 
that, in the polysomal RNA fraction, the RNA species carrying the upstream 5'-ends 
represent about 1% of the RNA species exhibiting the major 5'-end, and that this ratio is 
about 11% in the nuclear RNA fraction. 
Discussion 
Polysomal poly(A)-containing RNA from human cell lines has previously been shown 
to contain at least three distinct species of DHFR mRNA with sizes of 3.8, 1.0 and 0.8 
kb, differing in the length of the 3'-untranslated segment (Morandi et al., 1982). These 
RNAs are assumed to derive from the transcript of a single gene by distinct cleavage and 
poly(A)-addition events occurring in the 3' untranslated region (Masters et al., 1983; Chen 
et al., 1984), as has been suggested to be the case for the mouse DHFR mRNAs (Setzer 
et al., 1982). In the present work, by using Sl protection and primer extension 
experiments, we have shown that, while the majority of the DHFR gene transcripts map 
with their 5'-end at the recently identified transcription initiation site (Chen et al., 
1984), a minor portion of the DHFR specific RNAs map with their 5'-ends at multiple 
sites upstream of the main mRNA cap site. 
The major 5'-end, which was found in approximately 99% of the DHFR-specific 
transcripts, was mapped at position -71 in the 5'-flanking region of the human DHFR 
gene (Yang et al., 1984), in agreement with the data of Chen et al. (1984). In the latter 
mentioned work, evidence was presented indicating that this 5'-end is a major 
transcription initiation site. Consistent with this conclusion are our observations 
indicating that the 5'-ends of the three predominant DHFR mRNAs map m 
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correspondence to the site at position -71. Thirty nucleotides upstream of this site, at 
positions -101 to -94, there exists a possible "TAT A-like" sequence (Goldberg, 1979 ), 
CACAAATA. This sequence lies within and near the 3'-end of the 45 bp stretch that is 
homologous to the fourfold 45-48 bp repeat present in the mouse gene 5'-noncoding 
region (Crouse et al., 1982). Three of the four mouse repeats contain the same "TAT A-
like" sequence and it has been suggested that this fourfold repeat contains a DHFR 
mRNA 5'-end (Crouse et al., 1982). The 5'-flanking region of the human DHFR gene does 
not have any sequence homologous to the "CAAT" box (Efstratiadis et al., 1980); the 
latter is a sequence present in the 5'-flanking regions of various eukaryotic genes at 
positions -70 to -80 nucleotides from the transcription initiation site, and is thought to be 
part of eucaryotic promoters (Breathnach and Chambon, 1980). Flanking on both sides of 
the proposed "TAT A-like" sequence, there is an almost perfect direct repeat of a purine-
rich sequence at nucleotide positions -127 to -111 ( GGGGCGGGGGGGCGGGG) and 
positions -93 to -77 (GGGACGAGGGGGCGGGG). The presence of homopolymer purine 
or homopolymer pyrimidine tracts has been shown to correlate with 51 hypersensitive 
sites near the 5'-ends of transcribed genes (Larsen and Weintraub, . 1982; Schon et al., 
1983) and it has been suggested that they play a role in transcription initiation of 
eukaryotic genes. It is possible that the purine-rich sequence flanking the "TAT A-like" 
sequence of the human DHFR gene has a similar role. 
The most significant observation made in the present work is the identification of 6 
minor 5'-ends of human DHFR related transcripts at positions -480, -470, -466, -460, -456 
and -449 (Chen et al., 1984; Yang et al., 1984); these minor 5'-ends pertain to 
approximately 1% of the human DHFR transcripts found in the polysomal poly(A)-
containing RNA. The most upstream of these sites (position -480) maps to the 3' side of 
a sequence (CCCCGCCCCCCCAGCCCC, positions -497 to -480), which is an almost 
perfect inverted repeat of the purine-rich sequence flanking the major 5'-end at positions 
-93 to -77. Again, it is interesting to speculate that this pyrimidine-rich sequence may 
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play a role in the transcription initiation of these upstream sequences. In contrast to the 
major 5'-end at position -71, no "TAT A-like" sequence is found upstream of any of the 6 
minor 5'-ends discussed here. 
Transcripts of relatively low abundance have previously been found to initiate at 
various positions upstream (170-4500 bp) of the major transcription initiation site for the 
mouse a-globin gene (Hofer and Darnell, 1981) and the human a-globin gene (Carlson and 
Ross, 1983; Grindlay et al., 1984), y-globin gene (Grindlay et al., 1984) and e:-globin gene 
(Allan et al., 1983). The upstream sites for the human a-globin gene have been shown to 
be transcribed by RNA polymerase III (Pol III; Carlson and Ross, 1983); furthermore, at 
least one e:-globin transcript originates in an Alu repeat (Allan et al., 1983), raising the 
possibility that it is also transcribed by Pol III, since Pol III can initiate transcription at 
Alu repeat sequences in vitro (Duncan et al., 1979; Pan et al., 1981; Di Segni et al., 1981; 
Haynes and Jelinek, 1981; Manley and Colozzo, 1982). The 1.8 kb EcoRI fragment 
containing the 5'-end of the DHFR gene does not exhibit any Alu sequences (Chen et al., 
1984; Yang et al., 1984). However, the sequence at positions -507 to -497 
(T ACCCACAAGC) exhibits a reasonable homology (9/ 11 match) to the upstream control 
sequence (5' SN ~NN~~NGG 3') of the Pol III promoter consensus sequence (Sharp 
et al., 1981), and the sequence at positions -459 to -450 (GACAGAACCT) shows an 8/9 
rna tch to the downstream control sequence of the same promoter (5' G ~C ~ANNCN 3'). 
These observations suggest the possibility that at least some of the DHFR-related 
trancripts are transcribed by Pol III. 
Two translation initiation codons are present in the region between the upstream 
and the major 5'-end of the human DHFR specific transcripts, one at positions -(239-237), 
and the other, at positions -(225-223). The initiating codon at positions -(239-237) (singly 
underlined in Fig. 5) is not in frame with the DHFR reading frame, and the corresponding 
reading frame, potentially coding for a polypeptide of 48 amino acids, terminates at the 
TAG at position -(112-110). The other initiation codon at positions -(225-223) (doubly 
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underlined in Fig. 5) is in frame with the DHFR coding region, and its utilization could 
add 75 amino acids to the N-terminus of the DHFR polypeptide. A third translation 
initiation codon is found at positions -(478-476), 2 nucleotides down from the most 
upstream of the minor 5'-ends detected in this work. Its significance is doubtful, in view 
of the lack of an appreciable 5'-noncoding region in the corresponding transcript and of 
the low abundance of this transcript; however, if this initiating codon could be utilized, a 
peptide of 50 amino acids would be made before terminating at the TAG at positions 
-(328-326). 
Our data show no evidence for any RNA-splicing events in the region between 
positions -480 and -71 and suggest that the transcripts starting at the upstream initiation 
sites are spliced identically to the major DHFR specific RNAs, at least up to the 5'-end 
proximal side of the third DHFR exon. At this time we do not know where the 3'-ends of 
the upstream initiated RNAs map; therefore, we cannot say whether these upstream 
initiated transcripts contain the complete DHFR coding sequence. 
The analysis of the upstream initiating transcripts in nuclear RNA has suggested 
that these transcripts may be regulated differently from the major DHFR specific RNAs; 
in fact, the steady-state level of the upstream initiating transcripts, as estimated from 
the relative amounts of extended primers, is approximately 11% of that of the major 
DHFR specific transcripts in the nuclear fraction, while they represent only about 1% of 
the major transcripts in the cytoplasmic fraction. At what level this difference arises is 
not known, but the mechanism involved could conceivably operate at the transcriptional 
level, at the level of nuclear RNA processing and transport, or at the level of RNA 
stability. The observation that a substantial portion of these minor transcripts are 
present in the polyadenylated fraction of polysomal RNA suggests that they are utilized 
as mRNAs. Such possibility, if confirmed, would raise intriguing questions concerning 
the nature of the translation products of these mRNAs and their possible regulatory 
role. A relevant observation in this respect may be that the amount of the upstream 
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initiating DHFR transcripts is increased in the cell lines with amplified DHFR genes 
(VA2-B, 6A3) approximately in the same proportion as the main DHFR mRNAs. 
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Figure 1 
Restriction fragments used m the primer extension and Sl protection 
experiments. (a) pHD84 eDNA insert: the DHFR coding reg10ns contained in the six 
exons are shown. The restr iction sites utilized to isolate the 53 bp fragment (53R-H) 
used for primer extension analysis are indicated, and the fragment is aligned below. (b) 
The pBH31Rl.8 insert is diagramed to show the DHFR coding regions that it contains and 
the restriction sites used to generate the primers utilized in the extension experiments 
(99 Bn-B, 49 P-B) and the fragments utilized in the Sl protection experiments ( 199 H-B, 
1115 R-B, 1351 R-S): these fragments are aligned below. For the purpose of the above 
mentioned experiments, each fragment was labeled with 32P at the 5'-end of the non-
sense strand. Restriction site designations: B, BstNI; Bn, Banii; H, Hinfi; P, Pvuii; R, 
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Diagrammatic representation of the pnmer extension and 51 protection 
experiments utilizing the fragments shown in Figure 1. The transcripts to which the 
probes hybridize and the sizes of the extended primers and 51-resistant products obtained 
are shown. The scale at the top represents the nucleotide numbering of the human DHFR 
reading frame and upstream region. The DHFR transcripts corresponding to the major 
and minor 5'-ends are diagramed below. Wavy lines represent RNA molecules , solid 
lines, the DNA strands (with a star indicating the labeled end), and dashed lines, the 
extended primers. 
A) 53 R-H Primer Extension 
B) 620nt Extended Primer 
-S1 Protection 
C) 99Bn B Primer Extension 
D) 199 H-B S1 Protection 
E) 49 P- B Primer Extension 
F) 1115 R-B S1 Protection 
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Detection of minor human DHFR specific transcripts mappmg with their 5'-ends 
upstream of the major transcripts. (a) Lane l: l J.lg of 6A3 cell polysomal poly(A)-
containing RNA was reverse transcribed using the pHD84 derived 53R-H primer, and the 
products were electrophoresed through a denaturing 5% polyacrylamide gel. Lane 2 is a 
longer exposure of lane l to show a slower migrating band designated s. P indicates the 
* unreacted primer and P indicates the portion of the primer which reannealed with its 
complement strand and was extended four nucleotides by reverse transcriptase. M l 
shows human mtDNA, and M2, pBR322 DNA, both digested with Hpaii and 3'-end labeled 
with (a-32P)-dCTP and -dGTP and the large fragment of E. coli DNA polymerase I. (b) 
10 J.lg of 6A3 cell polysomal poly(A)-containing RNA were used in a primer extension 
reaction with the 53R-H primer; after fractionation of the products through a denaturing 
agarose gel, the material corresponding to the band B was eluted, and one-half was used 
in an Sl protection experiment with 6A3 RNA. The 51-resistant products were then 
electrophoresed through a denaturing polyacrylamide gel (lane 2), in parallel with a 
sample of the products of the primer extension reaction (lane l) and with the other half 
of the isolated B fragment (lane 3). Ml and M2 contain the same markers as in (a). 
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Detailed mapping of the 5'-ends of the RNA species corresponding to the bands a 1, 
a2 and s. (a) Electrophoresis through an 80 em sequencing gel of the primer extension 
and 51-resistant products obtained using 6A3 cell polysomal poly(A)-containing RNA and 
the 199 nt and the 99 nt probes, respectively, (Fig. lb). Lane 1: extended primers 
produced using the 99 nt fragment as a primer. Lane 2: S !-resistant products obtained 
with the 199 nt fragment using 80 units of 51 nuclease at 20°C. Lane 3: long exposure 
of lane 1. Lane 4: 51-resistant products obtained with the 199 nt fragment using 
80 S 1 units at 37°C. G, R, C, and Y represent the products of the sequencing reactions 
(G, G+A, C and C+ T) carried out on the 199 nt fragment. The sequence determined is 
shown, with an asterisk indicating the position of the 5'-end corresponding to a 1· (b) The 
Sl protection and primer extension products obtained with 6A3 cell polysomal 
poly(A)-containing RNA, using the 1115 nt and the 49 nt fragments of pBH31Rl.8, 
respectively, were electrophoresed through a 20 em denaturing polyacrylamide gel. 
Lane 1: products of the primer extension reaction using the 49 nt probe. Lane 2: 
51-resistant products obtained with the 1115 nt fragment using 200 units of Sl nuclease 
at 3JOC. Ml and M2 contain the same markers as in Figure 3. (c) Samples of the Sl 
protection and primer extension products from the experiments shown in panel B were 
electrophoresed through an 80 em sequencing gel. Lane 1: A portion of the sample 
analyzed in panel B, lane 1. Lane 2: 51-resistant products obtained with the 1115 nt 
fragment using 100 units of Sl at 37°C. Lane 3: A portion of the sample analyzed in 
panel B, lane 2. G, R, C and Y represent the products of the sequencing reactions (G, 
G+A, C and C+ T) carried out on the 1115 nt fragment. The sequence is shown, with 






































































































































































































Alignment of the major and minor 5'-ends of DHFR specific RNAs with the 
sequence upstream of the human DHFR reading frame. The sequence is numbered 
according to Yang et al. 0984); the sequence preceding the Psti site at position -394 is 
from Chen et al. (1984). The major 5'-end at position -71 is indicated by the arrow, and 
the minor 5'-ends are indicated by asterisks. The "TATA-like" sequence beginning at 
position -101 is indicated by a bracket over the sequence. The G-rich direct repeats at 
positions -127 to -111 and -9 3 to -77 are under lined with a dashed line, and an inverted 
repeat of the sequence at positions -93 to -77 is underlined at positions -497 to -480. The 
DHFR translation initiation codon is boxed; another ATG in the upstream sequence, in 
frame with the DHFR coding sequence (position -225), is doubly underlined. A third A TG 
in the upstream sequence (position -239) , not in frame with the DHFR coding sequence, 
as well a termination codon (TAG, position -95) in frame with this A TG, are singly 
under lined. 
!52 
* * * -524 CCCGCCTCCGCCCGCCTTACCCACAAGCCCCGCCCCCCCAGCCCCGATGGCCCTGCCCAG -465 
* * * -464 TCCCAGACAGAACCTACTACGTGCGGCGGCAGCTGGGGCGGGAAGGCGGGCGCTGGGGGC -405 
-404 GCTGCGGCCGCTGCAGCGCCAGGGTCCACCTGGTCGGCTGCACCTGTGGAGGAGGAGGTG -345 
-344 GATTTCAGGCTTCCCGTAGACTGGAAGAATCGGCTCAAAACCGCTTGCCTCGCAGGGGCT - 285 
-284 GAGCTGGAGGCAGCGAGGCCGCCCGACGCAGGCTTCCGGCGAGACAIQGCAGGGCAAGG~ -225 
-224 TGGCAGCCCGGCGGCAGGGCCCGGCGAGGAGCGCGAACCCGCGGCCGCAGTTCCCAGGCG -165 .... 
-164 TCTGCGGGCGCGAGCACGCCGCGACCCTGCGTGCGCC~~~~~~§~~~~~~~~§§CCTCGC -105 
~ 
-104 CTGCACAAATA~~~~~~~~~~~§~§§§§CGGCCACAATTTCGCGCCAAACTTGACCGCGC -45 
-44 GTTCTGCTGTAACGAGCGGGCTCGGAGGTCCTCCCGCTGCTGTC~ 3 
153 
Figure 6 
Occurrence of the major and minor 5'-ends of DHFR specific RNAs in cell lines 
with amplified DHFR genes (VA2-B cells, 6A3 cells) and with non-amplified genes (HeLa 
cells). Samples of polysomal poly(A)-containing RNA from HeLa cells (10 ~g), YA2-B 
cells (10 ~g) and 6A3 cells (0.5 ~g) were hybridized with the 1351 nt fragment from 
pBH31Rl.8 (Fig. 1B), digested with 80 units of 51 at 37°c, and electrophoresed through a 
denaturing 5% polyacrylamide gel. M1 and M2 contain the same markers as in Figure 3; 




Primer extension analysis of nuclear and polysomal RNA from 6A3 cells. the RNA 
samples were hybridized with the 53R-H fragment (Fig. lB), and the primer extension 
products were electrophoresed through a denaturing polyacrylamide gel. Lane 1: 1 J.lg 
nuclear poly(A)-containing RNA; lane 2: 1 Jlg polysomal poly(A)-containing RNA; lane 3, 
5 Jlg nuclear non-poly (A)-containing RNA; lane 4: 5 Jlg polysomal non-poly (A)-containing 
RNA. 
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